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ABSTRACT 
The double-stranded RNA binding domain (dsRBD) is a common motif found 
in proteins involved in RNA processing, localisation or interference. RNA recognition 
by these proteins depends on the secondary structure and not on the sequence. 
Adenosine deaminases that act on RNA (ADARs) are dsRBD-containing 
proteins which modify target adenosines into inosines in double-stranded RNA 
substrates, frequently in vicinity of 5´ splice sites, having a profound impact on the 
subsequent RNA processing events, including RNA splicing and stability. Accurate 
splicing of messenger RNAs coding for the subunit B of the glutamate receptor, for 
example, relies upon ADAR-mediated RNA editing at several positions, including the 
R/G site located in exon 13, just two nucleotides upstream of the exon-intron border. 
The exact macromolecular interaction affected by deamination at this site, however, 
has not been identified. We postulated that inosine in this critical position influences 
U1 snRNA base-pairing to this imperfect 5´ splice site. This hypothesis was tested by 
employing compensatory U1 snRNA mutants. Furthermore, the sequence 
surrounding the edited R/G site strongly resembles a splicing silencer consensus 
bound by splicing repressor proteins, like hnRNP A1 or hnRNP H. Therefore, the 
interaction between R/G site and these proteins was also investigated. 
MicroRNA precursors represent another prominent class of ADAR substrates 
whose processing is substantially altered upon RNA editing, as they become 
sensitive to cleavage by Tudor-SN, a cytoplasmic ribonuclease. Since ADAR1 is a 
dsRNA-binding shuttling protein that interacts with Exportin5, a main export receptor 
for miRNA precursors, a co-immunoprecipitation method was exerted to detect the 
interaction of ADAR1 and edited miRNA precursors in both nucleus and cytoplasm. 
In eukaryotic genomes, short interspersed elements (SINEs) are transposable 
regions mobilised through an RNA intermediate that interacts with dsRBD-containing 
proteins crucial for transcription and translation control. In this part of the study, it is 
being shown that plant SB1 SINE RNA interacts strongly with imperfect dsRNA-
binding protein HYL1, a key factor in the microRNA and trans-acting small interfering 
RNA (tasiRNA) production in plants, but not with perfect dsRNA-specific protein 
DRB4 in vitro. The binding site maps to stem-loop structure highly reminiscent of 
miRNA precursors, suggesting how SINE RNAs could regulate different RNAi 
pathways. 
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ZUSAMMENFASSUNG 
Doppelstrang RNA-bindende Domänen (dsRBDs) sind häufige Motive in 
Proteinen die in RNA Prozessierung, Lokalisierung oder RNA Interferenz involviert 
sind. Für RNA Bindung spielt dabei die Sekundärstruktur der RNA und nicht ihre 
Sequenz die entscheidende Rolle. 
„Adenosine deaminases that act on RNA” (ADARs) sind dsRBD-beinhaltende 
Proteine, deren Aufgabe die Deaminierung von Adenosin zu Inosin in spezifischen 
doppelsträngigen RNA Substraten ist. Die modifizierten Basen befinden sich häufig 
nahe an 5´ Spleißstellen und  haben infolgedessen einen breiten Einfluß auf RNA 
Spleißen und Stabilität. Korrektes Spleißen der mRNA der Untereinheit B des 
Glutamatrezeptors benötigt zum Beispiel RNA Editierung durch ADAR an mehreren 
Stellen, unter anderem auch an der R/G Position in Exon 13, die nur 2 Nukleotide 
von der 5´ Spleißstelle liegt. Der genaue Mechanismus, wie Deaminierung an der 
R/G Position Spleißen beeinflußt, ist jedoch unklar. Wir vermuteten, dass Inosine an 
dieser kritischen Position die Interaktion der 5´ Spleißstelle mit U1 snRNA ändert. 
Diese Hypothese wurde experimentell durch eine kompensierende U1 snRNA 
Mutante getestet. Weiters weist die Umgebung der R/G Stelle Ähnlichkeiten mit 
spleißhemmenden Sequenzen auf, an denen reprimierende Proteine wie hnRNP A1 
und hnRNP H binden. Deswegen wurde auch die Interaktion dieser Faktoren mit der 
R/G Stelle untersucht. 
Die Vorläufer der microRNAs („microRNA precursors“) stellen eine weitere 
bedeutende Klasse von ADAR Substraten dar. Die Prozessierung dieser Vorläufer ist 
ebenfalls stark durch RNA Editierung geändert. Sie werden, zum Beispiel, 
suszeptibel für den Abbau durch die cytoplasmatische Ribonuklease Tudor-SN. Da 
ADAR1 ein dsRNA-bindendes Protein ist, das zwischen Nukleus und Cytoplasma 
wandert und mit Exportin5, dem Hauptexportrezeptor der microRNA Vorläufer 
interagiert, wurden co-immunpräzipitierende Methoden angewandt, um die 
Interaktion von ADAR1 und editierten microRNA Vorläufer sowohl im Nukleus als 
auch im Cytoplasma zu untersuchen. 
In eukaryotischen Genomen findet man „Short Interspersed Elements“ (SINEs) 
als transposable Elemente, die durch ein RNA Intermediat mobilisiert werden. Dieses 
RNA Intermediat interagiert mit dsRBD-beinhaltenden Proteinen, die wichtig für 
Transkription und Translation sind. Diesbezüglich wurde gezeigt, dass pflanzliches 
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SB1 SINE RNA mit dem an partielle doppelsträngige RNA bindenden Protein HYL1, 
jedoch nicht mit DRB4, das für die perfekt doppelsträngige RNA Struktur spezifisch 
ist, in vitro interagiert. HYL1 ist ein wichtiger Faktor der microRNA und tasiRNA 
Produktion in Pflanzen. Die Bindestelle für HYL1 an SINE RNA befindet sich an einer 
„stem-loop“ Struktur, die stark an microRNA Vorläufer erinnert. Dies lässt Schlüsse 
zu, wie SINE RNAs RNAi Wege bestimmen könnten. 
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Part I: ADAR-mediated RNA editing 
1.1 Eukaryotic RNA processing 
Contrary to mRNAs in prokaryotes, whose 5’ ends are already being decoded 
by the ribosomes while their 3’ ends are still being transcribed, the majority of 
eukaryotic RNAs need to undergo extensive modification before they are released 
from the nucleus to the cytoplasm as mature transcripts. 
The eukaryotic pre-mRNA molecule is subjected to three main modifications 
which include 5' capping, 3' polyadenylation, and RNA splicing. 
5´ capping of the pre-mRNA involves the addition of 7-methylguanosine (m7G) 
to the 5' end. First, the terminal 5' phosphate is removed leaving the diphosphate 5' 
end which, in turn, attacks the α phosphorus atom of a GTP molecule in order to add 
the guanosine. The guanine ring gets methylated at the N-7 position to form a cap 
structure. Further methylations may occur at the 2' OH ribose groups of the 
downstream nucleotides, giving rise to more complex cap structures. The cap 
protects the 5' end of the primary RNA transcript from cleavage by 5´ exonucleases. 
The pre-mRNA processing at the 3' end involves cleavage of its 3' end and 
subsequent addition of approximately 200 adenosines to form a poly-A tail. Cleavage 
(5'-CA-3') and polyadenylation (5'- AAUAAA-3') signal sequences direct  the cleavage 
and adenylation reactions. Poly(A) polymerase then adds about 200 adenosine units 
to the new 3' end of the RNA molecule using ATP as a precursor. As the poly(A) tail 
is synthesised, it binds multiple copies of poly(A) binding protein, which protects the 
3' end from ribonuclease digestion. 
RNA splicing as the most remarkable of these alterations can be found in 
almost every eukaryotic pre-mRNA, which contains coding (exons) and non-coding 
(introns) regions. Although every intron is flanked by short sequences showing the 
splicing machinery where to excise the non-coding region, not every splice site is 
efficiently used.  Consequently, mRNAs transcribed from the same gene may vary in 
length and number of their fused exons. Thus, alternative splicing can provide the 
cell with a huge set of different proteins derived from a single gene. In fact, this 
mechanism is presumably one of the most important reasons why there are so many 
different proteins in contrast to the comparably low number of genes, especially in 
mammals. 
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1.2 RNA modification 
Chemical and structural diversity and extent of RNA posttranscriptional 
modification is extraordinary, with over 100 different nucleosides for which chemical 
structures have been assigned presently known in all types of RNA. The largest 
number with the greatest structural diversity are found in tRNA, followed by rRNA, 
mRNA and other RNA species (snRNA). Most modification sites and their positions 
are conserved, but the differences across distant phylogenetic domains are still 
reported. 
The mechanism of pre-rRNA modification raises special interest because it is 
guided by the partially complementary small nucleolar RNAs (snoRNAs). The primary 
rRNA transcript in eukaryotes is 7.5 kb RNA that gets specifically methylated at over 
100 sites in higher vertebrates: 80 % of these modifications are 2´-O-ribose 
methylations, while the rest occurs on either adenine or guanine nitrogenous bases. 
Additionally, up to 100 uridines in human pre-rRNA get converted into 
pseudouridines (Ψ). Both of these processes are directed by snoRNAs. These 100-
200 nucleotides long RNA species contain segments of 10-20 nt precisely 
complementary to conserved regions in rRNA. In the case of rRNA methylation, the 
so-called box C/D snoRNAs act to guide a methylation reaction, mediated by a 
nucleolar protein complex, including fibrillarin as the most prominent member. 
Similarly, the box H/ACA snoRNAs are guiding the pseudouridinylation of numerous 
uridines in eukaryotic rRNAs (Decatur and Fournier, 2003). 
Transfer RNAs contain large proportion, up to 25 %, of the modified 
nucleotides. Nearly 80 different types of modifications or hypermodifications at more 
than 60 different positions in tRNAs have been identified. Hypermodified nucleotides, 
such as i6A (N6-isopentenyladenosine), are usually found adjacent to the 3´ 
nucleotide of the anticodon, when this one is A or U. It is widely accepted that the low 
polarity of such hypermodified bases strengthens the otherwise relatively weak base-
pairing associations of the anticodon´s 3´ base with the codon. Furthermore, some of 
the tRNA modifications form important recognition elements for aminoacyl-tRNA 
synthetases, enzymes responsible for attaching the correct amino acid to a tRNA. 
Even the secondary structure elements in tRNA, like D loop and TΨC loop, are 
named after modified nucleotides dihydrouridine (D) and pseudouridine (Ψ), 
respectively (Bjork et al., 1987). 
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1.3 RNA editing 
RNA editing as a term is used to describe all the molecular processes which 
lead to the change in the information content of an RNA molecule on a single 
nucleotide level with respect to the information encoded in DNA. The process itself 
occurs either by enzymatic modification of nitrogenous bases of nucleotides or by the 
insertion or deletion of short nucleotide stretches. This type of minor 
posttranscriptional RNA modification has been observed in tRNA, rRNA, and mRNA 
molecules of eukaryotes, but not prokaryotes. 
1.3.1 Insertion and deletion RNA editing 
The first reported case of RNA editing was observed in the mitochondria of the 
parasitic kinetoplastid protozoan Trypanosoma brucei (Benne et al., 1986). The 
mechanism proceeds through binding of 50-70 nt trans-acting guide RNAs (gRNAs) 
to the newly transcribed mRNA. This class of small RNAs provides sequence-specific 
information where editing must occur because of the complementarity of its 5´ anchor 
sequence to its cognate mRNA just upstream of the first editing site. On the other 
hand, the central portion of trans-acting gRNA is complementary to the mature edited 
mRNA sequence. These insertions or deletions of the non-genomically encoded 
uridines in the coding regions of the protozoan mitochondrial mRNAs create 
methionine translation initiation codons, correct frameshift mutations or even give rise 
to new open reading frames (Alfonzo et al., 1997; Feagin et al., 1988; Maslov and 
Simpson, 1992). Remarkably, this mechanism has been found to be absolutely 
essential for producing functional proteins. Since this first discovery, many mRNA 
precursors of several kinetoplast protozoa have been found to be edited by insertion 
or, rarely, deletion of uridine residues (Estevez and Simpson, 1999; Gott and 
Emeson, 2000). 
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1.3.2 Ribonucleotide deamination 
As previously described, RNA editing includes both the insertion/deletion of 
nucleotides and the deamination of their nitrogenous bases. The latter type, although 
more recently discovered, is the more widespread type of RNA editing and includes 
the well-characterized conversion of cytidine (C) to uridine (U) and adenosine (A) to 
inosine (I) by hydrolytic deamination of C4 in pyrimidine and C6 in purine rings, 
respectively, as depicted in Figure 1.2.  
 
 
 
Figure 1.2: Cytidine and adenosine deamination 
The reaction mechanism of cytidine and adenosine conversion includes a nucleophilic attack 
of an activated water molecule at the C4 or C6 of the respective rings in an intermediate 
step. Subsequently, an ammonia molecule is released, resulting in a stable uridine or 
inosine, respectively (Gerber and Keller, 2001). 
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1.3.2.1 Cytidine to uridine (C-to-U) RNA editing 
Cytidine deamination in mRNA encoding the mammalian intestinal 
apolipoprotein B (ApoB) was the first observed RNA editing event of the deamination 
type in vertebrates (Chen et al., 1987; Powell et al., 1987). APOBEC1, the enzyme 
responsible for this site-specific alteration belongs to the APOBEC protein family and 
represents the catalytic subunit of the macromolecular complex known as editosome. 
APOBEC1, however, is not capable of carrying out the deamination reaction 
without additional factors. In vitro, a protein complex formed between APOBEC1 and 
an auxiliary protein factor, APOBEC1 complementation factor (ACF), was shown to 
be necessary and sufficient for the ApoB mRNA editing (Mehta et al., 2000). 
ApoB as a component of plasma lipoprotein particles is essential for the 
transport of cholesterol and triglycerides in the plasma. The protein exists in two 
versions in different tissues, each one involved in its distinct lipoprotein metabolism 
pathway (Chan, 1992). In the liver, the pre-mRNA encodes for the full-length protein, 
ApoB-100, which is part of the VLDL complex (Very low density lipoprotein) required 
for the transport of endogenously synthesized cholesterol and triglycerides in the 
blood stream. During lipid turnover, VLDL particles indirectly give rise to LDL particles 
(low density lipoprotein) whose increased plasma level is coupled with higher risk for 
developing atherosclerotic conditions (Herz and Willnow, 1995).  
In small intestine, on the other hand, a shorter version of ApoB, ApoB-48, is 
produced from the same gene locus but with the C-terminal truncation. This protein 
version contributes to synthesis and secretion of chylomicrons, large lipoprotein 
complexes of the intestines. These huge particles cannot be converted into LDL 
particles and, therefore, represent lower risk factor for acquiring cardiovascular 
diseases. ApoB-48 version of the protein arises due to specific deamination of a 
cytidine residue at the position 6666. This change gives rise to the premature stop 
codon (UAA) instead of glutamine codon (CAA) and, thus, results in the synthesis of 
a shorter protein (Chen et al., 1987; Powell et al., 1987).  
The APOBEC family members are also capable of deaminating cytidines in  
single-stranded DNA, this function being of high importance in the regulation 
mechanisms of the vertebrate immune system. Firstly, introduction of C-to-U 
hypermutations in the negative strand of the human immunodeficiency virus (HIV) 
DNA is mediated by the two APOBEC family members: APOBEC3F and APOBEC3G 
Introduction 
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(Harris and Liddament, 2004). Lentiviruses, however, have evolved the Vif gene in 
order to counteract this effect: Vif protein interacts with APOBEC3G and triggers the 
ubiquitination and degradation of APOBEC3G via the proteasomal pathway 
(Donahue et al., 2008; Sheehy et al., 2002). 
Additionally, activation-induced (cytidine) deaminase (AID) is a 24 kDa 
enzyme that also removes the amino group from cytidines in DNA. This enzyme 
exhibits in vitro activity on single-stranded DNA and has been shown to require active 
transcription in order to exert its deaminating activity (Bransteitter et al., 2003). AID is 
currently thought to be the main regulator of secondary antibody diversification. It is 
involved in the initiation of three separate immunoglobulin (Ig) diversification 
processes: somatic hypermutation (SHM), class switch recombination (CSR) and 
gene conversion (GC). During somatic hypermutation, base substitution mutations 
are introduced into the segments coding for the antigen binding region of vertebrate 
immunoglobulin genes. Furthermore, the constant regions of the immunoglobulin 
genes can also be replaced in a process known as class switch recombination.  AID 
is indispensable for both of these processes, but the exact mechanism still remains 
to be elucidated (Harris and Liddament, 2004).  
1.3.2.2 Adenosine to inosine (A-to-I) RNA editing 
 Similar to cytidine deamination, adenosines can be converted into inosines 
(Figure 1.2). In higher organisms, this is the most prevalent type of RNA editing since 
inosines are found in many RNAs, for example in human central nervous system. 
The enzymes responsible for this posttranscriptional modification belong to the family 
of adenosine deaminases. Their substrates are mostly double-stranded RNAs with 
loops and bulges and the mechanism of conversion consists of flipping the target 
adenosine out of the duplex and subjecting it to hydrolytic deamination. The resulting 
inosine does not posses adenosine´s base-pairing ability for uridine in the opposing 
strand, which can lead to destabilisation of the double-stranded structure. 
Thus far, editing events have been found in both coding and non-coding 
regions of protein-coding genes, in viral transcripts, in tRNAs, as well as in miRNAs 
(Athanasiadis et al., 2004; Cattaneo et al., 1988; Levanon et al., 2004; Li et al., 2009; 
Luciano et al., 2004; Morse et al., 2002; Polson et al., 1996). 
 Inosines are often encountered in the first anticodon position (wobble position 
34) in a number of tRNAs in higher eukaryotes and yeast, but also in tRNAArg2 of 
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prokaryotes and chloroplast. This is why it is believed that inosines play an essential 
role in protein synthesis. Their presence at this critical position gives a certain 
amount of flexibility to the otherwise rigid process of codon triplet recognition, 
allowing the formation of alternative base pairs with U, C or A in the third codon 
position (Sprinzl et al., 1998). In addition, N1-methylinosine (m1I37) is found at position 
37 of tRNAAla (A37), adjacent to the anticodon. In this case, adenosine deamination 
occurs first, followed by the methylation of the inosine (Grosjean et al., 1996). 
 The search for the enzyme responsible for this tRNA modification in yeast lead 
to the discovery of an open reading frame highly homologous to the already 
discovered adenosine deaminases in the 3´ region of their translated sequence. 
Indeed, the enzyme termed Tad1p (tRNA specific adenosine deaminase) or 
scADAT1 (Saccharomyces cerevisiae adenosine deaminase that acts on tRNA), was 
demonstrated to specifically target A37 of tRNAAla (Gerber et al., 1998) and was 
subsequently cloned from human (Maas et al., 1999), mouse (Maas et al., 2000) and 
from Drosophila melanogaster (Keegan et al., 2000). Some time after, two additional 
deaminases capable of triggering the conversion of A34 into an inosine have been 
described in yeast: Tad2p/scADAT2 and Tad3p/scADAT3. The two enzymes form a 
catalytically active heterodimer. Contrary to ADAT1, ADAT2 and ADAT3 yeast knock 
out strains are lethal, emphasising the importance of this editing mechanism. In 
contrast to other adenosine deaminases, ADATs do not contain an RNA binding 
motif, indicating that the deaminase domain directly recognises its substrate (Gerber 
and Keller, 1999; Gerber and Keller, 2001; Keegan et al., 2001). 
Another, more complex subfamily of adenosine deaminases, adenosine 
deaminases that act on RNA (ADARs), is thought to have evolved from the ADAT 
subfamily through the acquisition of double-stranded RNA-binding domains 
(dsRBDs) and slight alterations of the primary structure in the catalytic (deaminase) 
domain. Various aspects of ADAR function and activity are dealt with in this work and 
will be thoroughly explained in the following sections. 
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1.4 ADARs (adenosine deaminases that act on RNA) 
1.4.1 First reports on ADARs 
Changes in the structure of double-stranded RNAs formed between 
endogenous mRNAs and complementary antisense RNAs injected into Xenopus 
laevis oocytes were simultaneously observed by two research groups in 1987. The 
RNAs in question were also exhibiting altered mobility shifts on native RNA gels and 
an increased sensitivity to single-stranded RNA-specific RNAses (Bass and 
Weintraub, 1987; Rebagliati and Melton, 1987). The observed unwinding activity 
present in oocytes precluded the silencing of target mRNAs. Later on, it was reported 
that the failure to rehybridise is caused by the irreversible conversion of many 
adenosines into inosines. As a result, A-U base pairs are converted into I-U 
mismatches, leading to the destabilisation and the “unwinding” behaviour of the RNA 
duplex (Bass and Weintraub, 1988; Polson et al., 1991; Wagner et al., 1989). 
The enzyme responsible for this covalent modification was first identified in 
frogs (Hough and Bass, 1994) and shortly after in mammals (Kim et al., 1994a; 
O'Connell and Keller, 1994). 
Since the same RNA modifying activity was identified in two different 
laboratories, two names for the same enzyme, dsRAD (dsRNA adenosine 
deaminase) and DRADA (dsRNA adenosine deaminase), were published. Shortly 
after, a second enzyme with similar capacity to covalently modify adenosines to 
inosines in the dsRNA was identified, namely RED 1 (dsRNA specific editase 1) 
(Melcher et al., 1996). In order to avoid the confusion in the nomenclature system for 
the newly discovered enzyme family, a conclusion was reached to use ADAR1 and 
ADAR2 as the standardised  names for the proteins formerly known as 
dsRAD/DRADA and RED1, respectively (Bass, 1997).   
 Since then, ADARs have been found in animals only, but in organisms as 
evolutionarily divergent as Caenorhabditis elegans and Homo sapiens and have 
been shown to be essential for their development. 
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1.4.2 Members of the ADAR family 
As previously mentioned, ADARs are proteins specific for the animal kingdom, 
with one family member encoded in Drosophila melanogaster genome, two in 
Caenorhabditis elegans and three members found in mammals (Figure 1.3). 
 
Figure 1.3: ADAR family of enzymes 
Three human ADAR family members (ADAR1–3), D. melanogaster (Dm) ADAR and two C. 
elegans (Ce) proteins, ADAR-1 and ADAR-2, share common functional domains like dsRBDs 
and C-terminal deaminase domain (Nishikura, 2006). 
A single ADAR gene of the fruitfly is strongly expressed in the central nervous 
system of embryos and  the brains of adult insects (Ma et al., 2001; Palladino et al., 
2000b). The protein, termed dADAR, consists of two dsRBDs and C-terminal catalytic 
deaminase domain. It forms dimers on its substrates and the dimerisation occurs 
through contacts between N-terminus and the first dsRBD (Gallo et al., 2003). Almost 
all of its targets localise to the nervous system and comprise voltage- and ligand-
gated ion channels, as well as the members of the synaptic release complex 
(Hoopengardner et al., 2003). Another curious feature of this enzyme is the negative 
auto-regulation mechanism it employs: its own mRNA serves it as a substrate, where 
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a specific site in the deaminase domain is edited, leading to the synthesis of the 
protein isoform with the reduced deamination activity (Keegan et al., 2005; Palladino 
et al., 2000a). 
In C. elegans, two ADAR proteins are found. Adr1 has two dsRBDs and a 
functional catalytic domain, while Adr2 has a single dsRBD, with inactive deaminase 
domain due to absence of the conserved glutamate (Glu) residue required for its 
enzymatic activity (Hough et al., 1999; Tonkin et al., 2002). Similar to D. 
melanogaster, identified substrates are important for the functionality of the nervous 
system (Morse et al., 2002). 
In mammals, there are three proteins that belong to the ADAR family: ADAR1, 
ADAR2 and ADAR3. 
Two isoforms of ADAR1 are found in humans, because the ADAR1 gene locus 
has two distinct promoter sequences, a constitutive and an interferon-inducible one, 
which leads to the synthesis of two proteins differing in their N-termini. The shorter 
form, giving rise to a 110 kDa protein and transcribed from the constitutive promoter, 
is termed ADAR1-c. This isoform is lacking the translation product of the exon 1, 
because methionine at position 296 is used as a start codon (George and Samuel, 
1999; Patterson and Samuel, 1995). In contrast, the longer interferon-inducible 
variant, named ADAR1-i, starts at methionine 1 and predominantly localises to the 
cytoplasm where the 150 kDa protein is implicated in viral RNA editing (Wong et al., 
2003). Additionally, novel alternatively spliced versions of ADAR1 have been 
detected (Liu et al., 1997), indicating the importance of ADAR1 regulation on the 
transcriptional level, as well. ADAR1-i, but not ADAR1-c, has the N-terminal Z-DNA 
binding domain composed of the Zα and Zβ moieties. This domain is thought to play 
a role in guiding ADAR1-i to the active transcription sites where, due to unwinding, 
the DNA adopts a Z-like helical conformation (Herbert and Rich, 2001). The central 
part of the proteins comprises three dsRBDs, while the catalytic deaminase domain 
can be found at the C-terminus. 
ADAR2, on the other hand, is a much shorter protein of  80 kDa, but it exhibits 
high level of structural similarity to ADAR1. This comes as no surprise knowing that 
the protein has 31% sequence identity to ADAR1 with the deaminase domain being 
the most conserved one (Melcher et al., 1996). Importantly, ADAR2 contains two 
instead of three dsRBDs and has no Z-DNA binding domains (ZBDs). While ADAR1 
is expressed ubiquitously, explaining the observation that inosines can be found in 
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most tissues, ADAR2 is predominantly expressed in the brain, which correlates with 
the highest abundance of inosines in the brain (Paul and Bass, 1998). 
The most recently discovered member of the human ADAR family, 81 kDa 
ADAR3 shows an exclusive brain expression pattern, particularly in the amygdala 
and the thalamus (Mittaz et al., 1997). Its sequence is 50 % identical to ADAR2, with 
two dsRBDs and a conserved deaminase domain. Interestingly, an additional N-
terminal arginine-lysine-rich sequence (R-domain) of ADAR3 has been identified as a 
single-stranded RNA binding domain (Chen et al., 2000). However, the enzyme is 
believed to lack any catalytic activity, firstly because no substrate of ADAR3 has 
been identified so far and, secondly, because it is unable to edit any of the known 
ADAR1 or ADAR2 substrates. Even though it is not capable of performing the 
catalysis, ADAR3 could bind potential substrates of ADAR1 and ADAR2 and, thus, 
might serve as a negative regulator of the two enzymatically active deaminases 
(Chen et al., 2000). 
Additional ADAR-like gene in vertebrates, TENR, is expressed in the male 
germline and has only one dsRBD (Hough and Bass, 1997). TENR is missing a key 
glutamate residue in the active site of the deaminase domain and also lacks zinc-
chelating residues. The protein itself, however, has not yet been characterized 
(Keegan et al., 2004). 
1.4.3 Domain architecture of ADARs 
 All proteins belonging to either ADAR or ADAT family contain a conserved 
catalytic deaminase domain in their C-terminus, but show great variation in their 
central and aminoterminal regions. 
The deaminase domain bears high homology to the catalytic centres of DNA 
methyltransferases and cytidine deaminases that act on RNA (CDARs) (Hough and 
Bass, 1997; Kim et al., 1994b). It is composed of characteristic sequence motifs 
required for the catalysis of hydrolytic deamination. One of them includes highly 
conserved glutamate residue and is believed to mediate the proton transfer during 
catalysis. Additionally, conserved histidine and cysteine residues are indispensable 
for the complexation of a zinc ion, thereby constructing the active site of the enzyme. 
Similar to most metalloenzymes, a water molecule is activated by the zinc ion, 
enabling its oxygen atom to nucleophilically attack C6 atom of the adenosine´s purine 
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ring (Lai et al., 1995). The affected adenosine is flipped out of the RNA helix due to 
spatial reasons during the editing reaction (Stephens et al., 2000). Interestingly, the 
dsRBDs of ADARs might facilitate this conformational change through enhancement  
of the RNA duplex flexibility (Yi-Brunozzi et al., 2001). 
In addition to the deaminase domain, only the interferon-inducible isoform of 
ADAR1 (ADAR1-i) harbours two Z-DNA binding domains (Z and Z) in its N-
terminus. Structural analyses have shown that each domain builds up a helix-loop-
helix structure similar to the one found in DNA-binding proteins, and can bind left-
handed, supercoiled DNA Z-helix in vitro (Herbert et al., 1997; Schade et al., 1999; 
Schwartz et al., 1999). Although this type of DNA double helix has not been identified 
in vivo yet, it is speculated that the progressing RNA polymerases might leave such 
an unusual structure behind while performing transcription, which led to the 
proposition that the ZBDs direct ADAR1-i to the transcriptionally active sites (Herbert 
et al., 1997). For Xenopus laevis ADAR1, in contrast, it has been demonstrated that 
the ZBDs are dispensable for chromosomal localization (Eckmann and Jantsch, 
1999). Furthermore, there are hypotheses suggesting the importance of ZBDs for 
viral dsRNA binding in the cytoplasm, required for hyperediting in the antiviral 
response (Brown et al., 2000; Herbert et al., 1997). 
While ADAR1 contains three double-stranded RNA-binding domains (dsRBDs) 
in its central region, only two dsRBDs can be found in ADAR 2 and ADAR 3. They 
are involved in the substrate recognition and binding, but also serve as modulators of 
the intracellular trafficking of ADAR1 (Fritz et al., 2009; Strehblow et al., 2002). 
1.4.4 Substrate recognition by ADARs and the mechanism of 
adenosine deamination 
Although certain sequence contexts serve as preferred sites for ADAR binding 
and editing, substrate specificity of ADARs is mainly a matter of RNA structure, and 
not its sequence. Currently, it is poorly understood how the enzyme discriminates 
between adenosines that have to be converted into inosines and those that are not 
altered. Albeit, a longer double-stranded RNA helix interrupted by mismatches, 
bulges and loops represents an ideal ADAR-binding platform (Bass, 2002). However, 
there is evidence that the substrate recognition and catalysis by ADARs could involve 
the base that opposes the edited adenosine. In this case, adenosines in A:C 
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mismatches were edited at much higher rate by both ADAR1 and ADAR2 when 
compared to A:A or A:G mismatches, or even A:U base pairs at the same location 
within dsRNA (Wong et al., 2001). Also, the reports on 5´ nearest neighbour 
preference have been published (Dawson et al., 2004; Riedmann et al., 2008). 
The exchange of the deaminase domains between ADAR1 and ADAR2 
resulted in the substrate specificity typical for the enzyme whose deaminase domain 
was part of the protein chimaera (Wong et al., 2001). However, studies on chimaeric 
proteins containing two dsRBDs of the RNA-dependent protein kinase (PKR) 
combined with the ADAR1 deaminase domain revealed the importance of ADAR 
dsRBDs in the substrate recognition, as well (Liu et al., 2000). 
To give further insight into how the substrate specificity is achieved, an NMR 
chemical shift perturbation study was performed using the two dsRBDs of rat ADAR2 
and the GluR-B R/G site stem-loop as a substrate. The protein and the RNA surfaces 
involved in the complex formation were identified, with dsRBD1 found to recognize 
the conserved terminal pentaloop and dsRBD2 found to interact with two bulged 
nucleotides adjacent to the R/G editing site. It is, therefore, evident that different 
dsRBDs from the same protein can act cooperatively in order to achieve a productive 
recognition of the cognate substrate (Stefl et al., 2006). 
In order to clarify the exact reaction mechanism by which the adenosine 
deamination proceeds, crystal structure of the human ADAR2 catalytic domain was 
solved. The active site is defined by a zinc ion that coordinates a water molecule 
responsible for the ammonia displacement during the deamination reaction, with the 
coordination of the zinc ion appearing essentially identical to the geometry seen at 
the catalytic centers of cytidine deaminase and TadA, a member of the ADAT2 
family. The site of nucleophilic attack during the ADAR reaction (C6 of adenine) is 
buried in the major groove of the dsRNA. Due to its inaccessibility, ADARs are 
thought to employ a base-flipping mechanism to bend the target adenosine out of the 
dsRNA A-helix. Consistently, the catalytic zinc centre is located in a deep pocket 
surrounded by the positively charged residues, making it an ideal binding surface for 
the negatively charged dsRNA. Additionally, catalytic activity of ADAR2 depends on 
the incorporation of inositol hexakisphosphate (IP6) within the protein core. This 
polyphosphate is considered crucial for the protein-folding stabilization, but it could 
also be involved in the modulation of ADAR2 enzymatic activity (Macbeth et al., 
2005). 
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1.4.5 ADAR substrates 
ADARs in higher vertebrates have thus far been found to target three main 
types of substrates. Firstly, in mammals, as well as in flies and worms, ADAR-
mediated RNA editing regulates important functional properties of neurotransmitter 
receptors in the central nervous system (Maas et al., 2006). Furthermore, another 
important role for ADARs in mammals is thought to be editing and hyperediting of 
viral dsRNA as a defense mechanism against infections. Finally, in recent years the 
effects of adenosine deamination in the non-coding substrates, most notably the 
microRNA precursors, emerged as a significant regulatory mechanism in RNA 
interference (Ohman, 2007). 
1.4.5.1 ADAR editing in the central nervous system 
The most prominent and best described targets of ADARs in the central 
nervous system are the pre-mRNAs encoding subunits of the glutamate receptor, the 
serotonin 2C receptor in mammals or the potassium channel in squids (Burns et al., 
1997; Lehmann and Bass, 2000; Melcher et al., 1996; Patton et al., 1997). 
L-glutamate is the major excitatory neurotransmitter in the vertebrate central 
nervous system. There it serves the glutamate-gated ion channels in mediating rapid 
excitatory transmission and synaptic plasticity (Greger and Esteban, 2007). 
Structurally, glutamate-gated ion channels represent heterotetrameric cation 
channels which can be divided into three main subtypes: AMPA (α-amino-3-hydroxy-
5-methyl-4-isoxasolepropionic acid) receptors, NMDA (N-methyl-D-aspartate) 
receptors and kainate receptors, all concentrated at postsynaptic sites. Being largely 
Ca2+-impermeable and displaying extraordinarily fast kinetics, AMPA receptors are 
responsible for the primary depolarization in glutamate-mediated neurotransmission. 
Their functional properties mostly depend on the subunit composition and the 
modifications introduced through RNA splicing and RNA editing. They assemble from 
four subunits, termed GluR1-GluR4 or, alternatively, GluR-A – GluR-D. ADAR-
mediated editing occurs at multiple sites in the GluR-B subunit pre-mRNA (Seeburg 
et al., 1998). 
The editing site in exon 11 of the GluR-B pre-mRNA has been shown to be 
essential. Here, RNA editing leads to conversion of a glutamine (Q) codon (CAG) into 
an arginine (R) codon (CGG) with 99.9 % efficiency. The converted residue is found 
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in the second transmembrane domain, known to take part in the receptor´s central 
channel formation. The amino acid composition of the entire pore region is, of 
course, crucial for the ion transport efficiency, with the assembly of Q/R site-edited 
subunits into the receptor significantly lowering the channel´s Ca2+ permeability 
(Sommer et al., 1991). This arginine residue has also been shown to decrease the 
rate of the receptor assembly and its transport to the synaptic membranes in cultured 
hippocampal neurons (Greger et al., 2003; Greger et al., 2002). In this case, the 
editing is performed by ADAR2 and the binding platform for the enzyme is formed 
between the exon 11 and the editing complementary sequence (ECS) located in the 
downstream intron (Higuchi et al., 1993; Melcher et al., 1996). 
The second recoding editing site in GluR-B pre-mRNA is the R/G site, with 
adenosine deamination occurring  at up to 80 % efficiency in three out of four AMPA 
receptor subunits (GluR-B, -C and –D). It is located in exon 13, at position -2 with 
respect to the 5´ splice site of intron 13. In this case, an arginine (R) codon (AGA) is 
turned into a glycine (G) codon (GGA). This site exhibits varying editing levels during 
development and its physiological role is to increase recovery rates from 
desensitization (Lomeli et al., 1994). 
Editing at both Q/R and R/G site is having a crucial influence on splicing of 
GluR-B pre-mRNA. Reduced editing levels at Q/R site cause aberrant retention of 
the downstream intron 11 (Higuchi et al., 2000; Schoft et al., 2007). On the other 
hand, R/G site is situated only one nucleotide upstream of the intron 13 5´ splice site. 
Editing at this position leads to a retardation in the removal of the adjacent intron, 
thereby stimulating the correct alternative splicing decisions in the downstream 
regions of the transcript (Schoft et al., 2007). 
Serotonin (5-hydroxytryptamine) is a neurotransmitter important for neuronal 
functions such as sleep regulation, appetite or pain. The molecule interacts with a 
large family of receptors and triggers signaling that is crucial for proper 
neurotransmission. Indeed, binding of serotonin to its transmembrane receptor is 
involved in several physiological and behavioral processes such as production of 
cerebrospinal fluid and regulation of feeding behavior (Maas and Rich, 2000). The 
human 5-hydroxytryptamine receptor of subtype 2C (5-HT2CR) is ubiquitously 
distributed throughout the central nervous system and is believed to regulate mood, 
appetite and sexual behavior (Molineaux et al., 1989). Functionally, it belongs to the 
class of G-protein-coupled receptors which are linked to the activation of 
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phospholipase C, an enzyme that triggers synthesis of secondary messengers 
(Hoyer et al., 1994). 
Editing in this primary transcript takes place at five different positions in exon 
5, namely editing sites A,B,C,D and E.  All modified adenosines are situated within 
the pre-mRNA segment encoding the second intracellular loop of 5-HT2CR, a 
receptor domain important for G-protein coupling (Niswender et al., 1998). While 
editing at sites A and B is accomplished by ADAR1, sites C,D and E are deaminated 
by ADAR2 (Wang et al., 2000). 
Interestingly, in rat at least seven and in humans twelve different isoforms of 
the 2C subtype of serotonin receptor (5-HT2CR) have been found resulting from 
alternative editing at five different sites by ADARs. The receptor isoform whose pre-
mRNA is edited at all five sites carries amino acid substitutions at positions 156, 158 
and 160, where the genomic DNA-encoded isoleucine, asparagine and isoleucine 
(I,N and I) are converted into valine, glycine and valine (V,G and V), respectively. 
Strikingly, the resulting amino acid substitutions result in decreased G-protein 
coupling and less efficient triggering of the phospholipase C signaling cascade. The 
ligand affinity is also affected, with the unedited version exhibiting the highest  and 
the fully edited version the lowest affinity for the neurotransmitter, while partially 
edited isoforms show intermediate affinity (Burns et al., 1997; Flomen et al., 2004; 
Niswender et al., 1998). Mutant mice with the knocked-in pre-edited (VGV) receptor 
version were showing elevated energy expenditure and loss of fat mass due to 
constitutive activation of the sympathetic nervous system (Kawahara et al., 2008).  
Recently, a third notable target of ADAR editing in the central nervous system 
was reported in mouse, namely the gamma-aminobutyric acid (GABA) type A 
(GABAA) receptor subunit α3 (Gabra-3) pre-mRNA. This receptor is the member of 
the Cys-loop ligand-gated ion channel superfamily and conducts chloride (Cl-) ions 
upon GABA-mediated activation. The modified adenosine is found in exon 9 within a 
short stem-loop structure, opposing the cytidine residue, and leads to I/M (isoleucine 
to methionine) amino acid substitution in the transmembrane (TM) domain 3 in the 
subunit α3 of the five-subunit GABAA receptor. Both ADAR1 and ADAR2 can mediate 
this developmentally regulated adenosine deamination: 50 % of transcripts are edited 
in newborn mice at day 2, while those in adult mouse brain are edited to almost 100 
% (Ohlson et al., 2007). 
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1.4.5.2 Editing of viral dsRNA 
The full-length isoform of ADAR1, ADAR1-i, is transcribed from a promoter 
region containing an interferon-stimulated response element (ISRE) (George and 
Samuel, 1999). Like most genes whose activation is triggered through interferon 
signaling, it has been implicated in the cellular antiviral defense mechanism. 
Interferon synthesis is induced by dsRNA, a byproduct of the replication cycles of 
many RNA viruses and serves as the first line in combating viral infections in 
mammals (Sen, 2001). 
The alterations in cDNA sequences consistent with the ADAR enzymatic 
activity have been reported for many viruses. The editing of viral RNAs occurs 
promiscuously in almost every case examined, with up to 50 % of all adenosines 
modified. 
Such hypermutation is seen in viral RNA isolates of host cells invaded by 
parainfluenza virus, respiratory syncytial virus and vesicular stomatitis virus (Bass, 
2002). Pre-mRNA encoding the matrix protein of the measles virus, crucial in viral 
budding, is also found nonselectively deaminated at adenosine residues. This 
prevents the progression of the lytic cycle and forces the virus to remain in the 
persistent infection state (Sheppard et al., 1985). All of the above mentioned 
pathogens belong to the group of paramyxoviruses whose non-segmented RNA 
genome requires an RNA-dependent RNA polymerase for the transcription into an 
mRNA. Another similarity among them is the exclusively cytoplasmic replication 
cycle, leading the scientists to believe that there is a cytoplasmic endonuclease 
targeting only hyperedited dsRNAs. Indeed, such an enzyme, Tudor staphylococcal 
nuclease (Tudor-SN), has been discovered and the experiments have revealed its 
specificity for the highly edited dsRNAs comprising alternating I-U and U-I weak 
basepairing partners, leaving the moderately deaminated dsRNAs intact (Scadden, 
2005; Scadden and Smith, 2001b). 
A limited number of viruses, however, have already evolved different 
mechanisms to take advantage of the ADAR-mediated RNA editing. During the late 
stage infection with the polyoma virus, for example, newly synthesized transcripts 
form double-stranded regions with the complementary early mRNAs, leading to the 
hyperediting of the latter. While the hyperedited early transcripts become export-
incompetent, the late ones reach the cytoplasm and give rise to proteins fundamental 
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for the transition from early to late stage infection (Bass, 2002). In the nucleus, such 
hypermutated RNAs, like the polyoma virus early transcripts, are anchored to the 
nuclear matrix by the inosine-rich RNA-binding protein p54nrb, which forms a complex 
with the splicing factor PSF and the inner nucler matrix protein matrin 3, thereby 
preventing the nuclear exit of the promiscuously edited messages and, subsequently, 
their translation to the non-functional proteins (Zhang and Carmichael, 2001). 
There are also selective editing events described for viral RNAs, like in 
hepatitis delta virus (HDV), a subviral human pathogen that requires hepatitis B virus 
(HBV) for packaging. Its genome encodes a single open reading frame, giving rise to 
hepatitis delta antigen (HDAg). Due to ADAR-mediated RNA editing, this protein 
occurs in two forms. The shorter form is expressed constitutively, while the 
adenosine deamination within the amber (UAG) stop codon gives rise to tryptophane 
(UGG) codon in so-called amber/W site, resulting in the extension of the open 
reading frame by additional 19 amino acids (Polson et al., 1996). The shorter protein 
(HDAg-S) plays a role in the viral genome replication, while the longer isoform 
(HDAg-L) leads to the replication inhibition and promotes the assembly of new viral 
particles (Ryu et al., 1992). 
Recently, ADAR1 was shown to stimulate human immunodeficiency virus type 
1 (HIV-1) replication by using both editing-dependent and editing-independent 
mechanisms. Over-expression of ADAR1 in HIV-1 producer cells increases viral 
protein accumulation  in an editing-independent manner. Additionally, ADAR1 also 
associates with HIV-1 RNAs and edits adenosines in the 5' untranslated region (UTR) 
and the Rev and Tat coding sequences. It is believed that, just like polyoma virus and 
HDV, HIV-1 has adapted in a way to make use of specific RNA editing activity of the 
host cell (Doria et al., 2009). 
1.4.5.3 Non-coding ADAR substrates 
Recent developments in the field of RNA editing indicate that mRNA recoding 
at specific sites is not the principal function of RNA editing. Extensive bioinformatics 
screening for novel ADAR substrates revealed a completely new set of putative 
ADAR targets in Alu elements and among microRNA precursors (Athanasiadis et al., 
2004; Blow et al., 2006; Levanon et al., 2004; Li et al., 2009). 
Alu elements are found at approximately 1.4 million copies in the human 
genome and comprise just over 10 % of the entire genome content. These 300 bp 
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retrotransposon sequences contain inverted repeats that can fold into double-
stranded RNAs upon transcription, making them an ideal ADAR target (Athanasiadis 
et al., 2004; Levanon et al., 2004; Morse et al., 2002). When a closer look was taken 
on the nature of the newly emerged ADAR substrates, it was determined that 90 % of 
them resides in one of the members of Alu family. These editing events can cause 
creation or elimination of splicing signatures and affect the alternative splicing of Alu-
derived exons (Athanasiadis et al., 2004; Lev-Maor et al., 2007; Levanon et al., 
2004), but can also serve as a global regulatory mechanism in controlling RNA 
stability, splicing or translation (Nishikura, 2004). 
Another new class of non-coding RNAs crucial in the regulation of gene 
expression was shown to be targeted by adenosine deamination, namely the 
microRNA precursors. In the first report on the topic it has been demonstrated that 
the precursor of microRNA-22 (miRNA-22) forms an 85 nucleotide stem-loop that can 
be bound and edited at up to six sites by ADAR1 and ADAR2 in mammals (Luciano 
et al., 2004). At the time, it was poorly understood what the purpose of miRNA editing 
was, but over the years it became clear that such posttranscriptional modification has 
a profound influence on fate of both microRNAs and their targets. Second reported 
editing target among microRNA precursors was miR-142 that was exhibiting loss of 
function after RNA editing, because the cropping of inosine-containing primary 
transcripts into pre-miRNA-142 by the Drosha-DGCR8 complex was inhibited. 
Moreover, highly edited primary miR-142 transcripts, unlike unedited ones, were 
cleaved in vitro by Tudor-SN, a cytoplasmic endonuclease, specific for dsRNAs with 
high inosine content and a component of the RISC complex (Yang et al., 2006). 
Furthermore, in the study on miR-151 editing, it was reported that the inosine content 
was increasingly higher in pre-miRNA-151 and mature miRNA-151 in several mouse 
tissues (Kawahara et al., 2007a). Here, Dicer-TRBP processing of pre-miR-151 is 
affected when structure-destabilising inosines are present. Finally, miRNA editing 
can lead to the redirection of mature miRNA to a different mRNA target, like in the 
case of mature miR-376 where the editing site is found within the seed region crucial 
for initial interaction steps with the complementary sequence in cognate mRNA 
(Kawahara et al., 2007b). 
As soon as the first reports on miRNA precursor editing were published, the 
prospect of ADARs accompanying miRNA precursors through nuclear pores out to 
the cytoplasm began to emerge, mainly because it was not clarified how the edited 
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primary miRNA transcripts, thought to be export-incompetent, reach the cytoplasm 
for degradation. ADAR1p150, for example,  is an interferon-inducible shuttling protein 
known for its role in antiviral response through cytoplasmic RNA editing of various 
pathogens. This full-length isoform of ADAR1, however, is expressed at steady-state 
levels even in cells and tissues that have never been infected (Patterson and 
Samuel, 1995). Therefore, it is plausible that this fraction of ADAR1p150 could 
accompany editing targets among miRNA precursors to the cytoplasm. Furthermore, 
being a dsRBD protein, ADAR1p150 could exploit miRNA precursor as an RNA 
bridge in the formation of export-competent ternary complex with Exportin-5. 
Exportin-5 is the karyopherin identified as an export receptor for pre-miRNAs, as well 
as for other small structured RNAs like viral minihelix RNAs or tRNAs (Calado et al., 
2002; Gwizdek et al., 2003; Lund et al., 2004; Yi et al., 2003). This importin-β family 
member has first been identified as a nuclear export factor for ILF3, dsRBD-
containing protein (Brownawell and Macara, 2002). Later on, it was shown to mediate 
RNA-dependent export of a number of dsRBD proteins, like JAZ, Staufen-2 or eEF1A 
(Calado et al., 2002; Chen et al., 2004; Macchi et al., 2004). Remarkably, dsRBDs of 
cargo proteins are in most cases indispensable for the interaction with Exportin-5. In 
addition, this interaction is thought to be mediated, or at least strengthened, through 
an RNA bridge (Gwizdek et al., 2004). 
Exportin-5 was also shown to interact with dsRBDs of ADAR1 and interfere 
with its nuclear import via Transportin-1, implying its role in ADAR1 
nucleocytoplasmic distribution (Fritz et al., 2009; Poulsen et al., 2001; Strehblow et 
al., 2002). Together with the role of Exportin-5 in pre-miRNA nuclear export and 
ADAR1-mediated editing of miRNA precursors, this prompted us to address the 
question of ADAR1 association with miRNA precursors in both nucleus and 
cytoplasm and, possibly, their nuclear co-export in the second part of this thesis. 
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1.4.6 Biological importance of ADARs 
ADARs have been identified in all metazoan species, including C. elegans, D.  
melanogaster, X. laevis and humans (Bass, 1997). The biological relevance of the 
enzymes was investigated by generating knock-out animals in several species. 
Although the invertebrate species remain viable upon ADAR deletion, they exhibit 
severe phenotypes. ADAR elimination in mammals, on the other hand, results in 
lethality, proving the adenosine deamination to be essential for normal mammalian 
development. Altogether, it can be concluded that during the course of evolution the 
role of ADAR-mediated RNA editing became increasingly important, providing  higher 
vertebrates with yet another sophisticated mode of posttranscriptional gene 
regulation. 
Despite their viability, both adr-1 and adr-2 knock-outs in C. elegans have 
difficulties detecting and tracking chemoattractants, a phenotype described as 
aberrant chemotaxis (Tonkin et al., 2002). Strikingly, this phenotype could be partially 
rescued when animals deficient in one of the adr genes were crossed with the strains 
mutated in one of the genes responsible for the effective RNAi response. These 
findings, together with reports on low Dicer cleavage efficiency of hyperedited 
dsRNAs in vitro, have provoked a setting of a theory according to which RNA editing 
and RNAi act as two antagonistic processes (Scadden and Smith, 2001a; Tonkin and 
Bass, 2003). 
A-to-I RNA editing has also been reported for several D. melanogaster ion 
channel gene transcripts. The deletion mutants of the responsible enzyme, dADAR, 
that lack deamination activity in extracts lack all known site-specific RNA editing (25 
sites in three ion channel transcripts). Although D. melanogaster larvae homozygous 
for the deletion in their adar locus have no phenotypical changes, adults lacking 
dADAR show no morphological abnormalities, but exhibit extreme behavioural 
deficits including temperature-sensitive paralysis, locomotor uncoordination and 
tremors and, finally, changes in grooming and mating behaviour. Neurodegeneration, 
affecting particularly the retina and causing ubiquitous brain lesions, accompanies 
the increase in phenotypic severity. This study provided clear evidence that pre-
mRNA editing in D. melanogaster alters the nervous system targets to affect adult 
nervous system function, integrity, and behaviour (Palladino et al., 2000b). 
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In contrast to severe but viable phenotypes of invertebrate ADAR knock-outs, 
such deletions in mammals have been shown to be lethal. In the case of ADAR1 
locus deletion, heterozigosity lead to birth of apparently completely healthy mice. 
Homozygous deletants, on the other hand, die between days 11.5 and 12.5. Death 
occurs because of the halted developmental processes, distorted fetal liver structure 
and widespread programmed cell death in tissues including heart and vertebra. The 
apoptotic events, however, are most severely expressed in both hepatocyte and 
haematopoietic cell lineages of the fetal liver (Hartner et al., 2004; Wang et al., 
2004a; Wang et al., 2000). 
Recently, experiments with the inducible gene disruption in mice have shown 
that ADAR1 is not only essential for the maintenance of both fetal liver and adult 
bone marrow haematopoietic stem cells, but it can also act as a crucial suppressor of 
interferon signaling and, thus, protect cells from the deleterious consequences of the 
activation of interferon-stimulated pathways. The latter role of ADAR1 is attributed to 
the editing of as yet unidentified transcripts involved in the interferon-induced cellular 
response (Hartner et al., 2009). 
Point mutations in locus coding for ADAR1 are associated with 
dyschromatosis symmetrica hereditaria (DSH), a disease that leads to altered 
pigmentation pattern of the skin on hands and feet. Patients display only a mild 
heterozygous dominant phenotype, with their mental and physical condition 
seemingly unaffected by the mutation (Miyamura et al., 2003). 
Similar to ADAR1 mutants, mice heterozygous for the ADAR2 
deletion/disruption are viable and appear normal. Their homozygous mutant 
counterparts, however, die not long after birth, between postnatal days 0 and 20, 
exhibiting severe neurological symptoms, among them frequent epileptic seizures. 
This phenotype is a consequence of underediting at exclusively ADAR2-targeted Q/R 
site of the GluR-B pre-mRNA, giving rise to incorrectly spliced mRNA and, 
subsequently, receptors with increased Ca2+ permeability in hippocampal neurons, 
leading to hippocampal neurodegeneration. Interestingly, the viability and completely 
normal phenotype are reverted once both alleles for this underedited transcript get 
substituted with the genomically pre-edited ones, i.e. where target adenosine is 
mutated to guanosine. This observation defines the glutamate receptor subunit B 
pre-mRNA as the most important, if not the only essential, ADAR2 target in vivo 
(Higuchi et al., 2000). 
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ADAR2 dysfunction in humans has been implicated in couple of serious 
conditions, most of them unsurprisingly accompanied by neurological and psychiatric 
symptoms, considering that ADAR2 expression is highest in the brain where most of 
its substrates reside. Amyotropic lateral sclerosis (ALS), for example, is an illness 
characterized by the degeneration of motor neurons, leading to the muscular atrophy 
and respiratory failure. Impaired ADAR2 activity has been implicated in ALS because 
the editing at Q/R site of GluR-B pre-mRNA is incomplete in 56 % of ALS patients 
and the corresponding symptoms can be attributed to glutamate excitotoxicity and 
the excessive Ca2+ influx (Kawahara et al., 2004; Kwak and Kawahara, 2005). 
5-HT2C receptor pre-mRNA, on the other hand, is edited at five positions and, 
considering the role that serotonin plays in the central nervous system, it is believed 
that reduced or disrupted ADAR activity could play a role in psychiatric disorders like 
depression or schizophrenia. In comparison with healthy individuals, the 5-HT2C 
receptor pre-mRNA editing pattern is significantly changed in suicide victims with 
documented chronic major depression. These patients had overedited E and C sites 
and underedited D site when compared to samples of individuals without similar 
condition. Since all of the affected sites are ADAR2 targets, altered function of this 
protein seems to be a likely cause of the symptoms. Moreover, studies on mice have 
shown that the treatment with the antidepressant fluoxetine leads to exactly reverse 
changes in editing frequency at E, C and D sites when compared to the suicide 
victims, implying one of the possible mechanisms of action for this type of medication 
(Gurevich et al., 2002). 
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1.5 RNA splicing 
One of the main features of the protein-coding primary transcripts in higher 
eukaryotes is the existence of multiple non-coding intervening sequences known as 
introns. These long stretches of nucleotides interrupt the expressed sequences, 
named exons, and need to be precisely removed in order to obtain fully mature, 
export- and translation-competent message in a process called RNA splicing. All of 
the reactions leading to intron removal and exon fusion take place in a spliceosome, 
a macromolecular assembly characterized by a highly dynamic network of RNA-
protein and RNA-RNA interactions. The essential components of the spliceosome 
include five small RNAs – U1, U2, U4, U5 and U6 small nuclear RNAs (snRNAs), all 
of them in RNA-protein complexes known as snRNPs, small nuclear 
ribonucleoprotein particle. In addition, there are a plethora of extraspliceosomal 
protein factors required to make the correct splicing decisions (Guthrie and 
Patterson, 1988; Maniatis and Reed, 1987). 
1.5.1 Sequence requirements in RNA splicing 
The exact sites where the enzymatic reactions in RNA splicing take place are 
defined by the primarily intronic consensus sequences, close to both 5´ and 3´ splice 
sites. The 5´ end of the intron, the 5´ splice site, is relatively short and contains highly 
conserved dinucleotide GU at positions 1 and 2 of the intron. In contrast, 3´ splice 
sites are defined by three separate sequence elements – the branchpoint site, the 
polypyrimidine tract and the 3´ splice site consensus itself. Together, they make up a 
loosely defined 3´ splice site region extending up to 100 nucleotides upstream of the 
actual excision site: the branchpoint adenosine is found surrounded by the short 
consensus sequence, followed by the polypyrimidine tract and, finally, ending in the 
3´ terminal dinucleotide AG of the intron (Padgett et al., 1986). 
1.5.2 Chemistry of RNA splicing 
All introns within nuclear mRNA precursors are thought to be removed by the 
same two-step mechanism consisting of two consecutive transesterification reactions 
(Figure 1.4). The first step involves a direct nucleophilic attack of the 2´-OH of the 
branchpoint site adenosine on the phosphate at the 5´ splice site, which results in the 
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displacement of the 3´ oxygen of the 5´ exon and the formation of the 2´-5´ 
phosphodiester bond between the branchpoint and the 5´-terminal nucleotide of the 
intron. Therefore, two products of the first transesterification are a detached 5´ exon 
and an intron-3´exon fragment in a lariat configuration. In the second step, the same 
3´-OH of the 5´ exon that had been the leaving group in the first reaction reverts its 
role and now behaves as a nucleophilic group at the 3´ splice site to similarly 
displace the 3´ end of the intron with the 5´ end of the 3´ exon. This results in the 
ligation of 5´ exon with the 3´ exon via new phosphodiester bond and leaves the 
released intron still in the lariat structure (Padgett et al., 1986; Sharp, 1987). 
  
Figure 1.4: Two-step mechanism of RNA splicing 
Splicing of pre-mRNA takes places via two transesterification reactions. In the first step, the 
2'-hydroxyl group of the branchpoint site adenosine attacks the phosphate at the GU of the 
5'-splice site. This leads to cleavage of the 5' exon from the intron and the formation of a 
lariat intermediate. In the following step, a second transesterification reaction, which involves 
the phosphate at the 3' end of the intron and the 3'-hydroxyl group of the detached exon, 
ligates the two exons. This reaction releases the intron, still in the form of a lariat. (Pagani 
and Baralle, 2004). 
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1.5.3 Spliceosome assembly 
Before two crucial enzymatic reactions of RNA splicing can take place, target 
pre-mRNA needs to be forced into the splicing-competent configuration, the 
spliceosome. Immediately after transcription, nascent pre-mRNAs are bound by a 
multitude of heterogenous nuclear ribonucleoprotein particles (hnRNPs) (Pinol-Roma 
and Dreyfuss, 1992). However, the earliest event that specifically targets pre-mRNAs 
to the splicing pathway is the assembly of the early or commitment spliceosomal 
complex (E complex), where all consensus sequence elements need to be 
recognized (Figure 1.5). This is achieved through four distinct macromolecular 
interactions. At the 5´ end of the intron, U1 snRNP stably associates with the 5´ 
splice site by means of the base-pairing interaction between U1 snRNA and the 
consensus sequence at the 5´ exon/intron border (Rosbash and Seraphin, 1991). 
Further downstream, the branchpoint consensus is bound by the splicing factor 1 
(SF1), whereas the polypyrimidine tract and the 3´ splice site interact with the 65 kDa 
and 35 kDa subunits of the heterodimeric U2 snRNA auxiliary factor (U2AF), 
respectively (Berglund et al., 1997; Wu et al., 1999; Zamore et al., 1992). 
Subsequent to the formation of a commitment complex, U2 snRNP joins the 
growing macromolecular assembly by base-pairing of its U2 snRNA with the 
branchpoint consensus sequence, marking the formation of the A complex (Parker et 
al., 1987). Once the U4/U5/U6 tri-snRNP enters the spliceosome, the B complex is 
established (Konarska and Sharp, 1987). Upon profound rearrangements, including 
the displacement of the U1 snRNP from the 5´ splice site by the U6 snRNP and the 
loss of both U1 and U4 snRNPs from the spliceosome, a mature spliceosomal 
complex is assembled, namely the C complex (Figure 1.5), which catalyzes both 
reactions required for effective RNA splicing (Bessonov et al., 2008; Makarov et al., 
2002). 
Once the second step of the splicing is terminated, another macromolecular 
assembly, the exon-exon junction complex (EJC) accumulates 20-24 nucleotides 
upstream of exon borders in mature mRNA. The complex provides a binding platform 
for factors involved in mRNA export and nonsense-mediated mRNA decay, thereby 
providing an RNA quality control mechanism to determines whether the RNA species 
is translation-competent or it should be targeted for degradation (Le Hir et al., 2001). 
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Figure 1.5: Distinct steps of the spliceosome assembly 
Complex rearrangements in the structure of the spliceosome take place throughout the 
process of RNA splicing. E or the commitment complex consists of the U1 snRNP, SF1 and 
heterodimeric U2AF bound to the intronic consensus sites. Once the U2 snRNP joins, the A 
complex is formed. Transient B complex is defined through the association of the U4/U5/U6 
tri-snRNP with the A complex. The C or the catalytic complex is established after the 
rearrangements occur in the B complex. 
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1.5.4 Regulation of RNA splicing 
The mechanism of RNA splicing, during which the synthesis of both 
constitutively and alternatively spliced mRNAs occurs, is regulated by a system of 
trans-acting factors that bind to cis-acting sites on the pre-mRNA itself. Such trans-
acting factors include proteins known as splicing activators that promote the usage of 
a particular splice site, and splicing repressors that reduce the usage of a particular 
site. The 5′ splice site, the 3′ splice site and the branch point sequence as three core 
splicing signals are present in every intron and are also necessary for the splicing 
reaction, but the exact definition of the exon-intron boundary requires interplay of the 
cis-acting sequences in pre-mRNAs, known as splicing enhancers and splicing 
silencers that can map to both exonic and intronic regions (Matlin et al., 2005; Smith 
and Valcarcel, 2000). 
The protein regulators of the RNA splicing can be roughly divided into two 
groups. First group consists of SR proteins which mostly promote exon inclusion 
when bound to the cis-acting sequences, while the second group comprises hnRNP 
family of proteins whose interaction with the cis-acting signals often results in exon 
skipping (David and Manley, 2008). 
SR proteins preferentially interact with both exonic and intronic splicing 
enhancers (ESEs and ISEs), thereby assisting in the constitutive removal of the 
adjacent introns. They all have a modular organization and contain at least one N-
terminal RNA-binding domain that interacts with the pre-mRNA and a C-terminal RS 
domain that functions as a protein interaction domain (Graveley, 2000). 
Exonic and intronic splicing silencers (ESSs and ISSs), on the other hand, are 
in most cases bound by one of the members of hnRNP family of splicing factors. This 
interaction leads to the inhibition of the adjacent splice sites and, consequently, to 
intron retention (Wang et al., 2004b). The splicing repression at several alternative 
splice sites occurs through the negative regulation mediated by hnRNP A1 which 
exhibits strong affinity for the sequences UAGGGA/U and GGCAGGGUGG (Burd and 
Dreyfuss, 1994; Del Gatto-Konczak et al., 1999; Fairbrother and Chasin, 2000). 
Some hnRNPs, like hnRNP H, play roles as both splicing repressors and activators, 
determined by the cis-acting element they bind to (Caputi and Zahler, 2001). 
Furthermore, the crucial role of hnRNP H in the regulation of alternative splicing of 
the rat β-tropomyosin gene transcript has been reported (Chen et al., 1999). 
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In Figure 1.6, the summary of major alternative splicing pathways is depicted 
(panel A), also indicating the principal interactions that occur between cis-acting 
elements and trans-acting factors (panel B). 
 
 
 
Figure 1.6: Alternative splicing of pre-mRNAs 
A: Major alternative splicing pathways. The combination of two or more pathways give rise to 
more complex alternative splicing network. 
B: Regulation of splicing. Exons, introns and splice sites are represented as open boxes, 
jagged lines and brackets, respectively. The 5´ and 3´ splice site consensus sequences are 
shown in pictogram with the branchpoint site adenosine indicated. Two alternative splicing 
pathways (dashed lines) are indicated with the central exon either included or excluded. 
Regulatory cis-elements (ESE, ESS, ISS, and ISE) are spread all along the pre-mRNA and 
bound by trans-acting splicing factors (SR proteins and hnRNPs) (Wang and Burge, 2008). 
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1.5.5 Connection between RNA editing and splicing 
In most cases of ADAR-mediated RNA editing in protein-coding targets, 
efficient modification of the exonic editing sites relies upon the formation of the 
suitable double-stranded structure by means of base-pairing with the editing 
complementary sequence located in the downstream intron (Higuchi et al., 1993). 
Here, editing needs to occur co-transcriptionally, before the intron is removed 
through RNA splicing, suggesting that editing and splicing need to be coordinated 
(Keegan et al., 2001). 
There are many reports where RNA editing was shown to be important in 
making the correct downstream splicing desicions. In D. melanogaster, for example, 
if editing occurs upstream of alternative splice site, a strong correlation between 
editing efficiency and splice site selection is observed. In contrast, when editing 
occurs downstream of alternative splicing, no correlation is seen (Agrawal and 
Stormo, 2005). 
Auto-editing of ADAR2 pre-mRNA is another phenomenon where the 
importance of intimate interplay of editing and splicing is strongly emphasised. In 
rats, sequence analysis of ADAR2 genomic DNA revealed the presence of 
adenosine-adenosine (AA) and adenosine-guanosine (AG) dinucleotides at the 
proximal and distal alternative 3' splice sites of intron 4, respectively. The proximal 3' 
splice site recruitment depends upon the ability of ADAR2 to edit its own pre-mRNA, 
converting the intronic AA to an adenosine-inosine (AI) dinucleotide which then 
mimics the highly conserved AG dinucleotide usually found at 3' ends of introns. 
Introduction and use of this alternative splice site leads to premature translation 
termination and the synthesis of non-functional enzyme (Rueter et al., 1999). 
Furthermore, RNA editing of an intronic adenosine is crucial for the correct 
splicing of the pre-mRNA of the serotonin receptor 2C subunit because it results in 
the structure destabilisation around the adjacent 5´ splice site, facilitating the access 
of the spliceosomal components (Flomen et al., 2004). Previously, alternative splice 
variants of this transcript caused by underediting were found enriched in malignant 
gliomas, most probably because of the synthesis of the truncated non-functional 
version of the receptor subunit (Maas et al., 2001). 
In GluR-B pre-mRNA, RNA editing is crucial for the correct processing, most 
importantly the removal of introns 11 and 13, with the latter being coupled to proper 
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downstream alternative splicing decisions (Schoft et al., 2007). At the Q/R site in 
exon 11, ADAR2-mediated editing is coupled to the editing of the intronic editing 
hotspots in intron 11, at positions +60 and +262/263/264, respectively. This 
deamination event is indispensable for the proper removal of intron 11, because 
ADAR2 knock-out mice show an accumulation of intron 11-containing RNAs in the 
nucleus, although every other intron is regularly eliminated (Higuchi et al., 2000).  
Splicing of intron 13 in this transcript is decreased when the neighbouring R/G 
site, located at position -2 with respect to the 5´ splice site, is edited (Bratt and 
Ohman, 2003). This effect has been shown to depend solely on the presence of 
inosine at this position, but not on the steric hindrance for the spliceosome assembly 
that ADAR binding might cause (Kallman et al., 2003). Editing at the R/G site is also 
important for the correct alternative splicing of the mutually exclusive downstream 
exons 14 and 15. Erroneously spliced products where either both alternatively 
spliced exons are included in or completely omitted from the mature mRNAs have 
exhibited reduced editing extent at the R/G site, indicating the importance of this 
editing event for the downstream processing. It is believed that RNA editing at the 
R/G site only transiently slows down the activation of the adjacent 5´ splice site in 
order to recruit the branchpoint site either in intron 13 or in intron 14, leading to 
inclusion of either exon 14 or exon 15 in the mature transcript, respectively (Schoft et 
al., 2007). 
The proximity of the R/G site inosine to the actual 5´ splice site of intron 13 
could cause destabilisation in the base-pairing with U1 snRNA and lead to decreased 
splicing because the wild type adenosine at this position resembles 5´ splice site 
consensus sequence more closely than inosine introduced upon RNA editing (Mount, 
1982). Additionally, an 8 nucleotide stretch surrounding this inosine exhibits high 
sequence homology to a previously defined splice silencer consensus element 
(sequence surrounding the R/G site: UAIGgugg, with the intronic sequence in lower 
case, versus splice silencer consensus: CAGGGUGG) bound by hnRNP A1 or 
hnRNP H (Fairbrother and Chasin, 2000; Grabowski, 2004). 
In this thesis, an effort was made to elucidate which of these two scenarios, if 
not both, contribute to the decelerated kinetics in the removal of intron 13 of GluR-B 
pre-mRNA upon RNA editing of the adjacent R/G site. 
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Part II: SINE RNAs in RNA interference 
1.6 SINE RNA interaction with dsRBPs in plants 
In the final part of this thesis, the binding affinity of plant SINE-derived RNA 
intermediates for different double-stranded RNA-binding proteins (dsRBPs) was 
examined more closely in order to establish the role of these widely distributed RNA 
retroelements in the regulation of RNA interference. 
1.6.1 SINE RNAs 
Short interspersed elements (SINEs) are found in genomic sequences of most 
eukaryotic species. These 80 to 500 basepairs long repetitive regions are 
evolutionarily related to and descend mostly from tRNAs or, in some cases, from 7SL 
RNA or 5S RNA. The copy number of SINE elements in eukaryotic genomes ranges 
from several hundred to several thousand, with the exception of mammals where it 
can rise up to more than one million copies, as is the case with the human Alu family 
(Sun et al., 2007). Being non-autonomous RNA polymerase III transcripts, their 
propagation in the genome, mediated through reverse transcription and the 
subsequent integration, relies upon their interaction with the enzymatic machinery 
assembled from the translation products of another widespread group of eukaryotic 
transposable elements, namely the long interspersed elements (LINEs) (Arnaud et 
al., 2001; Dewannieux et al., 2003; Ohshima and Okada, 2005). 
Several studies have shed light on the role of SINE RNAs in the regulation of 
gene expression. In mammals, the active transcription of the members of the SINE 
B2 family is stimulated upon heat shock and results in the repression of general RNA 
polymerase II-mediated transcription (Allen et al., 2004; Espinoza et al., 2004). 
Increased transcription of other SINEs, like Alu RNAs, has also been reported upon 
stress activation. Here, Alu RNAs can indirectly repress translation by controlling the 
activity of the Protein Kinase R (PKR), a double-stranded RNA-binding protein known 
for its role in translational repression after stress induction (Schmid, 1998). Alu RNAs, 
however, can modulate the translational repression by a PKR-independent 
mechanism, as well (Hasler and Strub, 2006; Rubin et al., 2002). Furthermore, SINE-
related BC transcripts in mammalian neurons guide the RNA-binding protein FMRP 
Introduction 
34 
 
to a specific subset of neuronal mRNAs, thereby regulating their translation (Zalfa et 
al., 2003). Altogether, SINE RNA mechanism of the gene expression control is highly 
reminiscent of those employed by other PolIII-dependent riboregulators. 
The role of SINEs in plants, on the other hand, has remained somewhat 
obscure. In Arabidopsis thaliana, there are six different families of SINEs, located 
mostly in euchromatic regions and closely associated with genes (Lenoir et al., 
2001). Introduction of the transgenic SINE founder locus (SB1) into the genome of A. 
thaliana under the control of its natural promoter lead to a synthesis of the 
cytoplasmic polyA-tailed SINE transcripts, with a small fraction of transcripts lacking 
the polyA-tail (Pelissier et al., 2004). The constitutive production of SINE RNAs in 
these transgenic lines, however, lead to a phenotype exhibiting severe 
developmental defects, strikingly similar to the phenotype of the plants mutated in the 
miRNA or trans-acting small interfering (tasi) RNA pathways (Pouch-Pelissier et al., 
2008). Moreover, this particular SINE RNA (SB1) belongs to the family of tRNA-
derived SINEs. Unlike 7SL-derived SINE RNAs, tRNA-derived ones do not conserve 
the ancestral RNA folding pattern, but adopt a double-stranded structure consisting 
of three stem-loops with numerous mismatches and bulges (Sun et al., 2007). This 
configuration would make them ideal binding partners of dsRBPs, many of which are 
involved in RNAi-related pathways. 
1.6.2 Plant dsRBPs involved in RNA interference 
Most of the 17 dsRBPs encoded in the genome of A. thaliana are crucial 
factors in one of the RNAi-related pathways. This family comprises four Dicer-like 
proteins (DCL1 to DCL4), five double-stranded RNA-binding proteins (HYL1/DRB1 
and DRB2 to DRB5) and the HUA Enhancer1 (HEN1) protein (Hiraguri et al., 2005). 
Such wide spectrum of dsRBD-containing RNAi-related factors in plants is attributed 
to the specific roles that need to be performed in various RNAi pathways in plants, 
including miRNA, tasiRNA, viral siRNA, or heterochromatinising siRNA production 
(Curtin et al., 2008). 
HYL1/DRB1 (Hyponastic Leaves 1) is a dsRBD-containing protein in plants 
shown to be essential for miRNA production, but not for posttranscriptional gene 
silencing (PTGS) (Vazquez et al., 2004). It is a nuclear protein regulating plant 
response to many hormones and it is also controlling leaf morphology by cell division, 
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elongation and polarity (Lu and Fedoroff, 2000). Although HYL1 bears strong 
homology to C. elegans RDE-4 and to D. melanogaster R2D2, they are not 
functionally similar (Vazquez et al., 2004). As previously mentioned, HYL1 interacts 
with DCL1 in plants in order to produce mature miRNAs, but plays no role in tasiRNA 
synthesis. This indicates that it preferentially binds dsRNAs containing mismatches 
and loops, but not perfect double-stranded structures. 
DRB4, on the other hand, acts with DCL4 to produce mature tasiRNAs and 
has no role in miRNA biogenesis. During tasiRNA biogenesis, RNAs transcribed from 
non–protein-coding TAS genes are cleaved by a miRNA–programmed RNA-induced 
silencing complex. In contrast to classical miRNA targets, RNA-dependent RNA 
polymerase 6 (RDR6) converts one of the TAS RNA cleavage products into double-
stranded RNA, which is subsequently processed by DCL4/DRB4 complex to 
generate a 21-nucleotide tasiRNA population (Nakazawa et al., 2007; Vaucheret, 
2005). This suggests that the substrate specificity of DRB4 differs to a great extent 
from the one of HYL1/DRB1. 
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2 SPECIFIC AIMS 
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This thesis consists of three separate topics, each one dealing with different 
aspects of the function of double-stranded RNA-binding proteins,  their association 
with the respective interaction partners among RNAs and the biological 
consequences of this macromolecular interplay. 
1. Investigating the influence of ADAR-mediated RNA editing near the 5´ 
splice site on the spliceosome assembly 
The R/G site of the GluR-B pre-mRNA found just one nucleotide upstream of 
intron 13 5´ splice site is a known ADAR target. Upon RNA editing, the splicing 
efficiency of the neighbouring intron is decreased. R/G site editing destroys the 5´ 
splice site consensus that base-pairs with U1 snRNA by introducing inosine at the 
position of adenosine. Furthermore, it creates a sequence similar to splice silencers 
bound by hnRNP A1 or hnRNP H. Here, we investigated the role of U1 snRNA in the 
reduced splicing of GluR-B intron 13 after R/G site editing, as well as the association 
of known splicing repressors with this pre-mRNA. 
2. Detecting ADAR1 interaction with microRNA precursors in nucleus and 
cytoplasm 
Both ADAR1 and microRNA precursors are export-competent molecules that 
interact with Exportin5. Since both nuclear primary microRNAs and cytoplasmic pre-
microRNAs were reported as editing targets, we were interested to see if ADAR1, 
being a shuttling protein, accompanies its microRNA substrates on their Exportin5-
mediated nuclear export pathway. 
3. Determining SINE RNA binding partners among RNAi-related dsRBPs 
Transgenic plants overexpressing SINE RNAs, abundant highly structured 
retroelements consisting of three stem-loops with mismatches and bulges, have 
phenotypes similar to RNAi mutants. It is, therefore, plausible that these RNAs, being 
structurally similar to microRNA intermediates, serve as regulators of RNAi pathways 
in plants. We investigated in vitro interactions of SINE RNAs with different subtypes 
of dsRBPs involved in one of the RNAi processes to see if the protein affinity for this 
group of imperfect dsRNAs would match their in vivo preferences. 
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3 MATERIALS AND METHODS 
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3.1 In vivo splicing assay 
The system to analyse splicing efficiencies of reporter constructs bearing R/G 
site in different editing states was used to test the U1 snRNA base-pairing interaction 
with R/G site upon RNA editing by means of co-transfecting the vectors carrying 
mutant U1 snRNA genes. 
3.1.1 R/G site reporter constructs 
Wild type, pre-edited and uneditable R/G site reporter constructs were cloned 
previously by Vera Schoft in our lab and are described in detail (Schoft et al., 2007), 
as well as in the Results section of this thesis. 
Additionally, the RT-PCR experiment, where the decreased splicing efficiency 
of the pre-edited R/G site construct when compared to the wild type R/G site 
constructs was verified, has been performed on total RNA isolated from transfected 
culture cells. For the first strand cDNA synthesis, oligodeoxyribonucleotide MJ1000a 
was used (5´ CCTCTACAAATGTGGTATGGCTG 3´). For the amplification, primers 
MJ1136 (5´ GGTGGAGTTCAAGTCCATCTACATGG 3´; 5´ primer that hybridises to 
the RFP coding sequence) and MJ1020 (5´ TCGACCAGGATGGGCACCAC 3´; 3´ 
primer that hybridises to the GFP coding sequence). The corresponding experimental 
procedures are thoroughly explained below. 
3.1.2 U1 snRNA expression vectors 
Original vectors for U1 snRNA overexpression were kindly provided by Heiner 
Schaal from the Institute of Virology, University of Düsseldorf, Germany (Figure 3.1) 
and were described previously (Murphy et al., 1982). Both wild type and 
compensatory U1 snRNA mutations were introduced by using mutagenic primers for 
PCR on the template vector pUCB U1 5A (Figure 3.1 B) and inserting the resulting 
PCR products into the BglII and XhoI restriction sites of the vector pUCB del U1 
(Figure 3.1 A). 5´ mutagenic primers used for this PCR were MJ2392 (5´ 
CGAAGATCTCATACTTACCTGGCAGGGGAGATACC 3´; BglII restriction site is 
underlined; mutagenic nucleotide restoring the wild type sequence is highlighted in 
orange) and MJ2393 (5´ CGAAGATCTCATACTTACCCGGCAGGGGAGATACC 3´; 
BglII restriction site is underlined; mutagenic nucleotides restoring the wild type 
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sequence and introducing the compensatory mutation are highlighted in orange and 
red, respectively) for the wild type and compensatory U1 snRNA mutants, 
respectively. For both vectors, universal 3´ primer MJ2391 was used in mutagenic 
PCR reactions (5´ ATCCTCGAGCCTCCACTGTAGGATTAAC 3´; XhoI restriction site 
is underlined). The resulting PCR products were run on standard 1 % agarose gels, 
cut out and subjected to double restriction digestion using BglII and XhoI restriction 
endonucleases (Fermentas). The restricted fragments were ligated into the pre-
restricted pUCB del U1. The ligation products were transformed and propagated in 
Escherichia coli strain XL1-Blue. After the isolation and purification of plasmid DNA 
by the standard alkaline lysis method, the mutated clones were verified by 
sequencing. 
 
 
 
Figure 3.1: Plasmid maps of original U1 snRNA expression vectors 
Two depicted plasmids were used to clone wild type and compensatory U1 snRNA 
expression vectors. In the case of pUCB del U1 (panel A), the U1 snRNA coding sequence 
together with the 3´ HSD4 sequence was deleted from the HSD4 U1 snRNA expression 
cassette and this vector was subsequently used to clone the mutagenic PCR products into its 
BglII/XhoI restriction sites. pUCB U1 5A, on the other hand, was employed as a PCR 
template to introduce wild type and compensatory mutations into the U1 snRNA coding 
sequence (panel B). 
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3.1.3 Primer extension assay 
The expression of mutant U1 snRNAs was experimentally validated through 
primer extension assay. This experimental procedure was applied on total RNAs 
isolated from HEK293 cells in culture transfected with either wild type or 
compensatory U1 snRNA expression vectors. 
In more detail, a synthetic oligodeoxyribonucleotide primer MJ2413 (5´ 
CATGGTATCTCCCCTG 3´) complementary to nucleotides 13-28 of U1 snRNA was 
used to test for the expression of mutant U1 snRNA. This 16-mer was 5´ end-[γ-32P]-
labelled with 10 μCi of Redivue [γ-32P] ATP (GE Healthcare) using T4 polynucleotide 
kinase (New England Biolabs), according to the manufacturer´s instructions. The 
mixtures of increasing amounts of total RNA and 20 fmol of 5´-radioactively labelled 
primer were washed, dried and resuspended in the hybridisation buffer (25 mM Tris 
pH 8.4, 30 mM KCl and 20 mM MgCl2). After brief denaturation (2` on 95ºC), 
hybridisation was performed for 30 minutes on 42ºC. Extension itself was done in the 
presence of 0.2 mM dideoxyATP (ddATP), using  avian myeloblastosis virus reverse 
transcriptase (AMV-RT) from Promega, following the company´s protocol. In the 
presence of ddATP, dCTP, dGTP and dTTP, AMV-RT is capable of adding only 3 
nucleotides if the template is wild type U1 snRNA, but adds 7 nucleotides to the 
compensatory U1 snRNA mutant template. After 40 minutes on 42ºC, the reactions 
were stopped by ethanol precipitation. The reaction products were analysed on 15 % 
8M urea-denaturing 19:1 polyacrylamide gels. After the run, the gels were fixed in a 
fixing solution (10% methanol, 10% acidic acid), dried for 3 hours and exposed to 
Kodak PhosphorImager screens. After varying exposure times, the signals were read 
out, analysed and quantified with the QuantityOne software (Biorad). 
3.1.4  Cell culture and transfection 
Human embryonic kidney cells (HEK293) used for co-transfection experiments 
were cultured at 37ºC in Dulbecco´s modified Eagle medium (DMEM) supplemented 
with 10 % FCS, 0.2 mM L-glutamine and antibiotics. They were incubated in a humid 
atmosphere with 5 % CO2. 
Cells were transiently transfected using the Nanofectin transfection reagent 
(PAA) according to the manufacturer´s instructions and FACS-analysed 24 hours 
after the final transfection round. 
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3.1.5 FACS analysis 
Free access to FACScalibur system (Becton & Dickinson) was kindly provided 
by Gabriele Stengl from the Biooptics Department on the Institute of Molecular 
Pathology, Vienna, Austria. The CellQuest 3.3 software was used to collect the flow 
cytometry data, which was then further analysed with the FlowJo 8.3.1 software. The 
subsequent statistical analyses were performed in Microsoft Office Excel 2007. 
3.2 Co-immunoprecipitation and related procedures 
The co-immunoprecipitation approach in this study was exerted to identify 
RNA-protein interactions between mRNAs derived from R/G site reporter constructs 
and various hnRNPs on one hand, and microRNA precursors and ADAR1 on the 
other hand. In the former case, HEK293 cell line was used for transfection and 
subsequent co-immunoprecipitation, while in the latter case the cell line of choice 
was HeLa. 
3.2.1 UV crosslinking 
In order to stabilise the interaction of mRNAs derived from R/G site reporter 
constructs with hnRNPs A1 and H, UV crosslinking was performed using UV 
Stratalinker 2400 (Stratagene) as previously described (Dreyfuss et al., 1984). 
3.2.2 Subcellular fractionation 
In the second part of this study, we wanted to determine whether different 
ADAR1 isoforms interact with microRNA precursors in both nucleus and the 
cytoplasm. This is why these two subcellular compartments had to be separated. 
Immediately after gentle harvesting and washing, HeLa cell pellet was resuspended 
in 5 volumes of precooled Earle´s balanced salt solution (0.15 M NaCl, 16 mM 
K2HPO4, 2.5 mM KH2PO4 at pH 7.4), washed, pelleted and again resuspended, this 
time in 10 volumes of hypotonic RSB solution (10 mM NaCl, 1.5 mM MgCl2 and 10 
mM Tris pH 7.4) and left on ice. Then,  the swollen cells were homogenised by 10-12 
tight-fitting pestle strokes in Dounce glass homogeniser. Once the homogenised cell 
suspension had a free nuclei:intact cell ratio of 9:1, it was centrifuged to get the 
cytoplasmic fraction in the supernatant and the nuclear fraction in the pellet. 
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3.2.3 Co-immunoprecipitation 
Whole cell, cytoplasmic or nuclear fractions were sonicated and precleared in 
NET-2 buffer (150 mM NaCl, 50 mM Tris pH 7.4 and 0.05 % NP-40) to obtain lysates 
for immunoprecipitations. The corresponding primary antibodies (mouse 10D1/α-
hnRNP A1 for hnRNP A1 at 1:200; rabbit α-hnRNP H from Abcam for hnRNP H at 
1:200; rabbit Sat309 for both ADAR1 isoforms at 1:50; rabbit Sat1146 for 
ADAR1p150 at 1:50) were coupled to Protein A Sepharose beads (Amersham 
Biosciences) by overnight incubation on 4ºC. Then, the precleared lysates were 
added to the coupled antibodies in overall volume of 500 μl and immunoprecipitation 
was allowed to take place for 1 h on 4ºC. After this, the supernatant was removed 
and the beads were washed 5 times with NET-2 buffer. Then, 1/10 of beads was 
immediately resuspended in equal volume of 2xSDS sample buffer, boiled for 2 
minutes and used for the protein detection via Western Blot, while the rest was 
subjected to the co-immunoprecipitated RNA isolation, followed by RT-PCR. 
3.2.4 SDS polyacrylamide gel electrophoresis 
Protein separation on the molecular weight basis is achieved in SDS 
polyacrylamide gels. Such typical gel consists of resolving part (? % 30:1 
acrylamide:bis-acrylamide, 375 mM Tris pH 8.8 and 0.1 % SDS) and a stacking part 
(used to concentrate negatively charged proteins to a thin boundary; 3.6 % 30:1 
acrylamide:bis-acrylamide, 110 mM Tris pH 6.8, 0.1 % SDS and 13 % glycerol). The 
proteins boiled in equal volume of 2xSDS sample buffer (220 mM Tris pH 6.8, 2 % 
SDS, 20 % glycerol, 0.03 % bromophenol-blue and 2 % β-mercaptoethanol) were 
loaded onto such gel. Electrophoresis was performed in 1xSDS running buffer (3 g/l 
Tris-HCl, 14.2 g/l glycine and 1 g/l SDS) at 20 mA constant electric current. 
3.2.5 Western Blotting 
The electrophoresed proteins were transferred from the gel to the 
nitrocellulose membrane by means of tank blotting. For this purpose, the equilibrated 
membrane was placed on a gel between Whatman papers and sponges. The 
resulting blotting sandwich was put in an icepack-containing  tank filled with Transfer 
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buffer (20 mM Tris-HCl and 150 mM glycine) and subjected to transfer for 1 hour at 
360 mA. 
To visualise protein marker, after blotting the membrane was incubated in 
Ponceau S solution for 10 minutes and washed with water until protein bands 
became visible. The membrane was then blocked in 5 % dry milk in 1xTBS-T  (Tris-
buffered saline with 0.05 % Tween-20) for 10´ at room temperature. After that, the 
primary antibody solutions in 5 % dry milk in 1xTBS-T (rabbit α-hnRNP H at 1:10000; 
rabbit α-CBP80 at 1:1000; mouse 10D1/α-hnRNP A1 at 1:1000; rat Sat12/α-ADAR1 
at 1:1000) were applied to the membrane and shaken for 1 hour. Later on, after 3 
washing steps of 5 minutes in 0.5 % dry milk in 1xTBS-T, the membrane was 
incubated in one of the secondary antibody solutions in 5 % dry milk in 1xTBS-T 
(goat alkaline phosphatase-conjugated α-rabbit antibody at 1:1000; goat alkaline 
phosphatase-conjugated α-mouse antibody at 1:1000; goat horseraddish peroxidase-
conjugated α-rat antibody at 1:20000). This was also followed by three washing 
steps, each 5 minutes long. 
Blotted proteins were then detected either by chemiluminescence or by 
NBT/BCIP chromogen precipitation. If the secondary antibody was coupled to 
horseraddish peroxidase, the chemiluminescence was induced and detected by 
using SuperSignal Solution (Pierce) according to the manufacturer´s instructions. On 
the other hand, the secondary antibodies coupled to alkaline phosphatase require a 
chromogenic substrate NBT/BCIP (nitro-blue tetrazolium/5-bromo-4-chloro-3-
indolylphosphate-p-toluidine), which in the presence of this enzyme forms a dark 
precipitate on the membrane. 
3.2.6 RNA isolation and RT-PCR 
RNA isolation was performed by either directling applying the RNA isolation 
reagent Trizol (Invitrogen) to cultured cells in dishes or applying it to cell lysates or 
Protein A Sepharose beads with co-immunoprecipitated RNAs, all using the 
conditions recommended by the manufacturer. 
Two consecutive DNaseI (Roche) digestion steps were necessary to get rid of 
any traces of residual DNA which might lead to false positive signals in PCR and 
were made according to the manufacturer´s protocol. 
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Purified RNAs were then reversely transcribed with RevertAid M-MuLV 
Reverse Transcriptase (Fermentas) following the company´s instructions, using 
either MJ1000a for R/G site construct mRNAs or random hexanucleotide mixture 
(Roche) for priming miRNAs and γ-tubulin B-subunit mRNA. 
1/10 of heat-inactivated RT reactions served as a template for PCR reaction. 
Respective plasmids (in the case of transfections) and cell lysates (in all cases) were 
employed as control templates. 
Following primer combinations were used in PCRs: 
MJ1136 (5´ GGTGGAGTTCAAGTCCATCTACATGG 3´) and MJ1020 (5´ 
TCGACCAGGATGGGCACCAC 3´) for all the amplifications of R/G site constructs-
derived cDNAs; 
MJ1515 (5´ GGCAGAGGGCAACAGTTCTTC 3´) and MJ1516 (5´ 
GGCTGAGCCGCAGTAGTTCTTC 3´) for the amplification of cDNA derived from the 
miR-22 precursor; 
MJ1800 (5´ TGTCAGACAGCCCATCGACTG 3´) and MJ1801 (5´ 
TGTCGGGTAGCTTATCAGACTG 3´) for the amplification of cDNA derived from the 
miR-21 precursor; 
MJ1025 (5´ GACAACACAGCCCTGAACCG 3´) and MJ1026 (5´ 
GACTGGTCTGTAGTGAGCGG 3´) for the amplification of cDNA derived from the γ-
tubulin B-subunit mRNA. 
The PCR products were then analysed on 1-2 % agarose gels in either 1xTAE 
or 1xTBE running buffers. 
3.3 Nuclease protection assay 
To map regions of SINE RNAs that interact with different dsRBD-containing 
proteins, RNase V1 protection assay was employed. 
First, RNA structures were predicted using RNA/DNA folding and hybridisation 
software Mfold, version 2.3 (Zuker, 2003). 
Then, RNA was in vitro transcribed and radioactively trace-labelled (for 
quantification purposes) from linearised T7 promoter-containing vector using 
recombinant T7 RNA polymerase and [α-32P] ATP (GE Healthcare). Transcripts were 
gel-purified and ethanol-precipitated. 
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2 pmol of RNA was then dephosphorylated using calf intestinal phosphatase 
(New England Biolabs) according to manufacturer's protocol. Dephosphorylated 
RNAs were 5′-end labelled with T4 polynucleotide kinase (New England Biolabs) and 
[γ-32P] ATP (GE Healthcare).  
Gel-purified 5′-labeled RNAs were subsequently used for nuclease protection 
assays (Hallegger et al., 2006). RNase V1 recognizes any 4-6-nt segment of 
polynucleotide backbone with an approximately helical conformation and cleaves 
leaving 5′-phosphate (Lowman and Draper, 1986). For the partial digest with RNase 
V1, 20 fmol (corresponding to 50,000 cpm) of RNA were centrifuged, washed, dried 
and resuspended in structure buffer (Ambion: 100 mM Tris at pH 7, 1 M KCl, 100 mM 
MgCl2). After annealing, 1 µL of tRNA (1 µg/µL, Ambion) was added, followed by the 
addition of increasing protein concentrations (50 nM, 150 nM and 500 nM). To 
ensure protein binding to RNA, samples were incubated for 15 min at room 
temperature. Then, 0.005 units of RNase V1 (Ambion) were added and the reactions 
were incubated for additional 10 min at room temperature. Reactions were stopped 
by ethanol/salt precipitation. Samples were loaded together with alkaline hydrolysis 
ladder and denaturing RNase A (Ambion) and RNase T1 (Boehringer Mannheim) 
digests of RNAs on thin denaturing RNA gels. 
After the run, the gels were dried for 3-4 hours and exposed to Kodak 
PhosphorImager screens. After varying exposure times, the signals were read out, 
analysed and quantified with the QuantityOne software (Biorad). 
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4.1 Molecular mechanism of altered pre-mRNA splicing 
upon RNA editing 
A to I RNA editing is a posttranscriptional modification that contributes 
significantly to transcriptome diversification. Occurrence of editing sites in exons of 
mRNAs, however, has the potential of enriching the proteome repertoire, as well. In 
fact, the most prominent coding targets of ADARs identified thus far are messages 
coding for various receptors in the mammalian central nervous system: subunits of 
glutamate receptor superfamily, serotonin 5-HT2C-receptor and potassium channel 
KCNA1. In all of them, amino acid substitutions due to editing have major impact on 
properties of given proteins. Recently, a bioinformatics screen was used to identify 
novel editing targets and the substrates were verified experimentally (filamin A, 
CYFIP2, BLCAP and IGFBP7 mRNAs) (Levanon et al., 2005). Additionally, a 
genome-wide identification by parallel DNA capturing and sequencing greatly 
expanded the number of verified targets (Li et al., 2009). Interestingly, in some 
targets the editing sites are found in close proximity to 5´ splice sites where exon-
intron base-pairing interactions are formed to provide a suitable binding platform for 
ADARs. Editing in these positions can have a profound effect on initial steps of the 
splicing machinery recruitment, e.g. U1 snRNA base-pairing to exon-intron junction. 
Previously, a cell-based assay to monitor splicing efficiency established in our 
lab was employed to show effects of editing of R/G and Q/R sites on splicing in GluR-
B mRNA. Results from this screen prompted us to apply this method to take a closer 
look on the efficiency of U1 snRNP recruitment to edited 5´ splice sites in mRNAs, 
emphasising the importance of altered U1 snRNA::mRNA interaction potential upon 
RNA editing.  
Furthermore, high resemblance of the edited exon-intron junction regions to 
splice silencer consensus sequence suggests that the changes in splicing efficiency 
could be attributed to binding of splicing repressors, like hnRNP A1 or hnRNP H 
proteins which show high affinity for G-rich sequences. 
In this study, both of these possibilities were addressed in detail in order to 
elucidate the exact step in the pre-mRNA processing pathway that gets affected by 
adenosine deamination, leading to alterations in the splicing of editing substrates 
and, thereby, enriching the proteome repertoire in cells and tissues where ADAR 
family of enzymes exhibits catalytic activity. 
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4.1.1 Testing the imperfect 5´splice site hypothesis 
4.1.1.1 In vivo splicing assay 
As seen in Figure 4.1, an in vivo splicing assay already established in our lab 
by Vera Schoft was implemented to investigate the influence of the R/G site editing 
on the U1 snRNA base-pairing affinity for the intron 13 5´ splice site and its 
subsequent removal. This system was originally developed to monitor the splicing 
efficiencies of GluR-B pre-mRNA reporter constructs in different editing states. 
Coding sequences for red (RFP) and green (GFP) fluorescent proteins introduced 
into a mammalian expression vector were separated by a flexible region of the E. coli 
lacZ gene and a multiple cloning site (MCS) to maintain the open reading frame 
(ORF). The MCS was then used to insert the genomic sequences containing the 
exons and intron with the editing site of interest. In all these constructs, RFP is 
expressed constitutively, while the expression of GFP as a downstream reporter 
relies on the elimination of the stop codon-containing intron, splicing of which is 
severely influenced by RNA editing. Another special feature of the aforementioned 
constructs was the nuclear localisation signal (NLS) to allow for an unequivocal 
quantification of fluorescence during microscopic and FACS analysis. 
For this method, R/G site constructs in three different “editing states” were 
used (Figure 4.1 B): the wild-type construct (WT), the construct with the R/G site 
adenosine mutated to guanosine to mimic inosine (Pre-edited) and, finally, the 
construct with mutated editing complementary sequence (ECS), preventing the 
formation of the double-stranded structure and consequently ADAR binding 
(Uneditable). It is important to have the “uneditable” construct as an internal control 
because of the background level editing of the “wild-type” construct in the biological 
system used for the experiment, i.e. HEK293 cells. 
In this part of the study, the U1 snRNA base-pairing potential upon RNA 
editing was investigated by co-expressing U1 snRNA mutants with reporter 
constructs in human cells in culture (HEK293). 
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Figure 4.1: In vivo splicing assay 
A: mammalian expression vector with MCS between RFP- and GFP-coding sequences 
enables insertion of ADAR substrates and monitoring of splicing efficiencies in different RNA 
editing backgrounds by means of measuring ratios of green versus red fluorescence 
B: Schematic representation of different types of editing constructs used in the study: in pre-
edited constructs adenosine (A) was mutated to guanosine (G) to mimic inosine (I), a product 
of hydrolytic deamination upon RNA editing; uneditable constructs were made by mutating 
editing complementary site (ECS), thus preventing ADAR binding. 
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4.1.1.2 Reduction of splicing in pre-edited R/G site construct 
In contrast to the fully spliced wild type R/G site construct, there is still a 
substantial fraction of unspliced pre-edited pre-mRNA present in the transfected 
cells, as judged by the RT-PCR experiments (Figure 4.2). 
The aim of the overexpression of compensatory U1 snRNA mutant together 
with the pre-edited construct was to facilitate splicing for this splice-deficient 
substrate and restore the wild type splicing levels. 
 
Figure 4.2: Splicing in pre-edited R/G construct is decreased 
RT-PCR analysis reveals significant amounts of unspliced pre-edited message (“pre-edited 
+” lane) when compared to the wild-type mRNA (“wild type +” lane). Wild type plasmid was 
used as a positive control for unspliced messages (“P” lane). 
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4.1.1.3 Overexpression of U1 snRNA mutants 
The remarkable complementarity between the 5´ splice site consensus 
sequence and the sequence of U1 snRNA led to the proposal that the nucleotides 2-
10 at the 5´ end of U1 snRNA recognise the positions -3 to +6 in the mRNA 
precursors, with respect to the 5´ splice site. This was further corroborated by the 
variety of biochemical and evolutionary evidence, such as the accessibility of the 5´ 
end of U1 snRNA in the intact U1 snRNP, the abolishment of the in vitro splicing 
activity upon RNAse H treatment of U1 snRNP in the presence of the oligonucleotide 
complementary to the 5´ end of U1 snRNA, or the sequence conservation of the 5´ 
end of U1 snRNA in species as diverse as human, rat, mouse, chicken, frog, sea 
urchin or fruit fly (Zhuang and Weiner, 1986). Most importantly, the nucleotide 
changes in the 5´ splice sites of pre-mRNAs, reducing the match to the U1 snRNA 
consensus sequence, were usually found to weaken the splicing effectiveness. This 
scenario, of course, is the one easy to imagine taking place in the case of R/G site 
adenosine deamination at position -2 with respect to the 5´ splice site (Mount, 1982). 
Therefore, the mutant U1 snRNA construct was designed in this study to 
compensate for the splicing reduction in the editing substrates by means of the site-
directed mutagenesis at the nucleotide position base pairing with the R/G site of the 
GluR-B pre-mRNA (the original pUC-backbone U1 snRNA vectors were kind gift from 
Heiner Schaal, Institute of Virology, University of Düsseldorf, Germany and were 
previously described (Murphy et al., 1982). 
To verify expression of mutant U1 snRNA, primer extension assay on total 
RNAs isolated from transfected HEK293 cells was performed. In Figure 4.3 B, a 
cloverleaf U1 snRNA structure was used to depict 5´ end-labelled primer and its 
complementary sequence, as well as the uridines marking the reverse transcription 
stop when using dideoxyATP (ddATP) for wild type and compensatory U1 snRNA 
transcripts, respectively. Determined from band intensities in Figure 4.3 B, the 
expression levels of compensatory U1 snRNA mutant are boosted up to 15% of the 
expression levels of wild type U1 snRNA (Figure 4.3 C). 
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Figure 4.3: U1 snRNA overexpression 
Editing in GluR-B pre-mRNA affects the -2 position of the 5´splice site that base-pairs with 5´ 
end of the U1 snRNA. Therefore, compensatory point mutation was introduced into 
expression vector bearing U1 snRNA gene at a position base-pairing with inosine/guanosine 
in edited/pre-edited substrates in order to restore its base-pairing potential.  
A: Base-pairing interaction between U1 snRNA and 5´ splice site. The base pair affected by 
RNA editing is highlighted in red and orange in pre-mRNA and U1 snRNA, respectively. 
B: The cloverleaf secondary structure of U1 snRNA with marked complementary sequence 
for 5´ end-labelled primer (yellow) and ddATP-RT (dideoxyATP) reverse transcription stops 
for wild type (orange) and compensatory (red) U1 snRNAs. Increasing amounts of total RNA 
extracts from either wild-type or compensatory U1 snRNA HEK293 transfectants were added 
to the primer extension reactions. Samples were analysed on gel (upper right panel). 
C: U1 snRNA compensatory mutant expression was determined by quantification of band 
intensities from primer extension assay and it reaches up to 15% of endogenous wild type 
U1 snRNA expression  
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Since the number of transfected cells under our transfecting conditions ranges 
from 20-40% and the level of compensatory U1 snRNA mutant expression reaches 
15% of the wild type U1 snRNA levels (Figure 4.3 C), it can easily be estimated that 
the fraction of compensatory U1 snRNA mutant in cells that have actually been 
transfected could be as high as 50%. 
The confirmation of such a substantial level of mutant expression was 
indispensable to proceed with the experiments where mRNAs with editing site near 
the 5´ splice site and compensatory U1 snRNA mutants are brought together into the 
same biological system. This would enable them to interact intimately, because of 
their high level of complementarity, especially in comparison with the affinities they 
both exhibit for their respective “wild type” base-pairing interaction partners. 
4.1.1.4 Co-transfection experiments 
As already mentioned, the method of choice to investigate the base-pairing 
potential between 5´splice site of edited mRNAs and U1 snRNA was co-transfection. 
The cells were seeded out 12-24 hours at low density before the first round of 
transfection. When cells have reached 20-30% of confluency, they were first 
transfected with the increasing amounts of U1 snRNA-bearing constructs to allow for 
the assembly of U1 snRNPs containing mutant U1 snRNAs. 24 hours after this, the 
second round of transfection, the one with the R/G site reporter constructs carrying 
genes coding for RFP and GFP, was performed. On the following day, 24 hours after 
the second and final transfection round, the cells were harvested and processed for 
the FACS analysis. 
Cell line of choice for co-transfection was HEK293.  
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4.1.1.5 FACS analysis 
Offering the possibility of analysing large cell populations in relatively short 
amount of time, fluorescence-activated cell sorting (FACS) was employed to collect 
data for the statistically significant number of cells exhibiting red and green 
fluorescence. Intensities of red and green fluorescence of around 30 000 cells 
transfected first with U1 snRNA constructs and then with R/G site reporter constructs 
were analysed in this manner 24 hours after the second transfection round. 
in Figure 4.4, the representative 2D dot plots of different reporter constructs 
are depicted. The gate chosen for further analysis encompasses cells which exhibit 
medium red fluorescence (y-axis: FL2-H). The green fluorescence (x-axis: FL1-H) 
can only be detected after productive splicing occured and its threshold was set to 
the arbitrary value of 10 for this particular gate. Empty reporter vector (RNLG) was 
used as a control for constitutive red and green fluorescence (uppermost panel). The 
wild type R/G constructs (second panel from top) are showing high green 
fluorescence intensities for the chosen cell population. In the cells transfected with 
the pre-edited R/G constructs (second panel from bottom), due to impaired splicing, a 
decrease in green fluorescence is observed (a shift of the cell population to the left 
along the x-axis): in order to “rescue” splicing of this particular construct (restore the 
original green fluorescence intensities seen in the wild type construct), a 
compensatory U1 snRNA mutant was being co-transfected. Cells with the uneditable 
construct (lowest panel) evade RNA editing and, thus, show higher green 
fluorescence signals (a shift back to the right along the x-axis). 
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Figure 4.4: FACS analysis of R/G site constructs 
2D plots of red (FL2-H; y-axis) versus green fluorescence (FL1-H; x-axis) are depicted for 
representative HEK293 transfections of control RNLG vector (containing RFP-GFP fusion 
protein) and wild type, pre-edited and uneditable R/G site constructs, with or without wild 
type or compensatory U1 snRNA constructs. Gated events chosen for further statistical 
analysis are shown in purple, the number indicating the percentage of total events falling into 
this subset. 
Results 
57 
 
The statistical analysis of the gated events was performed by first calculating 
ratios of green versus red fluorescence intensities for each individual cell. Afterwards, 
the mean value for every sample, i.e. every construct combination could be obtained, 
together with the values for the standard deviation. The statistical significance of the 
observed differences was determined through application of paired Student´s T-test 
with two-tailed equal distribution. 
In Figure 4.5, the behaviour of each R/G site construct in combination with 
either wild type or compensatory U1 snRNA is presented as a bar diagram of mean 
ratios of green versus red fluorescence signals as the indicator of splicing efficiency, 
with standard deviation values depicted as error bars in the gated window. 
As seen in panel A of Figure 4.5, a slight increase in splicing can be observed 
for the wild type R/G site construct when the compensatory U1 snRNA construct is 
pre-transfected (lane 7), compared to the wild type U1 snRNA overexpression (lane 
4). This effect can be attributed to the residual ADAR activity in the HEK293 cell line. 
In the case of the pre-edited R/G site construct (Figure 4.5, panel B), 
overexpression of compensatory U1 snRNA mutant leads to a 10% increase in green 
fluorescence (lane 7), indicating that the partial restoration of the wild type splicing 
efficiency occurs once the modified -2 position of the 5´splice site is counteracted by 
the mutation of its U1 snRNA base-pairing partner. 
The slight increase (less than 3%) in the splicing efficiency of the wild type R/G 
site construct upon compensatory U1 snRNA overexpression, when compared to the 
wild type U1 snRNA overexpression, could be attributed either to the effect that the 
U1 snRNA vector has on the system or to the residual ADAR activity in HEK293 
cells. In the latter case, ADAR would convert some adenosines at the -2 position 
(with respect to the 5´ splice site) of this construct into inosines, resulting in the 
decrease of the splicing efficiency. Upon compensatory U1 snRNA overexpression, 
however, a slight increase in splicing would be observed because the inosine at -2 
position is able to base-pair with the compensatory cytidine in U1 snRNA, leading 
back to more productive splicing.  To distinguish between these two scenarios, the 
uneditable R/G site construct that can not be bound and modified by ADAR was used 
(Figure 4.5, panel C). As expected, this construct with high splicing efficiency shows 
a decrease in green fluorescence intensity in combination with the compensatory U1 
snRNA (lane 7), when compared to the wild type U1 snRNA co-expression (lane 4) 
because of its editing-resistant “wild type” 5´ splice site sequence. 
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Figure 4.5: Influence of U1 snRNA overexpression on splicing of R/G site 
constructs 
Wild type (panel A), pre-edited (panel B) and uneditable (panel C) R/G site constructs were 
cotransfected with either empty vector (lanes 1) or increasing amounts of wild type (lanes 2-
4) and compensatory U1 snRNA constructs (lanes 5-7). Mean values of green versus red 
fluorescence intensities for each sample were plotted as bar diagrams. RNLG vector was 
used as control (lanes RNLG). 
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In Figure 4.6, the data from the previous figure are summarised by including 
only the samples where the highest amounts of U1 snRNA constructs were 
cotransfected: this data set is showing the strongest effect of U1 snRNA 
overexpression, especially in restoring the wild type splicing “phenotype” for the pre-
edited R/G site construct when compensatory U1 snRNA is introduced into the 
system (Figure 4.6, lane 6). Furthermore, the observed splicing restoration for the 
aforementioned construct pair (around 10 %) is in line with the values expected for 
such transfection rates (approximately 15 %). In any case, only a moderate effect on 
splicing restoration could be seen in wild type R/G construct (Figure 4.6, lane 3), 
while in the case of uneditable R/G construct no significant change was observed 
(Figure 4.6, lane 9). 
. 
Figure 4.6: Summary of FACS data for the cotransfections of U1 snRNA and 
R/G site constructs 
Bar diagram shows mean values of green versus red fluorescence intensities for R/G site 
constructs cotransfected with the highest amounts (2 μg) of U1 snRNA constructs. Values for 
standard deviation are shown as error bars. 
The statistical significance of the observed differences in the analysed FACS 
data was determined by using paired Student´s T-test with two-tailed equal 
distribution. This statistical application detects the differences for the given 
parameters in two samples, expresses them as p-values and indicates if they are 
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high enough to consider the samples dissimilar. In Table 4.1, for each type of R/G 
site construct the p-values were calculated comparing the values of green versus red 
fluorescence ratios for every single event (cell) in the two samples being tested. 
As expected, the lowest p-values, i.e. the highest difference is derived for the 
set of pre-edited R/G site constructs, with compensatory U1 snRNA cotransfectant 
showing most notable discrepancy compared to both empty and wild type U1 snRNA 
ones. The differences are lowest for the set of wild type R/G site cotransfectants, 
showing that the U1 snRNA mutants influence the splicing of this pre-mRNA the 
least. 
These data go in line with the previous results and serve as an additional 
confirmation for the role of compensatory U1 snRNA mutant in reconstituting to some 
extent the splicing efficiency of the pre-edited R/G site construct. 
Table 4.1: Student´s T-test analysis of observed differences in FACS data 
Three main rows labelled on the left side (wild type, pre-edited and uneditable) indicate the 
transfected R/G site construct. The co-transfected U1 snRNA constructs (empty, wild type 
and compensatory) are indicated in the first row and in the last column of the table in order to 
enter p-values calculated by comparing differences between the cell populations carrying the 
same R/G site construct, but different U1 snRNA vectors. If the p-value obtained through 
student´s T-test is lower than 0.05, two samples or populations are considered dissimilar. 
R/G site empty wild type compensatory U1 snRNA 
 
 
wild type 
/ / / empty 
0.584 / / wild type 
0.394294 0.216722 / compensatory 
 
 
pre-edited 
/ / / empty 
0.50352 / / wild type 
0.009289 0.003184 / compensatory 
 
 
uneditable 
/ / / empty 
0.019601 / / wild type 
0.687504 0.021714 / compensatory 
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4.1.2 Interaction of R/G site pre-mRNAs with hnRNPs 
Alternative splicing occurs through the usage of different splicing signals, like 
alternative splice sites or exonic and intronic splicing enhancers and silencers, and 
contributes massively to the synthesis of various protein isoforms from a unique 
transcript. 
In the case of R/G site in GluR-B pre-mRNA, proper alternative splicing 
decisions are stimulated indirectly only upon RNA editing, which first leads to the 
splicing reduction and transient intron 13 retention, followed by correct processing of 
downstream introns. The resulting region (UUAIGgugg with intron sequence in lower 
case) exhibits strong sequence homology to an hnRNP A1-binding splice silencer 
consensus (GGCAGGGUGG). Moreover, the introduction of guanosine-mimicking 
inosine into this sequence raises the affinity of another splice silencing regulator, G-
rich binding hnRNP H, for this region. Thus, we decided to analyse the differences in 
association of wild type and pre-edited R/G site pre-mRNAs with candidate hnRNPs.  
 
Figure 4.7: Schematic drawing of RT-PCR for R/G site construct pre-mRNAs 
RT-PCR products with expected amplicon sizes are depicted for unspliced and spliced 
versions of R/G site construct messages in panels A and B, respectively. 
HEK293 cells were transfected with the reporter constructs and immediately 
before harvesting UV-crosslinking was performed to stabilise the interaction between 
mRNAs and hnRNPs (Dreyfuss et al., 1984). Cell lysates were then applied to 
Protein A Sepharose beads with covalently coupled anti-hnRNP A1 or anti-hnRNP H 
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antibodies for co-immunoprecipitation. The co-immunoprecipitated RNAs were further 
investigated by RT-PCR, using exonic primers that allow for unambiguous distinction 
between spliced and unspliced products (Figure 4.7). 
 
 
Figure 4.8: Co-immunoprecipitation of R/G site pre-mRNAs with hnRNP H 
A: Western Blot for hnRNP H IP detection: hnRNP H was successfully immunoprecipitated 
(upper panel, lane 3); CBP 80, a known interaction partner of hnRNP H, was used as a 
positive control for the IP efficiency (lower panel, lane 3); total cell lysate was used as a 
positive control for WB (lanes 1); uncoupled beads were used as negative control (lanes 2). 
B: RT-PCR of co-immunoprecipitated RNAs: the more efficiently spliced wild type construct 
is found more strongly associated with hnRNP H than the pre-edited construct (spliced 
variants; compare lanes 8 of upper and lower panels); as positive controls, plasmid DNA 
(lane 2, indicating the size of unspliced product) and total cell lysate RNA (lane 4, indicating 
the size of the fully-spliced product) were used as PCR templates (upper panel); “-“lanes 
represent PCR samples without RT enzyme in the reverse transcription reaction; n.b., all 
samples are placed exactly under their corresponding IP fractions from part A of this figure. 
To our surprise, the association of the wild type R/G site construct with hnRNP 
H was stronger than the one of the pre-edited construct (Figure 4.8). In both cases, 
only the correctly spliced product could be found associated with hnRNP H.  Then, 
we went on to see if any major difference could be observed in the association of 
these pre-mRNAs with hnRNP A1 (Figure 4.9).  
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Figure 4.9: Co-immunoprecipitation of R/G site pre-mRNAs with different 
hnRNPs 
A: Western Blot for hnRNP IP detection: two different hnRNPs (hnRNP H, upper panel; 
hnRNP A1, lower panel) were successfully immunoprecipitated (lanes 5 and 6, respectively); 
total cell lysate was used as a positive control for WB (lane 1); antibody purity and cross-
reactivity was tested for both anti-hnRNP H and hnRNP A1 in lanes 2 and 3, respectively; 
uncoupled beads were used as negative control (lane 4). 
B: RT-PCR of co-immunoprecipitated RNAs: the more efficiently spliced wild type construct 
is found associated with both hnRNP A1 (predominantly unspliced version; upper panel, lane 
12) and hnRNP H (spliced variants; upper panel, lane14); for the pre-edited construct, no 
such association could be observed (lanes 12 and 14, lower panel); as positive controls, 
plasmid DNA (lane 2, indicating the size of unspliced product) and total cell lysate RNA (lane 
4, indicating the size of the fully-spliced product) were used as PCR templates (upper panel); 
“-“lanes represent PCR samples without RT enzyme in the reverse transcription reaction; all 
samples are placed exactly under their corresponding IP fractions from part A of this figure. 
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Contrary to our original hypothesis, we could not detect any enrichment of pre-
edited messages in hnRNP A1- or hnRNP H-coimmunoprecipitated fractions, when 
compared to the wild type RNAs. In fact, no interaction whatsoever of the 
aforementioned hnRNPs with the pre-edited mRNAwas observed (Figure 4.9 B, 
lower panel, lanes 12 and 14). Interesting feature of the experiment was that the 
unspliced wild type mRNA was enriched in hnRNP A1 fraction (Figure 4.9 B, upper 
panel, lane 12), while the spliced version was found preferentially associated with 
hnRNP H (Figure 4.9 B, upper panel, lane 14).  
Results 
65 
 
4.2 ADAR1-mediated export of miRNA precursors 
The existence of both 110 kDa constitutively expressed (ADAR1-c or 
ADAR1p110) and the 150 kDa interferon-inducible shuttling isoform (ADAR1-i or 
ADAR1p150) of ADAR1, synthesised by translation initiation at alternative 
methionine codons, lead to a proposal that the role of the latter is in hyperediting of 
viral RNAs. However, upon the emergence of RNA interference and the 
establishment of its intimate connection with RNA editing, especially the RNA editing 
of the primary miRNA transcripts, the question of association of ADAR1-i and miRNA 
precursors during the export process was soon raised. Moreover, full length version 
of ADAR1 binds siRNAs with an exceptionally strong affinity (Yang et al., 2005). 
The idea of ADAR1-i escorting miRNA precursors through the nuclear pores 
was further encouraged after the identification of Exportin5, a Crm-1 related 
karyopherin known to interact with dsRBD-containing proteins, as the main export 
receptor of miRNA precursors (Brownawell and Macara, 2002; Fritz et al., 2009; Lund 
et al., 2004). 
First two microRNAs reported as editing targets were miR-22  and miR-142. 
Editing of primary miR-22 transcripts occurs in many tissues at relatively low levels. 
This scarcity of detectable microRNA editing products, however, could also be 
attributed to their increased susceptibility to degradation (Luciano et al., 2004). 
Precursors of hematopoietic tissue-specific miR-142, on the other hand, lose their 
silencing potential upon RNA editing, judged by the decreased Drosha-DGCR8 
processivity on the inosine-containing primary miR-142 and by the upregulation of 
mature miR-142 levels in spleen and thymus of both ADAR1 and ADAR2 null mice. 
Additionally, highly edited primary miR-142 transcripts, in contrast to the unedited 
ones, were prone to in vitro cleavage by exclusively cytoplasmic ribonuclease, Tudor-
SN, specific for inosine-containing dsRNA and previously identified as a RISC 
component (Yang et al., 2006). The residual enigma, how the solely nuclear primary 
transcript reaches Tudor-SN in the cytoplasm, remained to be clarified. Another open 
question was whether RNA editing of miRNA precursors was restricted to primary 
transcripts only, or could pre-miRNAs also be directly affected by this 
posttranscriptional modification (O'Connell and Keegan, 2006). 
This is why I set out to unveil interaction between ADAR1 and established 
RNA editing targets among miRNA precursors in these two cellular compartments. 
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4.2.1 ADAR1p150 and miR-22 precursor interact in both nucleus 
and cytoplasm 
The obvious experimental approach to detect RNA-protein interactions, in this 
case the association of ADAR1 and miR-22 precursor, is co-immunoprecipitation. In 
our lab, various antibodies against ADAR1 were raised. For our IP experiments, 
antibodies labelled Sat 309 and Sat 1146 (both raised in rabbits) were coupled to 
Protein A Sepharose and applied on cell lysates in attempt to pull down ADAR1 
miRNA targets. While a peptide from the central region of the protein was used to 
raise Sat 309, enabling it to recognise both ADAR1p110 and ADAR1p150, N-terminal 
fusion protein containing the amino-terminus of the full-length ADAR1 served as an 
antigen in Sat 1146 production, thus allowing the detection of ADAR1p150 only. 
Nuclear and cytoplasmic fractions of confluent HeLa cells were prepared by 
homogenisation. Then, the fraction lysates were made and applied to PAS-coupled 
antibodies for immunoprecipitation. The precipitated proteins and RNAs were 
detected by Western Blot and RT-PCR, respectively.  
As seen in Figure 4.10 A, Sat 309 antibody is able to recognise and precipitate 
the corresponding versions of ADAR1. Judging by the RT-PCR experiments done on 
the immunoprecipitated material in Figure 4.10 B, either both or just one version of 
ADAR1 interact with miR-22 precursor, a previously identified editing target, in both 
cytoplasm and the nucleus. The control miRNA precursor, miR-21, on the other 
hand, could not be detected in the immunoprecipitated fractions by means of RT-
PCR, corroborating the assumption that the interaction of miRNA precursors with 
RNA editing enzyme does not occur randomly, but is limited to the actual editing 
targets among this class of small RNAs. To control for the separation of nuclei from 
the cytoplasm, RT-PCR of  fully processed (i.e. exclusively cytoplasmic) γ-tubulin B-
subunit transcript was employed (Figure 4.10 B, lower panel). 
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Figure 4.10: Co-immunoprecipitation of ADAR1p110 and miR-22 precursor 
A: Western Blot used for ADAR1  IP detection: nuclear predominance of short (p110) and 
cytoplasmic predominance of long (p150) ADAR1 can be clearly seen (see Cytoplasm and 
Nucleus Lysate lanes); total cell lysate was used as a control (Total); adequate 
immunoprecipitation conditions were met, as seen in Sat309 lanes; uncoupled beads were 
used as negative control (Mock); for Western Blot detection, Sat12 antibody which detects 
both ADAR1 versions was used. 
B: RT-PCR of co-immunoprecipitated RNAs: miR-22, but not miR-21 precursor can be co-
immunoprecipitated with ADAR1 from both cytoplasmic and nuclear lysate (“+” lanes Sat309 
for both cytoplasmic and nuclear fractions; “-“ lanes indicate negative controls for reverse 
transcription, samples where no enzyme was added to the RT reaction); γ-tubulin B-subunit 
mRNA RT-PCR served as a control of separation of nuclei from the cytoplasm (lower panel); 
* lanes correspond to the ones denoted in A 
Next, we wanted to see if both ADAR1 versions interact with miR-22 
precursors or if it is restricted to ADARp150. This is why we used ADAR1p150-
specific antibody Sat 1146 for the next round of co-immunoprecipitation experiments 
(Figure 4.11). 
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Figure 4.11: Co-immunoprecipitation of ADAR1p150 and miR-22 precursor 
A: Western Blot used for ADAR1  IP detection: total cell lysate was used as a control (Total); 
adequate immunoprecipitation conditions were met, as judged by Sat1146 lanes; uncoupled 
beads were used as a negative control (Mock); for Western Blot detection, Sat12 antibody 
which detects both ADAR1 versions was used. 
B: RT-PCR of co-immunoprecipitated RNAs: miR-22, but not miR-21 precursor can be co-
immunoprecipitated with ADAR1p150 from both cytoplasmic and nuclear lysate (“+” lanes 
Sat1146 for both cytoplasmic and nuclear fractions; “-“ lanes indicate negative controls for 
reverse transcription, samples where no enzyme was added to the RT reaction); γ-tubulin B-
subunit mRNA RT-PCR served as a control of separation of nuclei from the cytoplasm (lower 
panel); * lanes correspond to the ones denoted in A. 
Indeed, the RT-PCR signals obtained for the miR-22 precursor co-
immunoprecipitated with ADAR1p150 showed similar intensity to the ones derived 
from the material co-immunoprecipitated with both ADAR1 isoforms (Figure 4.11, 
panel B).  
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This is why we conclude that the fraction of co-IP-ed miR-22 precursor was 
comparable using either antibody (no enrichment when using Sat 309), indicating 
that the interaction is probably restricted to the full-length, shuttling ADAR1 isoform 
(ADAR1p150). 
The co-immunoprecipitation experiment clearly shows the specific association 
of ADAR1p150 with miR-22 precursor in both nucleus and the cytoplasm, supporting 
our original hypothesis according to which miRNA precursor editing targets serve as 
RNA bridges between dsRBD protein ADAR1p150 and Exportin5 during nuclear 
export. 
The next step to further corroborate this working model was to check for the 
differences in editing levels of different miR-22 precursors and mature form in lysates 
versus ADAR1p150 immunoprecipitates from nuclear and cytoplasmic fractions, 
expecting to find a gradual increase of inosine content towards the mature miRNA 
forms, in the cytoplasm. This approach, however, had to be abandoned because of 
the technical difficulties caused by contamination in RT-PCR. 
Similar experimental concept was planned for another pronounced editing 
target among miRNA precursors, namely miR-142, expressed mainly in 
hematopoietic tissues. Unfortunately, due to time restrictions this project was put on 
hold. 
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4.3 SINE RNA interacts with HYL1, key member of RNAi 
pathway in plants 
A collaboration with the lab of Jean-Marc Deragon at the University of 
Perpignan, France was initiated to investigate the role of tRNA-derived SINE RNAs in 
the RNAi pathway in plants.  
Transgenic A. thaliana lines overexpressing SB1 SINE RNA exhibit 
developmental defects similar to the ones seen in some RNAi mutants. In 
Arabidopsis, SB1 transcription is associated with delayed growth and flowering time, 
reduction of leaf and root size, etc. Several of these defects resemble those 
observed in hyl1 and drb4 mutants, which are impaired in the two dsRBPs required 
for miRNA and trans-acting small interfering RNA (tasiRNA) pathways, respectively, 
suggesting that SB1 could interact with RNA-binding proteins of the miRNA or 
tasiRNA pathways (Pouch-Pelissier et al., 2008).  
Moreover, SB1 RNA does not conserve the ancestral tRNA folding pattern, but 
instead adopts a structure consisting of three stem-loops with bulges and 
mismatches (Sun et al., 2007). This, in turn, raises the possibility of interaction with 
various dsRBPs (double-stranded RNA binding proteins) given that the recognition of 
dsRNA by dsRBPs generally does not involve sequence specificity and several 
structured RNAs forming stem-loops with bulges or mismatches were shown to bind 
efficiently to dsRBPs, many of which are involved directly in RNAi (Stefl et al., 2005). 
In Arabidopsis, these proteins include the four Dicer-like proteins (DCL1 to 4), the 
five dsRNA-binding proteins (HYL1 and DRB2 to 5) and the HUA Enhancer 1 (HEN1) 
protein (Hiraguri et al., 2005). 
Because the production of SINE RNA induces growth anomalies reminiscent 
of those in hyl1 and drb4 null mutants, we hypothesised that if SB1 RNA mimicked 
the structure of natural mi/tasiRNA substrates, it could interact with and titrate 
proteins involved in the biogenesis of these small RNAs So, in order to explain the 
observed similarity between SB1 expressing lines and RNAi mutants, the affinity of 
SB1 SINE RNA for HYL1 and DRB4 was tested. 
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4.3.1 SINE RNA interacts with a subset of double-stranded RNA 
binding proteins 
 HYL1 is part of the DCL1 complex and is involved in processing miRNA 
primary transcripts (pri-miRNAs) and short precursors (pre-miRNAs). In gel 
retardation experiments, SB1 SINE RNA, but not DNA or single-stranded RNA 
fragments of a similar size, associated with a recombinant GST-HYL1 fusion protein 
(Pouch-Pelissier et al., 2008). Although a perfect RNA duplex also could bind HYL1, 
this association was less efficient compared to SB1 RNA, suggesting that HYL1 
prefers dsRNA substrates containing bulges and/or distal loops. RNase V1 protection 
assay helped us define more precisely the SB1 RNA binding sites of HYL1 (Figure 
4.12): HYL1 binds mainly to the first and longest SB1 stem-loop, adopting a fold 
similar to pre-miRNAs. Indeed, the protected region includes an RNA duplex 
containing mismatches and extends into the single-stranded terminal loop region. A 
structurally similar, although weaker HYL1 binding site also is present on the second 
stem-loop of SB1 RNA. We also tested the capacity of DRB4, a dsRBP involved in 
the production of tasiRNAs (Mallory and Vaucheret, 2006) to bind SB1 RNA. In this 
case, the GST-DRB4 fusion protein did not bind significantly to SINE RNA in our in 
vitro assay, although it did efficiently bind to a perfect RNA duplex, which likely 
resembles the structure of tasiRNA templates. This result suggests that SINE RNAs 
interact with dsRBPs specifically adapted to bind imperfect double-stranded RNA 
rather than those that bind perfect RNA duplexes. 
Recently, dsRBDs from two Xenopus laevis proteins, xlADAR1 and xlRPBA, 
were shown to bind efficiently to short stem-loop RNA structures containing bulges 
and mismatches (Hallegger et al., 2006), consistent with the observation that ADARs 
can modify miRNA precursors in vivo (Kawahara et al., 2007a). Because of structure 
similarity, it is possible that many SINE RNAs interact with dsRBPs. We performed 
binding experiments with SB1 RNA and the second double-stranded RNA binding 
domain of xlADAR1 (called Dr2) and mapped the RNA binding sites (Figure 4.12). 
We observed that Dr2 bound SB1 RNA in the same region as HYL1, suggesting that 
SINE RNAs have the potential to interact with a subset of dsRBPs across eukaryotic 
species, including the ones involved in miRNA production. DRB4 had no impact on 
RNase V1 cleavage pattern, confirming its inability to bind SB1.  
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Figure 4.12 
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Figure 4.12: Protection from RNase V1 digestions of SB1 SINE RNA by two 
different dsRBPs 
Prior to RNase V1 digestion, in vitro transcript of SB1 was subjected to protection by 
increasing concentrations of expressed dsRBPs: Dr2 (the second dsRBD of Xenopus laevis 
ADAR1), HYL1, combination of Dr2 and HYL1, or DRB4. Regions protected by Dr2 and 
HYL1 are marked alongside short run gel (A), long run gel (B) and predicted folding pattern 
(C) by brown and green bars, respectively. Three independent experiments gave similar 
results as the one presented. Nucleotides marked with asterisks seem to adopt more 
prominent helical structure upon protein binding and, therefore, become more prone to 
RNase V1 cleavage. DRB4 is showing no effect on RNase V1 cleavage, confirming its low in 
vitro binding affinity to SB1 RNA. Dr2 and HYL1, in this case, bind to and protect similar 
regions of RNA. HYL1 is, however, showing stronger binding affinity than Dr2. (HL) 
represents a partially hydrolyzed RNA ladder. Denaturating RNase A and T1 digests give the 
position of pyrimidine and G residues respectively. The control lane shows untreated RNA 
samples and the (0) lane represent RNase V1 digestion without recombinant proteins added. 
A labeled 23-mer oligoribonucleotide was also loaded on the gel to help in band size 
determination. 
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4.3.2 HYL1 induces conformational changes upon binding to RNA 
The binding of HYL1 appears to increase the RNase V1 sensitivity of certain 
regions of the SB1 RNA (indicated by asterisks on Figure 4.12 A). The RNase V1 
activity is sensitive to RNA conformation and, although sensitivity does not always 
imply hydrogen bonding of the bases in a canonical double stranded helix, it does 
require a structured, helix-like conformation. As such, the increased RNase V1 
sensitivity following HYL1 binding suggests that HYL1 is able to force some single-
stranded RNA regions to adopt a more structured helix-like conformation, possibly by 
promoting non Watson-Crick base pairing. 
To test a chaperon-like activity for HYL1 and to explore its generality, we 
performed binding experiments using the SELEX clone 11Dr2(7), a short imperfect 
double-stranded RNA known to bind the Dr2 motif. Following RNase V1 digestion, 
we confirmed the binding of Dr2 to 11Dr2(7) (Figure 4.13). We observed that HYL1 is 
able to bind strongly to 11Dr2(7) and generate regions protected from RNase V1 
activity (represented by green lines on Figure 4.13 B) and regions with increased 
sensitivity to RNase V1 (represented by asterisks on Figure 4.13 A and B). Again 
DRB4 was unable to bind 11Dr2(7) and no synergetic effect was observed when 
HYL1 and Dr2 were used together. Similar results were observed when the SB2 
Arabidopsis SINE RNA was used as a substrate (see Figure 4.14). Our results 
suggest that, upon binding RNA, HYL1 has the general capacity to force single-
stranded regions to adopt a more organized, helix-like configuration. 
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Figure 4.13 
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Figure 4.13: Protection from RNase V1 digestion of SELEX clone 11Dr2(7) by 
different dsRBPs. 
Prior to RNase V1 digestion, in vitro transcript of SELEX clone 11Dr2(7) was subjected to 
protection by increasing concentrations of expressed dsRBPs: Dr2, HYL1, combination of 
Dr2 and HYL1, or DRB4. Regions protected by Dr2 and HYL1 are marked alongside short 
run gel (A), long run gel (B) and predicted folding pattern (C) by brown and green bars, 
respectively. Three independent experiments gave similar results as the one presented. 
Nucleotides marked with asterisks seem to adopt more prominent helical structure upon 
protein binding and, therefore, become more prone to RNase V1 cleavage. DRB4 is showing 
no effect on RNase V1 cleavage of given RNA, confirming its low binding affinity for 
imperfect RNA duplexes. (HL) represents a partially hydrolyzed RNA ladder. Denaturating 
RNase A and T1 digests give the position of pyrimidine and G residues respectively. The 
control lane shows untreated RNA samples and the (0) lane represent RNase V1 digestion 
without recombinant proteins added. A labeled 23-mer oligoribonucleotide was also loaded 
on the gel to help in band size determination. 
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Figure 4.14 
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Figure 4.14: Protection from RNase V1 digestion of SINE SB2 RNA by different 
dsRBPs 
Prior to RNase V1 digestion, in vitro transcript of SB2 was subjected to protection by 
increasing concentrations of following dsRBPs: Dr2, HYL1, combination of Dr2 and HYL1, or 
DRB4. Regions protected by HYL1 are marked alongside short run gel (A), long run gel (B) 
and predicted folding pattern (C) by green bars. Three independent experiments gave similar 
results as the one presented. Nucleotides marked with asterisks seem to adopt more 
prominent helical structure upon protein binding and, therefore, become more prone to 
RNase V1 cleavage. (HL) represents a partially hydrolyzed RNA ladder. Denaturating RNase 
A and T1 digests give the position of pyrimidine and G residues respectively. The control 
lane shows untreated RNA samples and the (0) lane represent RNase V1 digestion without 
recombinant proteins added. A labeled 23-mer oligoribonucleotide was also loaded on the 
gel to help in band size determination. The binding of HYL1 to SB2 is weaker compared to 
SB1 or 11Dr2(7). In this case, both Dr2 and DRB4 are showing no effect on RNase V1 
cleavage, suggesting their low in vitro binding affinity to SB2 RNA. 
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5 DISCUSSION 
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5.1 Compensatory U1 snRNA partially restores the splicing 
efficiency of pre-edited R/G site construct 
ADAR family of enzymes catalyses hydrolytic deamination of adenosines to 
inosines within double-stranded RNAs. In mRNAs, this reaction can take place in 
exons, introns or untranslated regions (UTRs), leading to codon exchange, splice site 
introduction or stop codon abolishment. 
A → I RNA editing in exons can result in codon exchange and subsequent 
amino acid substitution. Codon exchange as a direct consequence of RNA editing in 
mammals has first been reported for the AMPA receptor subunit GluR-B (Higuchi et 
al., 1993). Adenosine deamination occurs at multiple sites in this particular transcript: 
in exon 11 (Q/R site), in intron 11 (editing hotspots 1 and 2) and, ultimately,  in exon 
13,  just two nucleotides upstream of the intron 13 5´splice site (R/G site). Editing at 
the R/G site causes a reduction in intron 13 splicing efficiency (Schoft et al., 2007). It 
is postulated that this transient arrest is necessary to ensure that proper alternative 
splicing decisions for the downstream, mutually exclusive exons 14 and 15 are made: 
underediting at the R/G site, apparently, could lead to hasty activation of the branch 
point sites (BPSs) in introns 13, 14 and 15, resulting in either inclusion of both exon 
14 and 15, or in skipping them entirely. This, in turn, would have the emergence of 
premature stop codons  and synthesis of non-functional receptors as a consequence. 
A similar effect of underediting on alternative splicing was perceived for the 
mammalian serotonin 5-HT2C receptor (Maas et al., 2001) and for the number of 
edited mRNAs in Drosophila melanogaster (Agrawal and Stormo, 2005). On the 
other hand, there is evidence that RNA editing stimulates developmentally regulated 
alternative splicing events (Gallo et al., 2002). 
The explicit step in the complex pre-mRNA splicing network that is affected by 
RNA editing, however,  was not yet determined. At the R/G site, deamination occurs 
at a conserved -2 position (with respect to the 5´splice site). This adenosine is 
involved in the base-pairing interaction with U1 snRNA in one of the very first steps of 
the spliceosome assembly, which lead us to speculate that mRNA:U1snRNA 
interaction gets profoundly destabilised once inosine comes into play. This is why the 
imperfect 5´splice site hypothesis was tested by employing compensatory U1 snRNA 
mutants to investigate the influence of inosine in this critical position on U1 snRNA 
base-pairing potential. 
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On the other hand, the sequence surrounding the edited R/G site bears strong 
resemblance to the hnRNP A1-binding or to the G-rich hnRNP H-binding splice 
silencer consensus sequences. It, therefore, seems also plausible that RNA editing 
creates a binding site for one of the hnRNPs which mediate splicing repression, 
explaining the observed effect on splicing. In this light, the question of association of 
these two hnRNPs with target mRNA in different editing states was addressed. 
5.1.1 U1 snRNA interaction with 5´ splice site is disrupted upon 
RNA editing at R/G site 
In this work, we focused on identifying the macromolecular interaction within 
the RNA splicing machinery that gets impaired once the co-transcriptional adenosine-
to-inosine RNA editing occurs in close proximity to 5´ splice site, resulting in reduced 
splicing efficiency, just as in the case of the R/G site editing in exon 13 of the GluR-B 
pre-mRNA. 
Using the in vivo splicing assay established in our lab, we are able to show 
that the introduction of the compensatory mutation into U1 snRNA in the nucleotide 
position forming a base-pair with the editied nucleotide in the pre-mRNA could 
increase the splicing competence of the affected RNA to some extent. The lack of the 
full restoration of the wild type splicing efficiency in this experimental system could be 
attributed to either lower transfection rates for the U1 snRNA-bearing constructs or 
the less favourable incorporation of the mutated U1 snRNA into U1 snRNP compared 
to the wild type small nuclear RNA, or both. It is also plausible that yet another, thus 
far unidentified, step in pre-mRNA maturation is affected by RNA editing of the 5´ 
splice site adjacent sequence. In any case, other experimental approaches that 
included overexpression of exogenous small nuclear RNAs like U1 or U2 snRNA also 
resulted in expression levels similar to the ones reached in our experiments (Pan and 
Prives, 1988; Zhuang and Weiner, 1986; Zhuang and Weiner, 1989).  
The role of the base-pairing interaction between the 5´ end of U1 snRNA and 
the 5´ splice site in pre-mRNA is indispensable for the 5´ splice site recognition by 
the splicing machinery (Zhuang and Weiner, 1986). However, before the recognition 
step may take place, a complex network of protein-protein and protein-RNA 
interactions has to be formed, most notably within the U1 snRNP and its interaction 
partners (Kohtz et al., 1994). U1 snRNA itself adopts extensive secondary structure 
consisting of four stem-loops and two relatively short single-stranded regions (Krol et 
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al., 1990). The first single-stranded stretch is found at the 5´ end and is responsible 
for the interaction with the 5´ splice site, while the other one represents the Sm-
binding site between stem-loops 3 and 4, around which seven Sm proteins assemble 
(Urlaub et al., 2001). Other protein components of U1 snRNP, namely U1-70K and 
U1-A use their RNA-binding domains to interact with stem-loops 1 and 2 of U1 
snRNA, respectively (Oubridge et al., 1994; Patton and Pederson, 1988). In contrast, 
U1-C protein is not able to bind free U1 snRNA, but is only capable of achieving this 
interaction once it establishes protein-protein contacts with U1-70K (Nelissen et al., 
1994). 
Recently, the crystal structure of human U1 snRNP was solved at 5.5 Å 
resolution (Pomeranz Krummel et al., 2009). The structure of U1 snRNP implies an 
involvement of U1-C in stabilising interaction between the 5´ end of U1 snRNA and 
the 5´ splice site in pre-mRNA, judged by the data showing that the loop region and 
helix A of the U1-C zinc finger domain bind to the RNA duplex mimicking the base-
paired U1 snRNA::5´ splice site dsRNA. Moreover, U1-C is crucial for the formation 
of the early spliceosomal complex, as the double mutant of U1-C fails to promote it 
(Heinrichs et al., 1990; Will et al., 1996). The binding occurs in the minor groove of 
RNA duplex where C8 and A7 nucleotides of U1 snRNA base-pair with conserved 
GU dinucleotide of the 5´ splice site, being highly likely that the adjacent base-pairs, 
among them the one formed by -2 nucleotide of the 5´ splice site (R/G site) and 
nucleotide 10 of U1 snRNA, also play a role in this protein-dsRNA association. The 
authors suggest that the conserved residues in the loop and helix A region of U1-C 
could serve to probe the hydrogen bonding of the base pairs in the minor groove of 
RNA duplex and, subsequently, allowing U1-C binding only to a correctly paired 5´ 
splice site and U1 snRNA would promote the following step in the splicing network. 
These propositions would also go along the same lines with the results we 
obtained in our studies and could explain the observations we came across. In our 
case, the inosine/guanosine instead of adenosine at the -2 position of the 5´ splice 
site would not be able to form a stable base pair with the U10 of U1 snRNA. In 
addition, U1-C would sense the unfavourable thermodynamic conditions, evading 
binding and failing to promote the formation of the complex required for the next step 
in RNA splicing. This would result in the decrease of the splicing efficiency, observed 
by us as reduction in green fluorescence intensities of our construct. On the other 
hand, introduction of the compensatory mutation in U1 snRNA (C10 instead of U10) 
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and the incorporation of the mutant into U1 snRNP would allow for the formation of 
stable base pair with the inosine/guanosine at the -2 position of the 5´ splice site. U1-
C could form a strong association with RNA duplex in this scenario, promoting further 
steps in the spliceosome assembly. This effect was displayed as the partial 
restoration of the original splicing efficiency in our experiments. 
5.1.2 Role for hnRNPs in regulation of splicing through RNA editing 
Alternative splicing of pre-mRNAs is a widespread phenomenon that 
contributes considerably to proteome variety in higher organisms. In mammals, for 
example, majority of genes undergo this process, often on a tissue-specific level, 
through alternative exclusion or inclusion of either introns (intron retention) or exons 
(exon skipping) during mRNA processing (Wang et al., 2006). 
On the molecular level, splicing enhancer signatures in mRNAs are generally 
bound by the serine/arginine (SR) rich proteins , which then promote the recognition 
of adjacent splice sites (Wang et al., 2004b). Splice silencer sequences, on the other 
hand, are most commonly recognised by one of the members of the hnRNP protein 
family, including hnRNP I/PTB (polypyrimidine tract-binding protein), hnRNP A1 or 
hnRNP H (Chen et al., 1999; Grabowski, 2004). Each of these protein factors has its 
own subset of the mRNA sequence motifs it associates with preferentially. 
In the case of R/G site in GluR-B pre-mRNA, proper alternative splicing 
decisions are stimulated indirectly only upon RNA editing, which first leads to the 
splicing reduction and transient intron 13 retention, followed by correct processing of 
downstream introns (Schoft et al., 2007). The resulting region (UUAIGgugg with 
intron sequence in lower case) exhibits strong sequence homology to an hnRNP A1-
binding splice silencer consensus (GGCAGGGUGG). Moreover, the introduction of 
guanosine-mimicking inosine into this sequence raises the affinity of another splice 
silencing regulator, G-rich binding hnRNP H, for this region. 
Here, we tried to screen for the differences in pre-edited pre-mRNA binding to 
two hnRNPs involved in splicing silencing, in comparison to wild type pre-mRNA. 
Although we expected to see stronger association of the pre-edited message with the 
previously identified splicing silencers hnRNP H and hnRNP A1, this particular mRNA 
seemed to associate altogether more weakly or transiently than its wild type 
counterpart in our co-IP experiments, precluding us from reaching any conclusions 
on the role of hnRNPs in splicing regulation upon RNA editing. 
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5.2 ADAR1p150 remains associated with edited miRNA 
precursor in the cytoplasm 
The biogenesis of microRNAs through processing activities in both nucleus 
and the cytoplasm requires a reliable nuclear export pathway where pre-miRNAs, 60-
70 nucleotide long stem-loop products of nuclear Drosha-DGCR8 activity on primary 
miRNA transcripts (Han et al., 2006; Lee et al., 2003), are delivered to the 
cytoplasmic Dicer-TRBP complex for the final processing step in which functional 
mature miRNAs are synthesised, 21-23 nucleotides long single-stranded RNAs 
capable of silencing their respective messenger RNA targets within the RISC 
complex. The karyopherin identified as an export receptor for pre-miRNAs was 
Exportin-5 (Lund et al., 2004). This export receptor was shown to mediate RNA-
dependent export of a number of dsRBD proteins. Remarkably, dsRBDs of cargo 
proteins are in most cases indispensable for the interaction with Exportin-5. In 
addition, this interaction is thought to be mediated, or at least strengthened, through 
an RNA bridge (Fritz et al., 2009). 
ADAR1 as dsRBP and microRNA precursors have both been shown to interact 
with Exportin5. Since both nuclear primary microRNAs and cytoplasmic pre-
microRNAs were reported as editing targets, we were interested to see if 
ADAR1p150, being a shuttling protein, escorts these substrates to the cytoplasm. 
At the time when this study was concieved, validated editing substrates among 
miRNA precursors were miR-22 and miR-142, both on the primary transcript level.  
Nuclear pri-miR-142, though, was shown  to be sensitive to cytoplasmic Tudor-SN 
cleavage, further corroborating our co-export hypothesis (Luciano et al., 2004; Yang 
et al., 2006). 
In this study we present evidence that ADAR1p150 and miRNA-22 precursor 
associate in the nucleus and continue to interact in the cytoplasm. It provides a 
strong indication that this is not merely a short-lived complex, but a dynamic  
macromolecular assembly  capable of trafficking through the nuclear pores. Also, the 
absence of miR-22 precursor enrichment in fractions immunoprecipitated with 
antibody recognising both full-length and, predominantly nuclear, short ADAR1 
isoform suggest that this miR-22 precursor interaction is restricted to ADAR1p150, 
rationalising its expression and/or shuttling behaviour in non-infected tissues and 
cells. 
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miR-142 as the other RNA editing substrate in the class of miRNA precursors 
was surprisingly reported as ADAR1p110 and ADAR2 target, but not as ADAR1p150 
target in vitro. In this case, adenosine deamination of nuclear pri-miR-142 at eleven 
sites leads to conversion of stable A=U Watson-Crick base-pairs into more flexible I-
U wobble structures, causing profound alterations in the structure and stability  of this 
dsRNA. This change results in complete blockage of the Drosha cleavage step and 
reduction in mature miR-142 levels. Out of eleven modified adenosines in this pri-
miRNA, the sites identified as the ones leading to inhibition of Drosha-DGCR8 
cleavage were positions +4 and +5 (with respect to the mature miR-142-5p 
sequence), located near the actual Drosha cleavage site.  Additionally, this 
modification provokes an increased sensitivity to Tudor-SN-mediated degradation 
(Yang et al., 2006). However, this ribonuclease specific for hyper-edited dsRNAs is 
confined to cytoplasm (Scadden, 2005), again raising the issue of how exactly the 
edited pri-miR-142 gets out of the nucleus, since RanGTP-Exportin5-dependent pre-
miRNA export mechanism applies only to properly processed molecules. On the 
other hand, the observation that even miRNA precursors longer than properly 
processed ones (85 nt long miR-22 in this case) can get exported from Xenopus 
laevis nuclei, possibly through  an Exportin-5-independent pathway, is compatible 
with the results we obtained for the miR-22 precursor (Lund et al., 2004). 
The next question we wanted to address in this study, but due to time 
restrictions failed to, was the level of miRNA editing throughout the entire miRNA 
biogenesis pathway, from the RNA Pol-II-mediated transcription in the nucleus to the 
mature miRNA delivery to the RISC complex in the cytoplasmic P-bodies. Since we 
found ADAR1p150 associated with miR-22 precursor also in the cytoplasm, it would 
be rational to expect the increased editing levels in this cellular compartment, when 
compared to the nucleus. The experimental approach for this type of analysis would 
include immunoprecipitation of ADAR1-associated miRNAs and RT-PCR of miRNAs 
in different maturation stages, followed by cloning and sequencing. A to I changes 
would then be detected as Gs in the examined sequence. Indeed, in one study  a 
rising inosine content in two intermediates of miRNA formation was reported for a 
novel miRNA editing target, miR-151, in several mouse tissues. Editing at Dicer 
cleavage site-adjacent positions -1 and, especially +3 (with respect to the mature 
miR-151-3p sequence) has proven to act repressive on the Dicer-TRBP processing 
of pre-miR-151, leading to detection of exclusively unedited mature miR-151 
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(Kawahara et al., 2007a). On the structural level, the plausible explanation for this 
inhibition would be the terminal loop extension as the consequence of the stem 
instability caused by the presence of wobble I-U basepairs, precluding the accurate 
stem length recognition by Dicer. While editing at +3 position in pri-miR-151 
fluctuated between 30-70%, all the detectable pre-miR-151 species (100%) had 
inosine at this site. In vitro experiments have also shown that pre-miR-151 alone gets 
highly edited by either ADAR1p150 or ADAR1p110, but not ADAR2, consistent with 
our detection of cytoplasmic ADAR1p150::pre-miR-22 association. This miRNA 
modification is thought to have a regulatory role in controlling the number of active 
mature miRNAs through the maturation repression, just like in the case of miR-142. 
The most dramatic effect of miRNA editing was the redirection of mature miR-
376 to a completely different set of mRNA targets. Here, one highly edited site is 
situated exactly in the middle of the seed region, responsible for the first steps in 
recognition and hybridisation of mature miRNAs to their mRNA targets within the 
RISC complex (Kawahara et al., 2007b). 
All these new developments are in line with our preliminary data and 
encourage further effort in elucidating fate of ADAR1-associated miRNA precursors 
from the nucleus out to the cytoplasm. Unfortunately, all further efforts to get clean 
RT-PCR reactions without any genomic DNA contamination for the cDNA sequencing 
failed for what we believe to be two reasons. Firstly, working with human genes or 
transcripts enormously increases the contamination risk in such sensitive applications 
like RT-PCR. Secondly, microRNAs are intronless transcripts, thereby precluding any 
possibility for distinction between the amplification products derived from cDNA and 
the genomic DNA ones. Currently, we are discussing alternative experimental 
approaches to circumvent the abovementioned technical difficulties.   
    
Discussion 
87 
 
5.3 SINE RNAs bind only a particular subset of dsRBPs 
Previously, it has been observed that the transgenic A. thaliana lines that 
overexpress exogenous SINE RNAs, abundant highly structured retroelements 
consisting of three stem-loops with mismatches and bulges, exhibit phenotypic 
aberrations similar to hyl1 and drb4 mutants, deficient in proteins essential for RNAi 
in plants (Pouch-Pelissier et al., 2008). Thus, it is easy to imagine that SINE RNAs, 
bearing high structural similarity to microRNA intermediates, serve as modulators of 
RNA interference mechanism in plants. This is why we investigated in vitro 
interactions of SINE RNAs with different RNAi-related dsRBPs . We have tested if the 
affinity of dsRBD-containing proteins for this group of imperfect dsRNAs was 
compatible with their in vivo preferences and obtained the results presented below. 
5.3.1 SINE RNA can bind HYL1 but not DRB4 
In our in vitro experiments, HYL1 binds efficiently different imperfect double-
stranded RNA molecules, including SB1  and SB2 SINE RNAs, while DRB4 only 
binds perfect RNA duplexes. These results are fully compatible with the known 
natural substrates of these two proteins. In vivo, HYL1 is known to interact with pri- 
and pre-miRNAs, which are organized as stem-loops containing mismatches and 
bulges. On the other hand, DRB4 binds perfect linear RNA duplexes formed by the 
action of RDR6 on a single stranded primary transcript (Hiraguri et al., 2005). The 
fact that HYL1 does not play a major role in double-stranded RNA-induced 
posttranscriptional gene silencing (PTGS) (Vazquez et al., 2004) further suggests 
that, in vivo, HYL1 preferentially interacts with imperfect double-stranded pri- and 
pre-miRNAs and not perfect double-stranded PTGS precursors. Based on our RNase 
V1 mapping results, the basis of this selectivity could be the capacity of HYL1 to 
interact with single-stranded RNA regions. Indeed, the binding specificity of other 
eukaryotic dsRBPs, such as ADARs and Staufen, was shown to depend on their 
ability to interact with single-stranded RNA loops (Ramos et al., 2000; Stefl et al., 
2005). It is, therefore, easily concievable that RNA binding specificities of HYL1 are 
much different from DRB4, determining their different set of interaction partners in 
vivo. 
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5.3.2 Chaperoning-like activity of HYL1 
We also observed that upon binding RNA HYL1 has the general capacity to 
force single-stranded regions to adopt a more organized, helix-like configuration. In 
vivo, HYL1 mainly is involved in promoting processing steps from pri-miRNA to pre-
miRNA in association with DCL1, another dsRBP (Song et al., 2007; Wu et al., 
2007). HYL1 also influences the cleavage positioning of DCL1 on the pre-miRNA to 
generate the mature miRNA (Kurihara et al., 2006). Consequently, in the hyl1-2 null 
mutant, pri-miRNAs accumulate and misplaced cleavages of pre-miRNAs were 
observed in some cases. However, HYL1 is not fully necessary for plant miRNA 
processing by DCL1 because the hyl1-2 mutant retains some ability to accumulate 
wild type miRNAs, although the accumulation level is reduced. Also, this reduction is 
variable depending on the different miRNAs (Han et al., 2004; Vazquez et al., 2004). 
HYL1 may therefore promote, to variable extents, the processing activity of DCL1. 
Based on our observations, one way HYL1 could do this is by inducing a 
conformational change in the RNA structure, forcing key single stranded regions to 
adopt organized, helix-like, configurations, including non Watson-Crick base pairing. 
This could in turn be important for promoting the cleavage activity of DCL1 on pri-
miRNAs or for helping to precisely define the cleavage site on pre-miRNAs to 
generate mature products. It remains to be determined whether the chaperoning-like 
activity of HYL1 is important for miRNA production. 
5.3.3 Possible evolutionary consequence of the SINE RNA/dsRBP 
interaction 
Related structural domains can be found  in many SINE RNAs from mammals, 
fishes and plants, suggesting common selective constraints imposed at the SINE 
RNA structural level (Sun et al., 2007). Using a double-stranded RNA binding domain 
from Xenopus laevis ADAR1, it is demonstrated in this work that the plant SB1 RNA 
is capable of binding strongly divergent dsRBPs. Therefore, it is plausible that the 
common trend of structural evolution observed for tRNA-related SINE RNAs could 
result in similar constraints imposed by a subset of dsRBPs across eukaryote domain 
of life. This rigid RNA-protein recognition mode would then enforce SINE RNAs to 
keep intact their capacity to interact with some dsRBPs. This would in turn forge the 
SINE RNA structure and impose, as observed, a common evolutionary history for 
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most eukaryote tRNA-related SINEs. The reason why SINE RNA/dsRBP interaction 
would be under positive selective pressure is unclear, but precise and punctual 
expression of SINEs during a key development step or in a stress situation, could 
induce genetic and/or epigenetic variations and increase diversity and/or adaptability. 
It is interesting to note that SINE-specific expression in their natural host is highly 
regulated at the transcriptional and post-transcriptional levels by complex genetic and 
epigenetic processes (Pelissier et al., 2004; Schmid, 1998). SINEs are non-
autonomous in their mobility and need the activation of an autonomous LINE partner 
to retrotranspose. Therefore, based on our results, we suggest that the main purpose 
of limiting SINE-specific transcription is not to prevent its mobility (the control of 
LINEs is sufficient to achieve this) but to preserve cell homeostasis by preventing 
SINE RNA to interact with a large subset of dsRBPs. 
References 
90 
 
6 REFERENCES 
  
References 
91 
 
Agrawal, R. and Stormo, G.D. (2005) Editing efficiency of a Drosophila gene 
correlates with a distant splice site selection. Rna, 11, 563-566. 
Alfonzo, J.D., Thiemann, O. and Simpson, L. (1997) The mechanism of U 
insertion/deletion RNA editing in kinetoplastid mitochondria. Nucleic Acids 
Res, 25, 3751-3759. 
Allen, T.A., Von Kaenel, S., Goodrich, J.A. and Kugel, J.F. (2004) The SINE-encoded 
mouse B2 RNA represses mRNA transcription in response to heat shock. Nat 
Struct Mol Biol, 11, 816-821. 
Arnaud, P., Yukawa, Y., Lavie, L., Pelissier, T., Sugiura, M. and Deragon, J.M. (2001) 
Analysis of the SINE S1 Pol III promoter from Brassica; impact of methylation 
and influence of external sequences. Plant J, 26, 295-305. 
Athanasiadis, A., Rich, A. and Maas, S. (2004) Widespread A-to-I RNA editing of Alu-
containing mRNAs in the human transcriptome. PLoS Biol, 2, e391. 
Bass, B.L. (1997) RNA editing and hypermutation by adenosine deamination. Trends 
Biochem Sci, 22, 157-162. 
Bass, B.L. (2002) RNA editing by adenosine deaminases that act on RNA. Annu Rev 
Biochem, 71, 817-846. 
Bass, B.L. and Weintraub, H. (1987) A developmentally regulated activity that 
unwinds RNA duplexes. Cell, 48, 607-613. 
Bass, B.L. and Weintraub, H. (1988) An unwinding activity that covalently modifies its 
double-stranded RNA substrate. Cell, 55, 1089-1098. 
Benne, R., Van den Burg, J., Brakenhoff, J.P., Sloof, P., Van Boom, J.H. and Tromp, 
M.C. (1986) Major transcript of the frameshifted coxII gene from trypanosome 
mitochondria contains four nucleotides that are not encoded in the DNA. Cell, 
46, 819-826. 
Berglund, J.A., Chua, K., Abovich, N., Reed, R. and Rosbash, M. (1997) The splicing 
factor BBP interacts specifically with the pre-mRNA branchpoint sequence 
UACUAAC. Cell, 89, 781-787. 
References 
92 
 
Bessonov, S., Anokhina, M., Will, C.L., Urlaub, H. and Luhrmann, R. (2008) Isolation 
of an active step I spliceosome and composition of its RNP core. Nature, 452, 
846-850. 
Bjork, G.R., Ericson, J.U., Gustafsson, C.E., Hagervall, T.G., Jonsson, Y.H. and 
Wikstrom, P.M. (1987) Transfer RNA modification. Annu Rev Biochem, 56, 
263-287. 
Blow, M.J., Grocock, R.J., van Dongen, S., Enright, A.J., Dicks, E., Futreal, P.A., 
Wooster, R. and Stratton, M.R. (2006) RNA editing of human microRNAs. 
Genome Biol, 7, R27. 
Bransteitter, R., Pham, P., Scharff, M.D. and Goodman, M.F. (2003) Activation-
induced cytidine deaminase deaminates deoxycytidine on single-stranded 
DNA but requires the action of RNase. Proc Natl Acad Sci U S A, 100, 4102-
4107. 
Bratt, E. and Ohman, M. (2003) Coordination of editing and splicing of glutamate 
receptor pre-mRNA. Rna, 9, 309-318. 
Brown, B.A., 2nd, Lowenhaupt, K., Wilbert, C.M., Hanlon, E.B. and Rich, A. (2000) 
The zalpha domain of the editing enzyme dsRNA adenosine deaminase binds 
left-handed Z-RNA as well as Z-DNA. Proc Natl Acad Sci U S A, 97, 13532-
13536. 
Brownawell, A.M. and Macara, I.G. (2002) Exportin-5, a novel karyopherin, mediates 
nuclear export of double-stranded RNA binding proteins. J Cell Biol, 156, 53-
64. 
Burd, C.G. and Dreyfuss, G. (1994) RNA binding specificity of hnRNP A1: 
significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. 
Embo J, 13, 1197-1204. 
Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders-Bush, E. 
and Emeson, R.B. (1997) Regulation of serotonin-2C receptor G-protein 
coupling by RNA editing. Nature, 387, 303-308. 
References 
93 
 
Calado, A., Treichel, N., Muller, E.C., Otto, A. and Kutay, U. (2002) Exportin-5-
mediated nuclear export of eukaryotic elongation factor 1A and tRNA. Embo J, 
21, 6216-6224. 
Caputi, M. and Zahler, A.M. (2001) Determination of the RNA binding specificity of 
the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family. J 
Biol Chem, 276, 43850-43859. 
Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V. and Billeter, M.A. 
(1988) Biased hypermutation and other genetic changes in defective measles 
viruses in human brain infections. Cell, 55, 255-265. 
Chan, L. (1992) Apolipoprotein B, the major protein component of triglyceride-rich 
and low density lipoproteins. J Biol Chem, 267, 25621-25624. 
Chen, C.D., Kobayashi, R. and Helfman, D.M. (1999) Binding of hnRNP H to an 
exonic splicing silencer is involved in the regulation of alternative splicing of 
the rat beta-tropomyosin gene. Genes Dev, 13, 593-606. 
Chen, C.X., Cho, D.S., Wang, Q., Lai, F., Carter, K.C. and Nishikura, K. (2000) A 
third member of the RNA-specific adenosine deaminase gene family, ADAR3, 
contains both single- and double-stranded RNA binding domains. Rna, 6, 755-
767. 
Chen, S.H., Habib, G., Yang, C.Y., Gu, Z.W., Lee, B.R., Weng, S.A., Silberman, S.R., 
Cai, S.J., Deslypere, J.P., Rosseneu, M. and et al. (1987) Apolipoprotein B-48 
is the product of a messenger RNA with an organ-specific in-frame stop 
codon. Science, 238, 363-366. 
Chen, T., Brownawell, A.M. and Macara, I.G. (2004) Nucleocytoplasmic shuttling of 
JAZ, a new cargo protein for exportin-5. Mol Cell Biol, 24, 6608-6619. 
Curtin, S.J., Watson, J.M., Smith, N.A., Eamens, A.L., Blanchard, C.L. and 
Waterhouse, P.M. (2008) The roles of plant dsRNA-binding proteins in RNAi-
like pathways. FEBS Lett, 582, 2753-2760. 
References 
94 
 
David, C.J. and Manley, J.L. (2008) The search for alternative splicing regulators: 
new approaches offer a path to a splicing code. Genes Dev, 22, 279-285. 
Dawson, T.R., Sansam, C.L. and Emeson, R.B. (2004) Structure and sequence 
determinants required for the RNA editing of ADAR2 substrates. J Biol Chem, 
279, 4941-4951. 
Decatur, W.A. and Fournier, M.J. (2003) RNA-guided nucleotide modification of 
ribosomal and other RNAs. J Biol Chem, 278, 695-698. 
Del Gatto-Konczak, F., Olive, M., Gesnel, M.C. and Breathnach, R. (1999) hnRNP A1 
recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell 
Biol, 19, 251-260. 
Dewannieux, M., Esnault, C. and Heidmann, T. (2003) LINE-mediated 
retrotransposition of marked Alu sequences. Nat Genet, 35, 41-48. 
Donahue, J.P., Vetter, M.L., Mukhtar, N.A. and D'Aquila, R.T. (2008) The HIV-1 Vif 
PPLP motif is necessary for human APOBEC3G binding and degradation. 
Virology, 377, 49-53. 
Doria, M., Neri, F., Gallo, A., Farace, M.G. and Michienzi, A. (2009) Editing of HIV-1 
RNA by the double-stranded RNA deaminase ADAR1 stimulates viral 
infection. Nucleic Acids Res. 
Dreyfuss, G., Adam, S.A. and Choi, Y.D. (1984) Physical change in cytoplasmic 
messenger ribonucleoproteins in cells treated with inhibitors of mRNA 
transcription. Mol Cell Biol, 4, 415-423. 
Eckmann, C.R. and Jantsch, M.F. (1999) The RNA-editing enzyme ADAR1 is 
localized to the nascent ribonucleoprotein matrix on Xenopus lampbrush 
chromosomes but specifically associates with an atypical loop. J Cell Biol, 
144, 603-615. 
Espinoza, C.A., Allen, T.A., Hieb, A.R., Kugel, J.F. and Goodrich, J.A. (2004) B2 
RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat 
Struct Mol Biol, 11, 822-829. 
References 
95 
 
Estevez, A.M. and Simpson, L. (1999) Uridine insertion/deletion RNA editing in 
trypanosome mitochondria--a review. Gene, 240, 247-260. 
Fairbrother, W.G. and Chasin, L.A. (2000) Human genomic sequences that inhibit 
splicing. Mol Cell Biol, 20, 6816-6825. 
Feagin, J.E., Abraham, J.M. and Stuart, K. (1988) Extensive editing of the 
cytochrome c oxidase III transcript in Trypanosoma brucei. Cell, 53, 413-422. 
Flomen, R., Knight, J., Sham, P., Kerwin, R. and Makoff, A. (2004) Evidence that 
RNA editing modulates splice site selection in the 5-HT2C receptor gene. 
Nucleic Acids Res, 32, 2113-2122. 
Fritz, J., Strehblow, A., Taschner, A., Schopoff, S., Pasierbek, P. and Jantsch, M.F. 
(2009) RNA-regulated interaction of transportin-1 and exportin-5 with the 
double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of 
ADAR1. Mol Cell Biol, 29, 1487-1497. 
Gallo, A., Keegan, L.P., Ring, G.M. and O'Connell, M.A. (2003) An ADAR that edits 
transcripts encoding ion channel subunits functions as a dimer. Embo J, 22, 
3421-3430. 
Gallo, A., Thomson, E., Brindle, J., O'Connell, M.A. and Keegan, L.P. (2002) Micro-
processing events in mRNAs identified by DHPLC analysis. Nucleic Acids 
Res, 30, 3945-3953. 
George, C.X. and Samuel, C.E. (1999) Human RNA-specific adenosine deaminase 
ADAR1 transcripts possess alternative exon 1 structures that initiate from 
different promoters, one constitutively active and the other interferon inducible. 
Proc Natl Acad Sci U S A, 96, 4621-4626. 
Gerber, A., Grosjean, H., Melcher, T. and Keller, W. (1998) Tad1p, a yeast tRNA-
specific adenosine deaminase, is related to the mammalian pre-mRNA editing 
enzymes ADAR1 and ADAR2. Embo J, 17, 4780-4789. 
Gerber, A.P. and Keller, W. (1999) An adenosine deaminase that generates inosine 
at the wobble position of tRNAs. Science, 286, 1146-1149. 
References 
96 
 
Gerber, A.P. and Keller, W. (2001) RNA editing by base deamination: more enzymes, 
more targets, new mysteries. Trends Biochem Sci, 26, 376-384. 
Gott, J.M. and Emeson, R.B. (2000) Functions and mechanisms of RNA editing. 
Annu Rev Genet, 34, 499-531. 
Grabowski, P.J. (2004) A molecular code for splicing silencing: configurations of 
guanosine-rich motifs. Biochem Soc Trans, 32, 924-927. 
Graveley, B.R. (2000) Sorting out the complexity of SR protein functions. Rna, 6, 
1197-1211. 
Greger, I.H. and Esteban, J.A. (2007) AMPA receptor biogenesis and trafficking. Curr 
Opin Neurobiol, 17, 289-297. 
Greger, I.H., Khatri, L., Kong, X. and Ziff, E.B. (2003) AMPA receptor tetramerization 
is mediated by Q/R editing. Neuron, 40, 763-774. 
Greger, I.H., Khatri, L. and Ziff, E.B. (2002) RNA editing at arg607 controls AMPA 
receptor exit from the endoplasmic reticulum. Neuron, 34, 759-772. 
Grosjean, H., Auxilien, S., Constantinesco, F., Simon, C., Corda, Y., Becker, H.F., 
Foiret, D., Morin, A., Jin, Y.X., Fournier, M. and Fourrey, J.L. (1996) Enzymatic 
conversion of adenosine to inosine and to N1-methylinosine in transfer RNAs: 
a review. Biochimie, 78, 488-501. 
Gurevich, I., Tamir, H., Arango, V., Dwork, A.J., Mann, J.J. and Schmauss, C. (2002) 
Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of 
depressed suicide victims. Neuron, 34, 349-356. 
Guthrie, C. and Patterson, B. (1988) Spliceosomal snRNAs. Annu Rev Genet, 22, 
387-419. 
Gwizdek, C., Ossareh-Nazari, B., Brownawell, A.M., Doglio, A., Bertrand, E., Macara, 
I.G. and Dargemont, C. (2003) Exportin-5 mediates nuclear export of 
minihelix-containing RNAs. J Biol Chem, 278, 5505-5508. 
References 
97 
 
Gwizdek, C., Ossareh-Nazari, B., Brownawell, A.M., Evers, S., Macara, I.G. and 
Dargemont, C. (2004) Minihelix-containing RNAs mediate exportin-5-
dependent nuclear export of the double-stranded RNA-binding protein ILF3. J 
Biol Chem, 279, 884-891. 
Hallegger, M., Taschner, A. and Jantsch, M.F. (2006) RNA aptamers binding the 
double-stranded RNA-binding domain. Rna, 12, 1993-2004. 
Han, J., Lee, Y., Yeom, K.H., Nam, J.W., Heo, I., Rhee, J.K., Sohn, S.Y., Cho, Y., 
Zhang, B.T. and Kim, V.N. (2006) Molecular basis for the recognition of 
primary microRNAs by the Drosha-DGCR8 complex. Cell, 125, 887-901. 
Han, M.H., Goud, S., Song, L. and Fedoroff, N. (2004) The Arabidopsis double-
stranded RNA-binding protein HYL1 plays a role in microRNA-mediated gene 
regulation. Proc Natl Acad Sci U S A, 101, 1093-1098. 
Harris, R.S. and Liddament, M.T. (2004) Retroviral restriction by APOBEC proteins. 
Nat Rev Immunol, 4, 868-877. 
Hartner, J.C., Schmittwolf, C., Kispert, A., Muller, A.M., Higuchi, M. and Seeburg, 
P.H. (2004) Liver disintegration in the mouse embryo caused by deficiency in 
the RNA-editing enzyme ADAR1. J Biol Chem, 279, 4894-4902. 
Hartner, J.C., Walkley, C.R., Lu, J. and Orkin, S.H. (2009) ADAR1 is essential for the 
maintenance of hematopoiesis and suppression of interferon signaling. Nat 
Immunol, 10, 109-115. 
Hasler, J. and Strub, K. (2006) Alu elements as regulators of gene expression. 
Nucleic Acids Res, 34, 5491-5497. 
Heinrichs, V., Bach, M., Winkelmann, G. and Luhrmann, R. (1990) U1-specific 
protein C needed for efficient complex formation of U1 snRNP with a 5' splice 
site. Science, 247, 69-72. 
Herbert, A., Alfken, J., Kim, Y.G., Mian, I.S., Nishikura, K. and Rich, A. (1997) A Z-
DNA binding domain present in the human editing enzyme, double-stranded 
RNA adenosine deaminase. Proc Natl Acad Sci U S A, 94, 8421-8426. 
References 
98 
 
Herbert, A. and Rich, A. (2001) The role of binding domains for dsRNA and Z-DNA in 
the in vivo editing of minimal substrates by ADAR1. Proc Natl Acad Sci U S A, 
98, 12132-12137. 
Herz, J. and Willnow, T.E. (1995) Lipoprotein and receptor interactions in vivo. Curr 
Opin Lipidol, 6, 97-103. 
Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., 
Feldmeyer, D., Sprengel, R. and Seeburg, P.H. (2000) Point mutation in an 
AMPA receptor gene rescues lethality in mice deficient in the RNA-editing 
enzyme ADAR2. Nature, 406, 78-81. 
Higuchi, M., Single, F.N., Kohler, M., Sommer, B., Sprengel, R. and Seeburg, P.H. 
(1993) RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-
exon structure determines position and efficiency. Cell, 75, 1361-1370. 
Hiraguri, A., Itoh, R., Kondo, N., Nomura, Y., Aizawa, D., Murai, Y., Koiwa, H., Seki, 
M., Shinozaki, K. and Fukuhara, T. (2005) Specific interactions between Dicer-
like proteins and HYL1/DRB-family dsRNA-binding proteins in Arabidopsis 
thaliana. Plant Mol Biol, 57, 173-188. 
Hoopengardner, B., Bhalla, T., Staber, C. and Reenan, R. (2003) Nervous system 
targets of RNA editing identified by comparative genomics. Science, 301, 832-
836. 
Hough, R.F. and Bass, B.L. (1994) Purification of the Xenopus laevis double-
stranded RNA adenosine deaminase. J Biol Chem, 269, 9933-9939. 
Hough, R.F. and Bass, B.L. (1997) Analysis of Xenopus dsRNA adenosine 
deaminase cDNAs reveals similarities to DNA methyltransferases. Rna, 3, 
356-370. 
Hough, R.F., Lingam, A.T. and Bass, B.L. (1999) Caenorhabditis elegans mRNAs 
that encode a protein similar to ADARs derive from an operon containing six 
genes. Nucleic Acids Res, 27, 3424-3432. 
References 
99 
 
Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., 
Saxena, P.R. and Humphrey, P.P. (1994) International Union of 
Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). 
Pharmacol Rev, 46, 157-203. 
Kallman, A.M., Sahlin, M. and Ohman, M. (2003) ADAR2 A-->I editing: site selectivity 
and editing efficiency are separate events. Nucleic Acids Res, 31, 4874-4881. 
Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T.L., 
Blendy, J.A. and Nishikura, K. (2008) Dysregulated editing of serotonin 2C 
receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci, 
28, 12834-12844. 
Kawahara, Y., Ito, K., Sun, H., Aizawa, H., Kanazawa, I. and Kwak, S. (2004) 
Glutamate receptors: RNA editing and death of motor neurons. Nature, 427, 
801. 
Kawahara, Y., Zinshteyn, B., Chendrimada, T.P., Shiekhattar, R. and Nishikura, K. 
(2007a) RNA editing of the microRNA-151 precursor blocks cleavage by the 
Dicer-TRBP complex. EMBO Rep, 8, 763-769. 
Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A.G. and 
Nishikura, K. (2007b) Redirection of silencing targets by adenosine-to-inosine 
editing of miRNAs. Science, 315, 1137-1140. 
Keegan, L.P., Brindle, J., Gallo, A., Leroy, A., Reenan, R.A. and O'Connell, M.A. 
(2005) Tuning of RNA editing by ADAR is required in Drosophila. Embo J, 24, 
2183-2193. 
Keegan, L.P., Gallo, A. and O'Connell, M.A. (2001) The many roles of an RNA editor. 
Nat Rev Genet, 2, 869-878. 
Keegan, L.P., Gerber, A.P., Brindle, J., Leemans, R., Gallo, A., Keller, W. and 
O'Connell, M.A. (2000) The properties of a tRNA-specific adenosine 
deaminase from Drosophila melanogaster support an evolutionary link 
between pre-mRNA editing and tRNA modification. Mol Cell Biol, 20, 825-833. 
References 
100 
 
Keegan, L.P., Leroy, A., Sproul, D. and O'Connell, M.A. (2004) Adenosine 
deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol, 5, 
209. 
Kim, U., Garner, T.L., Sanford, T., Speicher, D., Murray, J.M. and Nishikura, K. 
(1994a) Purification and characterization of double-stranded RNA adenosine 
deaminase from bovine nuclear extracts. J Biol Chem, 269, 13480-13489. 
Kim, U., Wang, Y., Sanford, T., Zeng, Y. and Nishikura, K. (1994b) Molecular cloning 
of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme 
for nuclear RNA editing. Proc Natl Acad Sci U S A, 91, 11457-11461. 
Kohtz, J.D., Jamison, S.F., Will, C.L., Zuo, P., Luhrmann, R., Garcia-Blanco, M.A. 
and Manley, J.L. (1994) Protein-protein interactions and 5'-splice-site 
recognition in mammalian mRNA precursors. Nature, 368, 119-124. 
Konarska, M.M. and Sharp, P.A. (1987) Interactions between small nuclear 
ribonucleoprotein particles in formation of spliceosomes. Cell, 49, 763-774. 
Krol, A., Westhof, E., Bach, M., Luhrmann, R., Ebel, J.P. and Carbon, P. (1990) 
Solution structure of human U1 snRNA. Derivation of a possible three-
dimensional model. Nucleic Acids Res, 18, 3803-3811. 
Kurihara, Y., Takashi, Y. and Watanabe, Y. (2006) The interaction between DCL1 
and HYL1 is important for efficient and precise processing of pri-miRNA in 
plant microRNA biogenesis. Rna, 12, 206-212. 
Kwak, S. and Kawahara, Y. (2005) Deficient RNA editing of GluR2 and neuronal 
death in amyotropic lateral sclerosis. J Mol Med, 83, 110-120. 
Lai, F., Drakas, R. and Nishikura, K. (1995) Mutagenic analysis of double-stranded 
RNA adenosine deaminase, a candidate enzyme for RNA editing of 
glutamate-gated ion channel transcripts. J Biol Chem, 270, 17098-17105. 
Le Hir, H., Gatfield, D., Izaurralde, E. and Moore, M.J. (2001) The exon-exon junction 
complex provides a binding platform for factors involved in mRNA export and 
nonsense-mediated mRNA decay. Embo J, 20, 4987-4997. 
References 
101 
 
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., 
Kim, S. and Kim, V.N. (2003) The nuclear RNase III Drosha initiates 
microRNA processing. Nature, 425, 415-419. 
Lehmann, K.A. and Bass, B.L. (2000) Double-stranded RNA adenosine deaminases 
ADAR1 and ADAR2 have overlapping specificities. Biochemistry, 39, 12875-
12884. 
Lenoir, A., Lavie, L., Prieto, J.L., Goubely, C., Cote, J.C., Pelissier, T. and Deragon, 
J.M. (2001) The evolutionary origin and genomic organization of SINEs in 
Arabidopsis thaliana. Mol Biol Evol, 18, 2315-2322. 
Lev-Maor, G., Sorek, R., Levanon, E.Y., Paz, N., Eisenberg, E. and Ast, G. (2007) 
RNA-editing-mediated exon evolution. Genome Biol, 8, R29. 
Levanon, E.Y., Eisenberg, E., Yelin, R., Nemzer, S., Hallegger, M., Shemesh, R., 
Fligelman, Z.Y., Shoshan, A., Pollock, S.R., Sztybel, D., Olshansky, M., 
Rechavi, G. and Jantsch, M.F. (2004) Systematic identification of abundant A-
to-I editing sites in the human transcriptome. Nat Biotechnol, 22, 1001-1005. 
Levanon, E.Y., Hallegger, M., Kinar, Y., Shemesh, R., Djinovic-Carugo, K., Rechavi, 
G., Jantsch, M.F. and Eisenberg, E. (2005) Evolutionarily conserved human 
targets of adenosine to inosine RNA editing. Nucleic Acids Res, 33, 1162-
1168. 
Li, J.B., Levanon, E.Y., Yoon, J.K., Aach, J., Xie, B., Leproust, E., Zhang, K., Gao, Y. 
and Church, G.M. (2009) Genome-wide identification of human RNA editing 
sites by parallel DNA capturing and sequencing. Science, 324, 1210-1213. 
Liu, Y., George, C.X., Patterson, J.B. and Samuel, C.E. (1997) Functionally distinct 
double-stranded RNA-binding domains associated with alternative splice site 
variants of the interferon-inducible double-stranded RNA-specific adenosine 
deaminase. J Biol Chem, 272, 4419-4428. 
Liu, Y., Lei, M. and Samuel, C.E. (2000) Chimeric double-stranded RNA-specific 
adenosine deaminase ADAR1 proteins reveal functional selectivity of double-
References 
102 
 
stranded RNA-binding domains from ADAR1 and protein kinase PKR. Proc 
Natl Acad Sci U S A, 97, 12541-12546. 
Lomeli, H., Mosbacher, J., Melcher, T., Hoger, T., Geiger, J.R., Kuner, T., Monyer, 
H., Higuchi, M., Bach, A. and Seeburg, P.H. (1994) Control of kinetic 
properties of AMPA receptor channels by nuclear RNA editing. Science, 266, 
1709-1713. 
Lowman, H.B. and Draper, D.E. (1986) On the recognition of helical RNA by cobra 
venom V1 nuclease. J Biol Chem, 261, 5396-5403. 
Lu, C. and Fedoroff, N. (2000) A mutation in the Arabidopsis HYL1 gene encoding a 
dsRNA binding protein affects responses to abscisic acid, auxin, and 
cytokinin. Plant Cell, 12, 2351-2366. 
Luciano, D.J., Mirsky, H., Vendetti, N.J. and Maas, S. (2004) RNA editing of a miRNA 
precursor. Rna, 10, 1174-1177. 
Lund, E., Guttinger, S., Calado, A., Dahlberg, J.E. and Kutay, U. (2004) Nuclear 
export of microRNA precursors. Science, 303, 95-98. 
Ma, E., Gu, X.Q., Wu, X., Xu, T. and Haddad, G.G. (2001) Mutation in pre-mRNA 
adenosine deaminase markedly attenuates neuronal tolerance to O2 
deprivation in Drosophila melanogaster. J Clin Invest, 107, 685-693. 
Maas, S., Gerber, A.P. and Rich, A. (1999) Identification and characterization of a 
human tRNA-specific adenosine deaminase related to the ADAR family of pre-
mRNA editing enzymes. Proc Natl Acad Sci U S A, 96, 8895-8900. 
Maas, S., Kawahara, Y., Tamburro, K.M. and Nishikura, K. (2006) A-to-I RNA editing 
and human disease. RNA Biol, 3, 1-9. 
Maas, S., Kim, Y.G. and Rich, A. (2000) Sequence, genomic organization and 
functional expression of the murine tRNA-specific adenosine deaminase 
ADAT1. Gene, 243, 59-66. 
References 
103 
 
Maas, S., Patt, S., Schrey, M. and Rich, A. (2001) Underediting of glutamate receptor 
GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A, 98, 14687-
14692. 
Maas, S. and Rich, A. (2000) Changing genetic information through RNA editing. 
Bioessays, 22, 790-802. 
Macbeth, M.R., Schubert, H.L., Vandemark, A.P., Lingam, A.T., Hill, C.P. and Bass, 
B.L. (2005) Inositol hexakisphosphate is bound in the ADAR2 core and 
required for RNA editing. Science, 309, 1534-1539. 
Macchi, P., Brownawell, A.M., Grunewald, B., DesGroseillers, L., Macara, I.G. and 
Kiebler, M.A. (2004) The brain-specific double-stranded RNA-binding protein 
Staufen2: nucleolar accumulation and isoform-specific exportin-5-dependent 
export. J Biol Chem, 279, 31440-31444. 
Makarov, E.M., Makarova, O.V., Urlaub, H., Gentzel, M., Will, C.L., Wilm, M. and 
Luhrmann, R. (2002) Small nuclear ribonucleoprotein remodeling during 
catalytic activation of the spliceosome. Science, 298, 2205-2208. 
Mallory, A.C. and Vaucheret, H. (2006) Functions of microRNAs and related small 
RNAs in plants. Nat Genet, 38 Suppl, S31-36. 
Maniatis, T. and Reed, R. (1987) The role of small nuclear ribonucleoprotein particles 
in pre-mRNA splicing. Nature, 325, 673-678. 
Maslov, D.A. and Simpson, L. (1992) The polarity of editing within a multiple gRNA-
mediated domain is due to formation of anchors for upstream gRNAs by 
downstream editing. Cell, 70, 459-467. 
Matlin, A.J., Clark, F. and Smith, C.W. (2005) Understanding alternative splicing: 
towards a cellular code. Nat Rev Mol Cell Biol, 6, 386-398. 
Mehta, A., Kinter, M.T., Sherman, N.E. and Driscoll, D.M. (2000) Molecular cloning of 
apobec-1 complementation factor, a novel RNA-binding protein involved in the 
editing of apolipoprotein B mRNA. Mol Cell Biol, 20, 1846-1854. 
References 
104 
 
Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P.H. and Higuchi, M. (1996) 
A mammalian RNA editing enzyme. Nature, 379, 460-464. 
Mittaz, L., Antonarakis, S.E., Higuchi, M. and Scott, H.S. (1997) Localization of a 
novel human RNA-editing deaminase (hRED2 or ADARB2) to chromosome 
10p15. Hum Genet, 100, 398-400. 
Miyamura, Y., Suzuki, T., Kono, M., Inagaki, K., Ito, S., Suzuki, N. and Tomita, Y. 
(2003) Mutations of the RNA-specific adenosine deaminase gene (DSRAD) 
are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet, 73, 
693-699. 
Molineaux, S.M., Jessell, T.M., Axel, R. and Julius, D. (1989) 5-HT1c receptor is a 
prominent serotonin receptor subtype in the central nervous system. Proc Natl 
Acad Sci U S A, 86, 6793-6797. 
Morse, D.P., Aruscavage, P.J. and Bass, B.L. (2002) RNA hairpins in noncoding 
regions of human brain and Caenorhabditis elegans mRNA are edited by 
adenosine deaminases that act on RNA. Proc Natl Acad Sci U S A, 99, 7906-
7911. 
Mount, S.M. (1982) A catalogue of splice junction sequences. Nucleic Acids Res, 10, 
459-472. 
Murphy, J.T., Burgess, R.R., Dahlberg, J.E. and Lund, E. (1982) Transcription of a 
gene for human U1 small nuclear RNA. Cell, 29, 265-274. 
Nakazawa, Y., Hiraguri, A., Moriyama, H. and Fukuhara, T. (2007) The dsRNA-
binding protein DRB4 interacts with the Dicer-like protein DCL4 in vivo and 
functions in the trans-acting siRNA pathway. Plant Mol Biol, 63, 777-785. 
Nelissen, R.L., Will, C.L., van Venrooij, W.J. and Luhrmann, R. (1994) The 
association of the U1-specific 70K and C proteins with U1 snRNPs is mediated 
in part by common U snRNP proteins. Embo J, 13, 4113-4125. 
Nishikura, K. (2004) Editing the message from A to I. Nat Biotechnol, 22, 962-963. 
References 
105 
 
Nishikura, K. (2006) Editor meets silencer: crosstalk between RNA editing and RNA 
interference. Nat Rev Mol Cell Biol, 7, 919-931. 
Niswender, C.M., Sanders-Bush, E. and Emeson, R.B. (1998) Identification and 
characterization of RNA editing events within the 5-HT2C receptor. Ann N Y 
Acad Sci, 861, 38-48. 
O'Connell, M.A. and Keegan, L.P. (2006) Drosha versus ADAR: wrangling over pri-
miRNA. Nat Struct Mol Biol, 13, 3-4. 
O'Connell, M.A. and Keller, W. (1994) Purification and properties of double-stranded 
RNA-specific adenosine deaminase from calf thymus. Proc Natl Acad Sci U S 
A, 91, 10596-10600. 
Ohlson, J., Pedersen, J.S., Haussler, D. and Ohman, M. (2007) Editing modifies the 
GABA(A) receptor subunit alpha3. Rna, 13, 698-703. 
Ohman, M. (2007) A-to-I editing challenger or ally to the microRNA process. 
Biochimie, 89, 1171-1176. 
Ohshima, K. and Okada, N. (2005) SINEs and LINEs: symbionts of eukaryotic 
genomes with a common tail. Cytogenet Genome Res, 110, 475-490. 
Oubridge, C., Ito, N., Evans, P.R., Teo, C.H. and Nagai, K. (1994) Crystal structure at 
1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein 
complexed with an RNA hairpin. Nature, 372, 432-438. 
Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seiler, S. and Sharp, P.A. (1986) 
Splicing of messenger RNA precursors. Annu Rev Biochem, 55, 1119-1150. 
Pagani, F. and Baralle, F.E. (2004) Genomic variants in exons and introns: 
identifying the splicing spoilers. Nat Rev Genet, 5, 389-396. 
Palladino, M.J., Keegan, L.P., O'Connell, M.A. and Reenan, R.A. (2000a) dADAR, a 
Drosophila double-stranded RNA-specific adenosine deaminase is highly 
developmentally regulated and is itself a target for RNA editing. Rna, 6, 1004-
1018. 
References 
106 
 
Palladino, M.J., Keegan, L.P., O'Connell, M.A. and Reenan, R.A. (2000b) A-to-I pre-
mRNA editing in Drosophila is primarily involved in adult nervous system 
function and integrity. Cell, 102, 437-449. 
Pan, Z.Q. and Prives, C. (1988) Assembly of functional U1 and U2 human-amphibian 
hybrid snRNPs in Xenopus laevis oocytes. Science, 241, 1328-1331. 
Parker, R., Siliciano, P.G. and Guthrie, C. (1987) Recognition of the TACTAAC box 
during mRNA splicing in yeast involves base pairing to the U2-like snRNA. 
Cell, 49, 229-239. 
Patterson, J.B. and Samuel, C.E. (1995) Expression and regulation by interferon of a 
double-stranded-RNA-specific adenosine deaminase from human cells: 
evidence for two forms of the deaminase. Mol Cell Biol, 15, 5376-5388. 
Patton, D.E., Silva, T. and Bezanilla, F. (1997) RNA editing generates a diverse array 
of transcripts encoding squid Kv2 K+ channels with altered functional 
properties. Neuron, 19, 711-722. 
Patton, J.R. and Pederson, T. (1988) The Mr 70,000 protein of the U1 small nuclear 
ribonucleoprotein particle binds to the 5' stem-loop of U1 RNA and interacts 
with Sm domain proteins. Proc Natl Acad Sci U S A, 85, 747-751. 
Paul, M.S. and Bass, B.L. (1998) Inosine exists in mRNA at tissue-specific levels and 
is most abundant in brain mRNA. Embo J, 17, 1120-1127. 
Pelissier, T., Bousquet-Antonelli, C., Lavie, L. and Deragon, J.M. (2004) Synthesis 
and processing of tRNA-related SINE transcripts in Arabidopsis thaliana. 
Nucleic Acids Res, 32, 3957-3966. 
Pinol-Roma, S. and Dreyfuss, G. (1992) Shuttling of pre-mRNA binding proteins 
between nucleus and cytoplasm. Nature, 355, 730-732. 
Polson, A.G., Bass, B.L. and Casey, J.L. (1996) RNA editing of hepatitis delta virus 
antigenome by dsRNA-adenosine deaminase. Nature, 380, 454-456. 
Polson, A.G., Crain, P.F., Pomerantz, S.C., McCloskey, J.A. and Bass, B.L. (1991) 
The mechanism of adenosine to inosine conversion by the double-stranded 
References 
107 
 
RNA unwinding/modifying activity: a high-performance liquid chromatography-
mass spectrometry analysis. Biochemistry, 30, 11507-11514. 
Pomeranz Krummel, D.A., Oubridge, C., Leung, A.K., Li, J. and Nagai, K. (2009) 
Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution. 
Nature, 458, 475-480. 
Pouch-Pelissier, M.N., Pelissier, T., Elmayan, T., Vaucheret, H., Boko, D., Jantsch, 
M.F. and Deragon, J.M. (2008) SINE RNA induces severe developmental 
defects in Arabidopsis thaliana and interacts with HYL1 (DRB1), a key 
member of the DCL1 complex. PLoS Genet, 4, e1000096. 
Poulsen, H., Nilsson, J., Damgaard, C.K., Egebjerg, J. and Kjems, J. (2001) CRM1 
mediates the export of ADAR1 through a nuclear export signal within the Z-
DNA binding domain. Mol Cell Biol, 21, 7862-7871. 
Powell, L.M., Wallis, S.C., Pease, R.J., Edwards, Y.H., Knott, T.J. and Scott, J. 
(1987) A novel form of tissue-specific RNA processing produces 
apolipoprotein-B48 in intestine. Cell, 50, 831-840. 
Ramos, A., Grunert, S., Adams, J., Micklem, D.R., Proctor, M.R., Freund, S., Bycroft, 
M., St Johnston, D. and Varani, G. (2000) RNA recognition by a Staufen 
double-stranded RNA-binding domain. Embo J, 19, 997-1009. 
Rebagliati, M.R. and Melton, D.A. (1987) Antisense RNA injections in fertilized frog 
eggs reveal an RNA duplex unwinding activity. Cell, 48, 599-605. 
Riedmann, E.M., Schopoff, S., Hartner, J.C. and Jantsch, M.F. (2008) Specificity of 
ADAR-mediated RNA editing in newly identified targets. Rna, 14, 1110-1118. 
Rosbash, M. and Seraphin, B. (1991) Who's on first? The U1 snRNP-5' splice site 
interaction and splicing. Trends Biochem Sci, 16, 187-190. 
Rubin, C.M., Kimura, R.H. and Schmid, C.W. (2002) Selective stimulation of 
translational expression by Alu RNA. Nucleic Acids Res, 30, 3253-3261. 
Rueter, S.M., Dawson, T.R. and Emeson, R.B. (1999) Regulation of alternative 
splicing by RNA editing. Nature, 399, 75-80. 
References 
108 
 
Ryu, W.S., Bayer, M. and Taylor, J. (1992) Assembly of hepatitis delta virus particles. 
J Virol, 66, 2310-2315. 
Scadden, A.D. (2005) The RISC subunit Tudor-SN binds to hyper-edited double-
stranded RNA and promotes its cleavage. Nat Struct Mol Biol, 12, 489-496. 
Scadden, A.D. and Smith, C.W. (2001a) RNAi is antagonized by A-->I hyper-editing. 
EMBO Rep, 2, 1107-1111. 
Scadden, A.D. and Smith, C.W. (2001b) Specific cleavage of hyper-edited dsRNAs. 
Embo J, 20, 4243-4252. 
Schade, M., Turner, C.J., Kuhne, R., Schmieder, P., Lowenhaupt, K., Herbert, A., 
Rich, A. and Oschkinat, H. (1999) The solution structure of the Zalpha domain 
of the human RNA editing enzyme ADAR1 reveals a prepositioned binding 
surface for Z-DNA. Proc Natl Acad Sci U S A, 96, 12465-12470. 
Schmid, C.W. (1998) Does SINE evolution preclude Alu function? Nucleic Acids Res, 
26, 4541-4550. 
Schoft, V.K., Schopoff, S. and Jantsch, M.F. (2007) Regulation of glutamate receptor 
B pre-mRNA splicing by RNA editing. Nucleic Acids Res, 35, 3723-3732. 
Schwartz, T., Rould, M.A., Lowenhaupt, K., Herbert, A. and Rich, A. (1999) Crystal 
structure of the Zalpha domain of the human editing enzyme ADAR1 bound to 
left-handed Z-DNA. Science, 284, 1841-1845. 
Seeburg, P.H., Higuchi, M. and Sprengel, R. (1998) RNA editing of brain glutamate 
receptor channels: mechanism and physiology. Brain Res Brain Res Rev, 26, 
217-229. 
Sen, G.C. (2001) Viruses and interferons. Annu Rev Microbiol, 55, 255-281. 
Sharp, P.A. (1987) Splicing of messenger RNA precursors. Science, 235, 766-771. 
Sheehy, A.M., Gaddis, N.C., Choi, J.D. and Malim, M.H. (2002) Isolation of a human 
gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. 
Nature, 418, 646-650. 
References 
109 
 
Sheppard, R.D., Raine, C.S., Bornstein, M.B. and Udem, S.A. (1985) Measles virus 
matrix protein synthesized in a subacute sclerosing panencephalitis cell line. 
Science, 228, 1219-1221. 
Smith, C.W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: the logic of 
combinatorial control. Trends Biochem Sci, 25, 381-388. 
Sommer, B., Kohler, M., Sprengel, R. and Seeburg, P.H. (1991) RNA editing in brain 
controls a determinant of ion flow in glutamate-gated channels. Cell, 67, 11-
19. 
Song, L., Han, M.H., Lesicka, J. and Fedoroff, N. (2007) Arabidopsis primary 
microRNA processing proteins HYL1 and DCL1 define a nuclear body distinct 
from the Cajal body. Proc Natl Acad Sci U S A, 104, 5437-5442. 
Sprinzl, M., Horn, C., Brown, M., Ioudovitch, A. and Steinberg, S. (1998) Compilation 
of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res, 26, 
148-153. 
Stefl, R., Skrisovska, L. and Allain, F.H. (2005) RNA sequence- and shape-
dependent recognition by proteins in the ribonucleoprotein particle. EMBO 
Rep, 6, 33-38. 
Stefl, R., Xu, M., Skrisovska, L., Emeson, R.B. and Allain, F.H. (2006) Structure and 
specific RNA binding of ADAR2 double-stranded RNA binding motifs. 
Structure, 14, 345-355. 
Stephens, O.M., Yi-Brunozzi, H.Y. and Beal, P.A. (2000) Analysis of the RNA-editing 
reaction of ADAR2 with structural and fluorescent analogues of the GluR-B 
R/G editing site. Biochemistry, 39, 12243-12251. 
Strehblow, A., Hallegger, M. and Jantsch, M.F. (2002) Nucleocytoplasmic distribution 
of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-
binding domains, a leucine-rich export signal, and a putative dimerization 
domain. Mol Biol Cell, 13, 3822-3835. 
References 
110 
 
Sun, F.J., Fleurdepine, S., Bousquet-Antonelli, C., Caetano-Anolles, G. and Deragon, 
J.M. (2007) Common evolutionary trends for SINE RNA structures. Trends 
Genet, 23, 26-33. 
Tonkin, L.A. and Bass, B.L. (2003) Mutations in RNAi rescue aberrant chemotaxis of 
ADAR mutants. Science, 302, 1725. 
Tonkin, L.A., Saccomanno, L., Morse, D.P., Brodigan, T., Krause, M. and Bass, B.L. 
(2002) RNA editing by ADARs is important for normal behavior in 
Caenorhabditis elegans. Embo J, 21, 6025-6035. 
Urlaub, H., Raker, V.A., Kostka, S. and Luhrmann, R. (2001) Sm protein-Sm site 
RNA interactions within the inner ring of the spliceosomal snRNP core 
structure. Embo J, 20, 187-196. 
Vaucheret, H. (2005) MicroRNA-dependent trans-acting siRNA production. Sci 
STKE, 2005, pe43. 
Vazquez, F., Gasciolli, V., Crete, P. and Vaucheret, H. (2004) The nuclear dsRNA 
binding protein HYL1 is required for microRNA accumulation and plant 
development, but not posttranscriptional transgene silencing. Curr Biol, 14, 
346-351. 
Wagner, R.W., Smith, J.E., Cooperman, B.S. and Nishikura, K. (1989) A double-
stranded RNA unwinding activity introduces structural alterations by means of 
adenosine to inosine conversions in mammalian cells and Xenopus eggs. 
Proc Natl Acad Sci U S A, 86, 2647-2651. 
Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D.L., Weiss, M.J. and 
Nishikura, K. (2004a) Stress-induced apoptosis associated with null mutation 
of ADAR1 RNA editing deaminase gene. J Biol Chem, 279, 4952-4961. 
Wang, Q., O'Brien, P.J., Chen, C.X., Cho, D.S., Murray, J.M. and Nishikura, K. 
(2000) Altered G protein-coupling functions of RNA editing isoform and 
splicing variant serotonin2C receptors. J Neurochem, 74, 1290-1300. 
References 
111 
 
Wang, Z. and Burge, C.B. (2008) Splicing regulation: from a parts list of regulatory 
elements to an integrated splicing code. Rna, 14, 802-813. 
Wang, Z., Rolish, M.E., Yeo, G., Tung, V., Mawson, M. and Burge, C.B. (2004b) 
Systematic identification and analysis of exonic splicing silencers. Cell, 119, 
831-845. 
Wang, Z., Xiao, X., Van Nostrand, E. and Burge, C.B. (2006) General and specific 
functions of exonic splicing silencers in splicing control. Mol Cell, 23, 61-70. 
Will, C.L., Rumpler, S., Klein Gunnewiek, J., van Venrooij, W.J. and Luhrmann, R. 
(1996) In vitro reconstitution of mammalian U1 snRNPs active in splicing: the 
U1-C protein enhances the formation of early (E) spliceosomal complexes. 
Nucleic Acids Res, 24, 4614-4623. 
Wong, S.K., Sato, S. and Lazinski, D.W. (2001) Substrate recognition by ADAR1 and 
ADAR2. Rna, 7, 846-858. 
Wong, S.K., Sato, S. and Lazinski, D.W. (2003) Elevated activity of the large form of 
ADAR1 in vivo: Very efficient RNA editing occurs in the cytoplasm. Rna, 9, 
586-598. 
Wu, F., Yu, L., Cao, W., Mao, Y., Liu, Z. and He, Y. (2007) The N-terminal double-
stranded RNA binding domains of Arabidopsis HYPONASTIC LEAVES1 are 
sufficient for pre-microRNA processing. Plant Cell, 19, 914-925. 
Wu, S., Romfo, C.M., Nilsen, T.W. and Green, M.R. (1999) Functional recognition of 
the 3' splice site AG by the splicing factor U2AF35. Nature, 402, 832-835. 
Yang, W., Chendrimada, T.P., Wang, Q., Higuchi, M., Seeburg, P.H., Shiekhattar, R. 
and Nishikura, K. (2006) Modulation of microRNA processing and expression 
through RNA editing by ADAR deaminases. Nat Struct Mol Biol, 13, 13-21. 
Yang, W., Wang, Q., Howell, K.L., Lee, J.T., Cho, D.S., Murray, J.M. and Nishikura, 
K. (2005) ADAR1 RNA deaminase limits short interfering RNA efficacy in 
mammalian cells. J Biol Chem, 280, 3946-3953. 
References 
112 
 
Yi-Brunozzi, H.Y., Stephens, O.M. and Beal, P.A. (2001) Conformational changes 
that occur during an RNA-editing adenosine deamination reaction. J Biol 
Chem, 276, 37827-37833. 
Yi, R., Qin, Y., Macara, I.G. and Cullen, B.R. (2003) Exportin-5 mediates the nuclear 
export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17, 3011-3016. 
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B. and 
Bagni, C. (2003) The fragile X syndrome protein FMRP associates with BC1 
RNA and regulates the translation of specific mRNAs at synapses. Cell, 112, 
317-327. 
Zamore, P.D., Patton, J.G. and Green, M.R. (1992) Cloning and domain structure of 
the mammalian splicing factor U2AF. Nature, 355, 609-614. 
Zhang, Z. and Carmichael, G.G. (2001) The fate of dsRNA in the nucleus: a 
p54(nrb)-containing complex mediates the nuclear retention of promiscuously 
A-to-I edited RNAs. Cell, 106, 465-475. 
Zhuang, Y. and Weiner, A.M. (1986) A compensatory base change in U1 snRNA 
suppresses a 5' splice site mutation. Cell, 46, 827-835. 
Zhuang, Y. and Weiner, A.M. (1989) A compensatory base change in human U2 
snRNA can suppress a branch site mutation. Genes Dev, 3, 1545-1552. 
Zuker, M. (2003) Mfold web server for nucleic acid folding and hybridization 
prediction. Nucleic Acids Res, 31, 3406-3415. 
 
 
 113 
 
ACKNOWLEDGEMENTS 
 
This is to express my deepest gratitude to all people who contributed to this work in 
one way or another... 
 
My supervisor  Michael Jantsch is thanked for offering me the opportunity to explore 
many different aspects of RNA biology, guiding me on the way and paying all the 
bills... 
 
All the past and present colleagues and friends from MJ lab are forever remembered 
for making my stay there as pleasant as it was... 
 
Reviewers of this thesis are acknowledged for taking the trouble of reading through 
this versatile work and evaluating it... 
 
The members of the Department of Chromosome Biology have always been friendly, 
creating a nice working atmosphere... 
 
Friends in Sinj, Zagreb and Vienna are thanked for all the extracurricular activities 
and an occasional shoulder to cry on... 
 
Last but not least, I want to say a big thank you to my family for being there ever 
since the 23rd of July, 1980 (and 9 months before, obviously)... 
 
HVALA-THANK YOU-DANKESCHÖN 
 114 
 
CURRICULUM VITAE 
PERSONAL DATA 
 
Full name: Draško Boko 
Date of birth: 23.07.1980. 
Place of birth: Sinj, Croatia 
Citizenship: Croatian 
Present address: Gablenzgasse 33/27, A-1150, Vienna, Austria 
E-mail: drasko.boko@univie.ac.at 
EDUCATION 
 
School education: 
09/1986 – 06/1994: Primary school in Sinj, Croatia 
09/1994 – 06/1998: Secondary school Gimnazija Dinka Šimunovića Sinj, Croatia 
 
Higher education: 
10/1998 – 07/2004: Undergraduate studies of molecular biology, Department of 
Biology, University of Zagreb, Croatia 
11/2003 – 07/2004: Diploma thesis research, Department of Biochemistry, 
University of Zagreb, Croatia 
Title of thesis: Amber suppression in bacterium 
Escherichia coli using archaeal orthologous seryl-tRNA 
synthetase/suppresor tRNA pair 
Supervisor: Prof. Dr. Ivana Weygand-Đurašević 
  
 115 
 
02/2005 – ongoing: Doctoral studies of molecular biology, University of Vienna, 
Austria 
Institution: Department of Chromosome Biology, Max F. 
Perutz Laboratories, University of Vienna 
Title: Role of RNA editing in RNA splicing and in nuclear 
export of microRNA precursors 
Supervisor: ao Univ-Prof. Dr. Michael Jantsch 
 
POSTERS/PRESENTATIONS: 
09/2004 – 10/2004: Conference of the Croatian Society of Molecular Biology and 
Biochemistry (HDBMB), Bjelolasica, Croatia 
Title of poster: Lesjak S, Boko D, Rokov-Plavec J, Weygand-
Đurašević I: Amber suppression in bacterium Escherichia 
coli using archaeal orthologous seryl-tRNA 
synthetase/suppressor tRNA pair. 
07/2008 – 08/2008: 13th Annual Meeting of the RNA Society, Berlin, Germany 
Title of poster: Boko D and Jantsch M: Regulation of splicing 
by RNA editing in protein-coding targets. 
 
PUBLICATIONS: 
Pouch-Pelissier, M.N., Pelissier, T., Elmayan, T., Vaucheret, H., Boko, D., 
Jantsch, M.F. and Deragon, J.M. (2008) SINE RNA induces severe 
developmental defects in Arabidopsis thaliana and interacts with HYL1 (DRB1), a 
key member of the DCL1 complex. PLoS Genet, 4, e1000096. 
Lesjak, S., Boko D. and Weygand-Đurašević I. (2009) Seryl-tRNA synthetases 
from methanogenic archaea: suppression of bacterial amber mutation and 
heterologous toxicity. (submitted). 
